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Abstract 
Medical robotics is increasingly demonstrating the potential to improve patient care through more 
precise interventions. However, taking inspiration from industrial robotics has often resulted in large, 
sometimes cumbersome designs, which represent high capital and per procedure expenditures, as well 
as increased procedure times. This thesis proposes and demonstrates an alternative model and method 
for developing economical, appropriately scaled medical robots that improve care and efficiency, while 
moderating costs. Key to this approach is a structured design process that actively reduces complexity. A 
selected medical procedure is decomposed into discrete tasks which are then separated into those that 
are conducted satisfactorily and those where the clinician encounters limitations, often where robots’ 
strengths would be complimentary. Then by following deterministic principles and with continual user 
participation, prototyping and testing, a system can be designed that integrates into and assists with 
current procedures, rather than requiring a completely new protocol. This model is expected to lay the 
groundwork for increasing the use of hands-on technology in interventional medicine. 
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1. Introduction 
The practice of interventional medicine is currently being improved by the introduction of robotics 
into the clinic.  In the media, this often gives rise to fanciful visions, ranging from nanobots coursing 
through the bloodstream and attacking pathogens to autonomous surgical interventions. However, in 
the quest to provide patients with better, faster and cheaper care, these visions are still well in the 
future. In reality, interventional medical practice is still predominantly manual, relying heavily on 
operator skill and dexterity, but where the clinician encounters limitations, opportunities for robotic 
assistance can be identified. 
Early medical robotic research drew inspiration from articulated industrial robots, often fitting them 
with end effectors customized for medical procedures. While significant progress has been made in 
developing robots to augment clinicians’ capabilities, most current robots still evidence high capital and 
operational costs, large size scales and complex mechanisms that are reminiscent of industrial robots, as 
well as necessitate significant operator training. However, as the state-of-the-art advances, it is 
becoming apparent that a structural loop anchored to the floor and typically able to achieve sub 
millimeter endpoint precision, is mismatched to a human “workpiece” having a density on the order of 
water and comprised of soft, moveable tissues. Moreover, with the costs of medical care in the US 
reaching unsustainable levels, as well as the demand for improved care in secondary and developing 
markets, it is imperative to consider the economics of technology in medicine. 
In the Innovator’s Dilemma [1], Christensen explains how the trajectory of steadily increasing 
technological sophistication, which chases the “high end” of the market, creates room for disruptive 
innovation, which seeks to serve the bottom of the market with simpler, reasonably satisfactory 
products at a much lower price point. Accordingly, this thesis proposes and demonstrates an alternate 
and model for medical robot development. The underlying philosophy is that of appropriate scale 
medical robotics. This asserts that the robots and tools used to conduct a procedure ought not to greatly 
exceed the physical size or characteristic dimensions of the procedures. Rather than revolutionizing 
clinicians’ practice with a multifunction robot, the aim is to target specific procedures and sub tasks that 
are identified as inefficient, i.e. repetitious or precision limiting, with tightly constrained solutions that 
work in partnership with clinicians and integrate into existing procedures’ workflows. The methodology 
presented in this thesis is proposed as a means to prototyping robotic “smart tools” that are appropriate 
in scale, cost and complexity and, potentially, represent disruptive technology. 
This thesis first provides an overview of the history of medical robotics, including those where their 
industrial heritage is evident to more recent developments of patient-mounted robotics. Special 
consideration is given to the da Vinci Surgical System, the most successful and advanced robot, 
particularly its cost and the challenge of demonstrating efficacy. With this background, the core design 
process is presented, the goal of which is to rapidly and efficiently place prototypes into clinicians’ 
hands. This method follows deterministic principles and was developed and demonstrated during two 
prototype projects: Robopsy, a system to assist in the performance of image-guided percutaneous 
biopsies, and the Minimally Invasive Tissue Extractor (MITE), a hand tool that morcellates, extracts and 
contains excised tissue during minimally invasive surgery.  The method was further optimized and 
formalized during four years teaching experience with the MIT Precision Machine Design course that 
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pairs student teams with local clinicians to conceive, prototype and test new devices in just 14 weeks. 
The best practices from the course, three case studies that epitomize this method and student and 
project outcomes are reported. 
1.1. Definitions 
Three terms require definition: efficient, precision and robot. Firstly, the Oxford English Dictionary 
provides a broad definition of efficient as “Productive of effects; effective; adequately operative” [2]. 
Colloquially, it refers to a maximization of results for a given, limited set of inputs. In the context of 
designing medical devices, a device is efficient if it improves patient care, reduces physician strain 
and/or decreases procedure time, without substantially increasing overall per-procedure costs. The 
importance of this is highlighted by quoting an editorial comment in a urological article  on the costs of 
robot assisted prostatectomies: “We must be aware of our responsibility to society and to our patients 
to deliver the best possible care at justifiable cost” [3]. 
Secondly, the engineering definition of precision comprises accuracy, repeatability and resolution 
[4]. Of primary concern in interventional procedures is the ability to address a target within the body 
while minimizing damage to surrounding tissues. In current practice, accuracy is often limited by the 
manual dexterity of the operator, who must manipulate tools within patients’ bodies, often through 
small openings ranging from a 19 gauge needle (0.912 mm) to a 12 mm trocar port, while closing the 
control loop visually.  
Thirdly, according to ISO 8373 [5] robots are “automatically controlled, reprogrammable, 
multipurpose manipulators that are programmable in three or more axes and may either be fixed in 
place or mobile for use in industrial automation applications.” Furthermore, robots used in welding, 
assembling, painting, and general handling tasks comprise more than 75% of the world’s stock of robots 
[6]. Broadening and adjusting this to the context of medical tools, the proposed definition is:  An 
electromechanical tool having one or more axes which are actuated semi-autonomously under the 
guidance of a physician to perform a task upon a patient. This rules out devices which are operated by a 
clinician but have no autonomy, such as a drill, as well as those with only monitoring capabilities, such as 
an EKG machine. The goal is to develop devices that incorporate decision making aids and/or mechanize 
multiple procedural steps. This encourages the division of tasks between the operator and the tool, 
rather than focusing on maximizing procedural automation. Physicians and patients already respond 
positively to robotic technology and as comfort levels rise, increased autonomy can be incorporated into 
medical robotics. Additionally, increasing the use of technology in medicine has the potential to serve as 
a “skills leveler” by enabling clinicians with variable levels of training to conduct procedures in a 
repeatable manner that follows “best practices.” 
A useful distinction is suggested in [7] between robots that serve as “CAD/CAM” systems and 
“Surgical Assistants.”  The former utilize medical imaging for pre-procedural planning and modeling 
purposes and then guide the clinician in procedure, with the aid of a registration step.  The latter are 
tools that provide clinicians with “superhuman” capabilities, by increasing dexterity and assisting in 
positioning tools. Such robots can reduce cognitive load and reduce staffing needs. Thirty-six medical 
robotics projects in development up until 2003 were reviewed, with 21 categorized as CAD/CAM and 15 
as Surgical Assistants.  The paper identified “small, reduced power robots” as offering ergonomic and 
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safety advantages, thus reinforcing the concept of appropriate scale medical robotics, as well as 
providing a good summary of typical challenges encountered during medical robot design, all of which 
are touched upon in this thesis and re reproduced here: 
 Placement and mounting of the robot in the confines of the operating environment while not 
hindering patient access. 
 Ensuring sterility through sheathing and disposable components. 
 Compatibility with imaging modalities, with magnetic resonance imaging (MRI) identified as 
particularly challenging. 
 Designing for safe operation. 
 Trading off between multi-purpose robots, which represent a high capital expense, and simpler 
more focused systems with modular elements.  
1.2. Economics in Medical Robotics Design 
Focusing on efficient design is important, particularly in the United States where healthcare is one of 
the largest industries. In 2009 total healthcare expenditures totaled $2.65 trillion, comprising 17.6% of 
the Gross Domestic Product, as reported by the Centers for Medicare & Medicaid Services (CMS). 
Annual spending growth is projected at 6.1% with a predicted rise to 19.3% by 2019 [8]. Additionally, the 
Agency for Healthcare Research and Quality (AHRQ) began a large-scale, ongoing Medical Expenditure 
Panel Survey in 1996 which tracks households, medical providers and employers with the primary goal 
of tracking health care use expenditures [9].  
 
Figure 1 – Cumulative growth rates of GDP and health care spending: United States, 1960-2007 and 
projected for 2008-2018 [10]. 
The key issue, pinpointed in a 2009 Social Security Advisory Board report entitled “The 
Unsustainable Cost of Health Care,” is that since 1960 healthcare expenditures have grown at a rate 
2.1% faster than the GDP, as shown in Figure 1 [10]. Additionally, out-of-pocket expenses are growing 
faster than the incomes of Medicare beneficiaries and 60% of those workers who receive employer 
health coverage. New technologies, including procedures, drugs and devices, are estimated to account 
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for 38% – 65% of that growth and the Board states: “Some technology may provide tremendous value 
while other forms are simply more expensive ways of producing similar outcomes.” Frequently cited are 
“high-tech” imaging procedures, such as computed tomography (CT) and MRI. Comparisons with other 
industrialized nations indicate that the US spends more for similar levels of care, attributable to higher 
prices and, possibly, technology and obesity [11]. In sum, continually increasing medical costs are 
becoming politically and financially untenable. 
Device companies are also recognizing that designing for production and operational cost efficiency 
will enable them to access secondary and developing markets, i.e. those outside Canada, the US, 
Western Europe and Japan. Many of the National Institutes of Health’s calls for proposals identify 
improving care and reducing costs as mutual goals. Cost minimization is of great concern in developing 
regions where improving overall patient care is more important than revolutionizing a single procedural 
subset, as a recent editorial in Pakistan exemplifies: “Robotic Surgery in Public Sector Hospitals: 
Irrational Use of Healthcare Resources” [12]. To date robotic surgery has not demonstrated cost 
competitiveness, so defining cost reduction as a design goal is a key feature of this method. 
While there is no strict definition of “low cost,” hospital and government purchasers typically 
categorize equipment as capital or non-capital. The former is comprised of durable items costing on the 
order of $5K or more, an estimate used by local hospitals, that require independent line items on the 
budget. The latter typically includes items consumed during procedures, such as ablation probes, 
endoscopic grippers, needles, syringes and dressings. Medical robots, such as the daVinci Surgical 
System, represent a (large) capital expense to a healthcare institution while each procedure also 
requires a set of consumables, such as sterile protective sheaths. Unlike disposables, capital 
expenditures can be planned, budgeted and amortized with general operations; therefore, in some 
hospitals they are not accounted for in per-procedure costs. 
Unfortunately, monetizing the benefits of robot aided surgery proves consistently challenging. The 
US healthcare system is based on a complex public and private reimbursement model and a description 
of it is beyond this document’s scope. Baseline rates which will be reimbursed to a hospital (or other 
care facility) and a physician (or his/her organization) for a specific procedure are set by the CMS [13] 
and are adjusted geographically. Private insurers or payees often reimburse at higher rates, which are 
negotiated with each healthcare chain, though these rates are not public. Unfortunately, a hospital’s 
billed rates and actual fees collected rarely agree. It is not possible to reliably determine the exact costs 
or revenues associated with a particular procedure. In most cases where a device (or consumable) is 
employed in a procedure, the cost of its use is borne by the facility. For example, during a biopsy 
procedure the drapes, needles, anesthetic, etc., consumed by the procedure are not billed separately. It 
is only after a device’s efficacy is well proven that it receive a Common Procedure Terminology (CPT) 
code and payees will reimburse its use directly; only at this point does it cease to be a cost for the 
healthcare provider. Therefore, any new device introduced into a procedure should either improve 
patient care and outcomes so substantially that it becomes the “gold standard,” irrespective of cost, or 
indirectly reduce hospital expenses, through the reduction of procedure time, hospital stays or 
complication rates.  
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2. Background on Medical Robotics 
Medical robotics has been an area of active research since the 1980’s. A 1991 IEEE paper [14] 
provides an overview of the early art as well as the varied fields in medicine where robots are 
applicable, including automation of repetitive laboratory work, rehabilitative and assistive technology, 
prosthetics and surgery in an assistive capability, i.e. tool positioning, and an active capability, i.e. for 
conducting transurethral resection of the prostate (TURP) and arthroplasty (joint repair). The foreword 
of the 2006 IEEE Special Issue on Medical Robotics [15] broadly defined the field to encompass surgical 
planning and execution tools, rehabilitation devices and assistive technology, targeted for the elderly 
and disabled. In the lead article [16], Taylor provides an overview of the state of the art based upon his 
17 years of research experience in the field. He states that “surgical robots and robotic systems may be 
thought of as “smart” surgical tools that enable human surgeons to treat individual patients with 
improved efficacy, greater safety, and less morbidity than would otherwise be possible.”  
This paper provides a chart, reproduced in Table 1, which summarizes the strengths and limitations 
of robots and humans.  When designing a new tool to be integrated into a procedure, this is an aid in 
apportioning tasks between the clinician and the tool. As detailed in the chart, humans are able to 
process complex information, develop creative solutions and operate with dexterity within a human 
range of motion (ROM) while robots respond well to numerical data, provide operations requiring great 
strength or fine dexterity and operate within hostile environments. 
Table 1 – Strengths and limitations of robots and humans, adapted from [16], originally 
presented in [17]. 
 Strengths Limitations 
H
u
m
an
s 
Judgment 
Hand-eye coordination 
Dexterity & haptics (human-scale) 
Complex information integration 
Easily trained 
Able to improvise 
 
Fatigue & inattention 
Fine motion tremor 
Dexterity (non-human scale) 
Human vision 
Physical finger size 
Difficult to maintain sterility 
Radiation sensitivity 
R
o
b
o
ts
 
Geometric accuracy 
No fatigue or inattention 
Stable 
Radiation insensitive 
Fine/coarse capability 
Integration of numerical & sensor data 
Non-autonomous judgment 
Low adaptability 
Dexterity 
Hand-eye (or imaging) coordination 
Haptics (not yet perfected) 
Complex information synthesis 
 
 
2.1. Early Robots 
The first commonly accepted use of a robot in medicine took place in 1985 when a 6 degree of 
freedom (DOF) Unimation PUMA 200 (Programmable Universal Machine for Assembly), an off-the-shelf 
industrial robot, was used with CT guidance to position a needle guide through which a brain biopsy was 
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conducted. Proposed as a replacement for stereotactic frames, the robot’s relative accuracy was 
specified as 0.05 mm [18]. As further literature review indicates, the lowest barrier to entry from a 
safety (and liability) perspective exist for robots which position a tool guide, but do not actively 
manipulate it within the body. 
A PUMA-based solution was also tested for applicability to TURP procedures. These involve inserting 
a resectoscope (endoscope with an electrocautary ring) through the penis into the prostate and moving 
it so as to remove a conical section of tissue. Executing this motion is challenging and can lead to back 
and neck strain in surgeons. A PUMA was fitted with an endoscope and rotary cutting apparatus and 
inserted through an artificial penis into a prostate, simulated with a potato1. The surgeon then specified 
the desired conical trajectory which was semi-autonomously executed. Robot execution reduced the 
cutting task time from 1 hr to approximately 5 min. However, the unconstrained industrial robot was 
deemed too unsafe; therefore a “safety frame” was developed, shown in Figure 3. This comprised a 
clamp for the resectoscope attached to an arc that, in turn, was attached to a ring; together the arc and 
ring confined the scope to adjustable, conical volumes.  In a 30 patient clinical study outcomes were 
similar to that of the traditional procedure. [19] 
 
Figure 2 – Safety frame used 
with PUMA robot setup [19]. 
 
 
 
 Figure 3 – PROBOT testing and operation [20]. 
Shortcomings of the PUMA-based system inspired the addition of motors to the frame and the 
resulting limited DOF and ROM robot was called the PROBOT, shown in Figure 3. Driving the 
resectoscope holder along the arc, rotating the ring and extending the cutter enables a cone shaped 
tissue profile to be removed. To operate: first the prostate’s position was measured with the scope, 
than an ultrasound probe was inserted to scan and create a 3D model which was used to design the 
“cutting cones” and, finally, the surgery was executed. The PROBOT was tested at Guy's Hospital, 
London, first only to position a transurethral ultrasound probe, then in a successful 10 patient validation 
trials where only a small amount of manual “tidy up” was needed. [20-22]  
                                                          
1
 Long term potato outcomes are not reported, though salt and vinegar may have been involved. 
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2.2. Orthopedic Robots 
Robots have successfully brought computer numeric control (CNC) machining to total joint 
replacement surgery, where an accurate fit and alignment of the joint is crucial to ensure its stability and 
reduce the incidence of revision surgery. The history of both the Robodoc and the Acrobot highlight the 
challenges in bringing a medical device concept from early prototype through to Food and Drug 
Administration (FDA) approval and clinical use.   Time frames often exceed 10 years, with projects 
passing through multiple financings and corporate hands. However, both systems are currently enabling 
significantly more precise implantations. 
2.2.1. Robodoc 
The Robodoc is reputedly the first surgical robot to complete 
a task autonomously. Development was begun in the late 1980’s 
in Sacramento, CA by an orthopedic surgeon and a veterinarian, 
with the goal of precisely milling cavities for femoral stems during 
total hip arthroplasty, as an alternative to manual broaches. Bone 
cement breakdown was proving to be a long-term implant failure 
mode and the newer cement-less porous implants required a 
close press fit to promote bone ingrowth. The system is 
comprised of two parts: the Orthodoc orthopedic presurgical 
planner console and the Robodoc, which consists of a mobile 
base, a 5-axis SCARA (Selective Compliance Assembly Robot Arm), 
a 6-axis load cell (for monitoring cutting force) and a rotary 
cutting head. To use the system, three bone screws are placed as 
fiducials into the femur, which is then CT imaged.  A 3D model of 
the femur is generated on which the implant insertion is planned. 
The patient’s leg is secured in a frame, connected to the robot, 
and a ball probe touched to each screw to register the head. The 
probe is then replaced with a ball grinder and the pocket milled in 
the femur under CNC control.  
In a laboratory cadaveric bone study the desired geometry was achieved to within 0.5 mm, with 
minimal gaps when using the robot. Milled cavities were only 0.54% oversized as compared to 31.33% 
when hand broached. Hand broaching was found to be limited by manual dexterity and the tools tended 
to tear out chunks of bone as well as misalign during insertion. In contrast, burr grinders provide smooth 
cuts, but manually they can only be used for clearing tissue, rather than precise countering. This 
demonstrates how robotics can enable the use of new tools and techniques. [24] 
The first in vivo Robodoc trials were conducted on 26 pet canines with hip injuries. In 1992 a 10 
person, FDA approved IDE (Investigational Device Exemption) trial was conducted at Sutter General 
Hospital, Sacramento, CA.  In 1994, a multi-center, 300 patient PMA (Pre-Market Approval) study began, 
and a system was also installed at the Berufsgenossenschaftliche Unfallklinik, Frankfurt, Germany. 
Results from both trials (partial from the US study) are reported in [25]. The US study of 65 Robodoc and 
62 control patients showed improved fit. However, using the robot significantly increased surgical time; 
with 1 hour attributable to fixation, registration and milling.  Blood loss also increased due to longer 
 
Figure 4 – Robodoc [23]. 
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surgical time. The German study comprised 900 patients and focused on the human factors of 
implementing the robot and patient safety. In 30 revision surgeries the robot successfully removed 
cement and fibrous tissue. While the robot hardware performed adequately, in 32 cases CT, user and 
software errors required that the procedure be aborted and continued manually. Overall, the authors 
assert: “Robot assisted surgery can be performed without exposing the patient to uncertain risks. The 
fear of engineers that a rather powerful robot with a large workspace can endanger patients or 
personnel seems to be unfounded.” However, the authors also state that, while aiding in implant sizing 
and selection, “placing a dollar figure on effectiveness is very difficult, if not impossible.” The efficacy of 
the system was questioned by a study [26] of 143 hip replacements at the BG Trauma Hospital, 
Germany, which failed to show any clear advantages and also demonstrated technical issues. 
Commercialization of the Robodoc also followed a long path, summarized in [27-29].  Initially, in 
1986, the inventors partnered with IBM Research, U.C. Davis and the US division of Sankyo Seiki Mfg. Co. 
Ltd., Boca Raton, FL, which manufactures industrial robots. In 1990 Integrated Surgical Systems Inc., 
Fremont, CA was founded with IBM seed funding. CE (Conformité Européenne) approval was received in 
1996; sales began and in 1997 the company was floated on the NASDAQ. In the same year the Orthodoc 
received FDA 510(k) clearance, but not the Robodoc, for which the PMA required study was ongoing. In 
2002 this was converted to a lower threshold 510(k) filing, citing the da Vinci Surgical System as a 
predicate device. ISS ran out of capital in 2004 and suspended operations until 2006 when it was bought 
entirely by Curexo Inc., Seongnam, South Korea [30]. Clearance was received in 2008 [31] and the 
system is currently marketed by the Robodoc subsidiary of Curexo, Freemont, CA. 
2.2.2. Acrobot 
While the Robodoc operates autonomously, the Acrobot (Active Constraint Robot) is directly guided, 
hands-on by a surgeon. Designed at Imperial College, London as a replacement for the complex set of 
jigs and fixtures used to shape a patient’s femur, tibia and patella to receive total knee replacement 
implants, the system consists of a planning station and cutting head mounted to a micro-macro 
mechanism.  The system uses 3D CT scan data to model the knee, size the prosthesis and plan its 
placement.  Registration was initially accomplished by implanted fiducials, as was done with the 
Robodoc, but was later accomplished by probing the exposed bone at the beginning of the surgery to 
generate a point cloud. The orthopedic cutter is mounted to a 3DOF (yaw, pitch, extension) head that 
has a limited ROM and low force. Gross position of the head is accomplished by a robot arm, which locks 
in place for the cutting of each plane. The Acrobot is guided by the surgeon via a handle attached to the 
head through a 6-axis load cell. “Active constraint control” is applied whereby the robot is permitted to 
move freely within the defined cutting region, but as the cutting head approaches the boundaries 
resistance is applied. This guidance approach keeps the surgeon “in the control loop” and utilizes his 
“superior human senses and overall understanding of the situation to perform the surgery.” [32, 33] 
Initial trials were conducted in 2002 and in 2004 the system was validated in a randomized clinical 
study [34], published in the J. of Bone and Joint Surgery, where 13 of 28 unicompartmental knee 
arthroplasties (partial replacement) were performed with the Acrobot.  The results showed that angular 
alignment, measured with post procedure CT scanning, of the femoral and tibial components was 
achieved within 2° (the minimum reasonable measurable amount) for all Acrobot cases, as compared to 
only 40% of the traditional cases. The Acrobot Co. Ltd., London was spun off from Imperial by the 
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project’s lead investigators and the London Technology Fund co-lead B round funding in 2007 [35].  In 
2010, with a 4 hospital installed base, the Acrobot Co. was sold to Stanmore Implants Worldwide Ltd., 
which manufactures patient specific implants.   Ten years after the initial trials, this technology underlies 
the innovative, personalized “Savile Row” knee replacement system, which epitomizes the precision 
improvements which can be enabled by robotics. Pre-procedure CT scans are uploaded to Stanmore 
whereupon the implant is designed and approved using an online conference. Then during surgery the 
same model used to design the implant guides the Stanmore Sculptor (Robotic Guidance Arm) RGA and 
the surgeon. As of 2012, 20 cases had been successfully completed using this system. 
  
Figure 5 – Acrobot showing cutting head and robot 
arm [32, 33]. 
Figure 6 – Stanmore Sculptor RGA [36]. 
2.2.3. Zeus 
 A group of interventional surgical systems were created in the 1990s by Computer Motion, Inc., 
Santa Barbara, CA. The first system, the AESOP 1000 (Automated Endoscopic System for Optimal 
Positioning), was a foot pedal operated arm which held and positioned an endoscope.  This received 
FDA clearance in 1993 and later models added voice activation and greater DOF.  The master-slave, 
joystick driven Zeus Robotic Surgical System attached to an operating table, filtered the surgeon’s hand 
tremors and manipulated surgical instruments. Eventually, 28 laparoscopic surgical instruments were 
manipulated. The first human procedures were conducted in 1998: a tubal re-anastomosis and a 
coronary artery bypass graft. The Hermes system networked various elements of the operating room, 
including the surgical table, lighting and instruments, to place them all under voice control and link them 
to the robotic system. The Socrates system sought to extend these capabilities to enable tele-surgery.  
No evidence was found that these two systems were widely accepted. Computer motion was acquired 
by Intuitive Surgical in 2003 after a lengthy and costly patent infringement battle. [37-39] 
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2.2.4. Steady Hand 
The Steady Hand, developed in the late 
1990’s at John Hopkins University, Baltimore, 
MD, is another example of the surgeon-robot 
partnership, illustrated previously with the 
Acrobot. Its development spanned 
departments and made significant progress 
away from the industrial model of medical 
robotics. The Steady Hand increases the 
precision of ophthalmic surgery via 
“interactive cooperation” which enables 
micromanipulation. The system consists of a 
traditional XYZ Cartesian frame, a 2-angle DOF 
remote center of motion module (RCM) 
developed for percutaneous biopsies and discussed in Section 2.3.1, and an end piece/tool holder with 
axial rotation and insertion. The tool is connected to the arm via a load cell and grasped by the operator, 
this way the operator’s commanded forces are detected.  Microsugical tools, such as picks and forceps 
are instrumented with strain gauges to monitor the forces delivered to the tissue. A control algorithm 
filters out tremors, translates the operator’s forces into motions and applies safety limits. As with the 
Arcobot, this system has the advantages over a master-slave system of transparent tool manipulation; 
continuing development of such systems may facilitate the introduction of more robots into clinical 
practice. [40, 41] 
2.3. Probe Insertion Robots 
 A special subset of robots is devoted 
to the percutaneous probe insertion 
challenge. Typical percutaneous 
procedures include: needle biopsies for 
pathological analysis, fluid drainages, 
catheter placement, deep medication 
injection and thermal or cryo ablation of 
tumors. In all these cases, the practitioner 
must first locate a desired insertion point 
on the patient’s skin, orient a tool about a 
compound angle in Cartesian space and insert it at this point, as shown in Figure 8. While some 
procedures can be conducted by feel, such as spinal taps, many require the assistance of X-ray, C-arm 
fluoroscopy or CT image guidance, which can provide coordinate positional data. When using 
fluoroscopy, the clinician wears a lead vest and uses graspers to reach into the beam and manipulate 
the probe under real-time guidance. With X-ray and CT guidance, the clinician takes limited 
measurements from the imaging display and uses these to manually place the probe. This often results 
in a procedure that is iterative and time consuming. The probe is gradually introduced to the target 
angular and depth adjustment alternating with imaging. This differs from laparoscopic procedures 
 
Figure 7 – JHU Steady Hand, [40]. 
 
Figure 8 – Insertion of probe into a target location in 
patient’s chest also showing anatomical planes. 
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where probes are inserted then moved relatively freely under direct visual guidance with a laparoscope. 
There are clear opportunities to improve percutaneous probe insertion procedures by developing robots 
that harness coordinate image data in guiding the instrument more directly to its target location. 
2.3.1. PAKY-RCM 
The URobotics (Urology Robotics)  program at Johns Hopkins University, Baltimore, MD, has worked 
on the minimally invasive percutaneous needle insertion challenge and one notable system, summarized 
in a 1998 paper [42], consists of the percutaneous access of the kidney (PAKY) needle driver coupled 
with a remote center of motion mechanism (RCM). The PAKY comprises a pair of radiolucent acrylic 
rollers that grip and drive a needle. The motor, with its x-ray-distorting metallic elements, is offset so as 
to lie outside the imaging range of interest. The driver is coupled to the compact RCM module, which 
tilts it in two directions about the center of rotation. A laser shines from the device and a needle is 
inserted until its tip just contacts the beam; this is the remote center of rotation. Subsequently, this is 
positioned in contact with the desired insertion point via a 7 DOF, multi-joint, passive arm attached to 
the imaging table. Then the clinician uses a joystick to orient and advance the needle about 3 DOF under 
C-arm fluoroscopic guidance. The clinician remains completely separated from the radiation field. More 
automated control under CT guidance is proposed as a further advancement. Recently, Johns Hopkins 
has developed and patented a fully non-ferromagnetic pneumatic stepper motor, capable of operating 
inside the MRI bore, described in [43]. 
 Between 1997 and 2001 a 48 patient clinical study [44] was conducted at the Johns Hopkins 
Hospital whereby half the patients received completely manual percutaneous nephrolithotomy (kidney 
stone removal) and half with assistance from the PAKY. The procedure entails inserting a needle into the 
kidney towards the target calix(s) (stone) then passing a guide wire down its length.  The needle is then 
removed and a series of dilators inserted until a sheath can be placed through which a nephroscope and 
various tools are used to remove the stones. The PAKY-RCM was used for placement of the 18 gauge 
needle and the primary result was partial validation of the system’s functionality with 20 of the 23 
  
Figure 9 – Left: PAKY-RCM schematic. Right: Detail of PAKY and RCM with laser indicating the needle tip 
and insertion point [42]. 
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procedures completed with its assistance. Mean 
access attempts were reduced from 3.2 to 2.2, albeit 
not significantly, and procedure time from 15.1 to 10.1 
min with marginal significance.  
A further development of the PAKY-RCM system is 
the AcuBot [45] which mounts it onto a bridge that 
straddles a patient on a CT scanner, shown in Figure 
21. Added to this system is an X-Y-Z stage at the base 
of the passive arm; the passive arm effects gross 
alignment and the stage is used to place the needle tip 
at the desired insertion point under CT guidance and 
align it to the scanner’s laser indicators. At all times 
the clinician remains in direct control of the robot’s 
motion. Despite the AcuBot’s large structure, the 
combined system is specialized and represents significant advancement over repurposed industrial 
robots.  
2.3.2. Piga CT 
More recently, there have been commercially successful probe insertion robots. One such is the Piga 
CT, manufactured by Perfint Healthcare Pvt. Ltd., Madras, India [46]. The system was observed in 
operation during a visit to Madras in July 2011. This Cartesian robot docks to a plate in the floor of a 
computer tomography (CT) room and moves a biopsy needle about X-Y-Z and two inclinations.  A 
software interface allows 3D needle path planning, from insertion point to target, directly on the CT 
images. [47, 48] Considering that a much smaller scale solution to the biopsy challenge is developed in 
Section 5, it is pertinent to review the Piga’s operating procedure in Table 2. 
Table 2 – Piga CT-guided Biopsy Protocol 
1. Robot maneuvered and docked to fixed floor plate and system initialized. 
2. Patient is placed on the bed, inserted into the scanner bore and a planning scan acquired. 
3. Data is transmitted to the Piga console where the needle placement is planned from insertion 
point on the skin to the target. 
4. Patient is withdrawn from the bore up to a set axial stop position. 
5. The robot is activated and positions its end piece in 3D space, just above the selected insertion 
point, and angled appropriately. 
6. A sterile, plastic guide bushing is placed into the robot’s gripper and clamped. 
7. The needle is inserted manually through the busing to the target’s depth in a single pass. 
 
Figure 10 – AcuBOt mounted to CT table [45]. 
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From observation, the initial docking procedure 
involving wheeling the robot into position and engaging the 
plate with a foot pedal was identified as cumbersome.  
During positioning, the robot moved smoothly and 
successfully used the CT image to locate and orient the 
guide bushing at the desired position and angle. The 
disposable bushing successfully addressed the need for 
sterility.  Placing the actual needle insertion step in the 
clinicians’ hands reduced risk and was expected to ease the 
path to adoption and regulatory approval.  
A significant challenge with this product, however, is the 
requirement that the patient remains stationary between 
the scan and the probe placement.   Should he or she move, 
scanning and robot orientation will need to be repeated. 
Moreover, the needle must be inserted with a single pass; 
the system does not facilitate an incremental needle 
insertion and adjustment. Nevertheless, the PIGA CT shows 
promise, has received the European CE mark and is being tested worldwide. (Currently there is no clear 
regulatory procedure in India.) 
2.3.3. CT Bot 
The CTBot, developed at the Institut National des Sciences Appliquées and the Laboartoire des 
Sciences de l’Image, de l’Informatique et de la Télédétection in Strasbourg, France, targets abdominal 
tumor biopsies and ablation.  It is ostensibly the first example of a patient-mounted robot. Described in 
2004-8 [49-51], the robot consists of a 5 DOF actuator weighing 3 kg that straps directly onto the 
patient. Together they fit into a 700 mm diameter CT bore. The investigators identified patient motion 
and respiration, which causes both external and internal organ motion, as posing challenges in robotic 
interventions and thus, the robot is intended to rise and fall with respiration, while internal organ 
motion is addressed by assuming that the needle will only be inserted during the low point in a 
respiratory cycle. 
The frame consists of a combined 6 and 4 bar mechanism that can describe an approximately 
spherical workspace and is capable of withstanding 20 N of force. Five ultrasonic motors with 50:1 
backlash-free harmonic drives and encoders actuate the robot to translate in Cartesian space to locate 
the insertion point and then angulate the needle about 2 DOF. Surmounting the top platform is a 
separate module that inserts and simultaneously rotates the needle and incorporates 3 load cells that 
measure the insertion force and send it to a commercially available haptic interface. As with the PAKY, 
the frame is designed so as to leave a central region unobstructed with metallic elements for imaging 
the needle.  The base also comprises integrated fiducials, in the form of a plastic block with embedded 
metallic rods that enable automated registration. Position guidance is provided via a point-and-click 
interface that uses the CT’s Digital Imaging and Communications in Medicine (DICOM) data standard. 
 
Figure 11 – PIGA CT system [47]. 
- 18 - 
As the device improved over the years, the base was separated into two parts so that the robot 
could be placed in varied angular orientations as well as rapidly removed independently of the straps.  
Attached to the underside of the base is a bag filled with small polystyrene balls that conforms to the 
geometry of the patient and is then locked into position by drawing a vacuum on the bag. Testing of the 
device with a passive needle guide and manual insertion into a phantom yielded an accuracy of 5 mm at 
10 cm depth, appropriate for the target procedure. 
 
 
 
Figure 12 – CTBot on phantom in CT [50].  Figure 13 – Light Puncture Robot [52]. 
2.3.4. Light Puncture Robot 
Another, similar French project, the Light Puncture Robot (LPR), was executed at the Université de 
Grenoble’s Techniques de l’Ingénierie Médical et de Complexité Laboratoire and described in 2008 [52]. 
Like the CTBot, the LPR sits directly upon the patient’s abdomen or thorax to account for patient motion.  
The entire device is fabricated from polymers and non-ferromagnetic metals which are MRI safe. The 
needle-holding module rotates and inclines (2 DOF), so as to access a conical needle workspace.  
Perpendicular straps connect the needle-holding module to a frame that mounts to the CT bed and 
straddles the patient.  Once the robot is placed approximately in the desired location the straps are 
tensioned to keep it in contact with the patient and then actuated to slide the robot about in the X-Y 
plane.  Various pneumatic actuators, including a dual ratchet and pawl that converts linear to 
bidirectional rotary motion, are employed and connected by 7 m tubes to a controller and compressor 
outside the MRI room. 
The needle is held with pneumatically actuated clamps and passes through a guide in the base, 
which keeps it centered. Needle insertion is accomplished in a multistep procedure. First the rotary 
actuator positions a stop.  Then a piston rapidly actuates a linkage that moves the needle clamp 
downwards at 9 cm/s until it reaches the stop. This rapid plunging motion closely replicates clinical 
practice for many biopsy procedures, particularly a percutaneous lung biopsy where a slow insertion can 
cause a localized depression in the lung’s pleura (covering membrane).  This clamp and variable-stop 
mechanism allows the needle to be inserted incrementally, with the clamp releasing the needle and 
regripping it further up to continue the insertion. Reference is made to ungripping of the needle 
allowing for organ motion. Both the quick plunge and needle releasing abilities were independently 
verified to be essential features that set this robot apart from other research efforts.  
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The robot’s initial position is determined via a fiducial frame incorporated into the base of the 
needle holder, consisting of glass tubes containing a solution visible under MRI. An algorithm is used to 
identify and localise the needle holder’s position and rotation in the image. However, inclination is not 
directly sensed and relies upon a known start position. Reimaging for position confirmation is possible 
after each step of the insertion.  The physician executes control via a point-and-click graphical user 
interface (GUI). Phantom experiments achieved millimetre accuracy. Four in-vivo porcine experiments 
confirmed functionality and achieved 1 cm accuracy, which was deemed clinically acceptable, especially 
considering that the porcines could not hold their breath on command. One of the challenges identified 
was the fitting of a bariatric patient and robot with needle into a MRI bore. 
2.3.5. Innomedic 
 At the time of the LPR project, only one other MRI compatible 
robot had been developed, the Innomedic [53] by Innomotion 
GmbH, Herxheim, Germany based on work begun in 1998 at the 
Forschungszentrum Karlschule, Baden-Württemberg, Germany. This 
robot was a large 6 DOF arm, mounted to a semicircular bridge that 
spanned the MRI bed and reached into the bore. This system 
reached a product-level of development, received the CE mark in 
2005 for MRI-guided sciatic pain treatment, biopsies, drainages, etc. 
and a trial unit was even shipped to the US for testing in a clinical 
setting. In personal conversation with Innomotion’s founders at the 
2006 Radiological Society of North America (RSNA) conference in Chicago the technology to develop 
feedback-based position control with pneumatic actuators, as opposed to stepper control, took years to 
develop and was not publically disclosable. Additionally, while the system originally included a system 
for needle insertion, it was later removed to reduce complexity and address safety concerns, leaving a 
passive needle guide with insertion accomplished by the clinician. The system showed promise; however 
Innomedic was purchased by Synthes, Zuchwil, Switzerland, and no longer appears active.  
2.3.6. Spine Assist 
The SpineAssist, and updated Renaissance system, from Mazor Robotics, Caesarea, Israel [54], 
brings increased precision to spinal interventions and is marketed as a way for hospitals to set 
themselves apart from the competition. The company’s product assists with a wide range of spinal 
interventions including biopsies, fusions, scoliosis treatment, osteotomies and pedicel screw implant 
placement. The technology is based on a patent [55] filed in 2001, the same year that the company was 
founded, and issued in 2004. The system consists of a frame that mounts to and stabilizes the vertebrae 
and a soda can-sized robotic hexapod that mounts to the frame, is encased in a rubber sheath and 
positions an arm and guide [56]. The procedure begins with a 3D CT scan that is used to plan the 
intervention.  During surgery the frame is attached to the patient’s spine with a clamp or a supporting 
mount and K-wires. A plastic grid containing fiducial markers is mounted to the frame and two 
perpendicular fluoroscopic scans are taken, whereupon the software matches the frame to the surgical 
plan.  The robot is placed upon the control station’s base and zeroed. Then the clinician selects each 
vertebra where he intends to intervene and the software indicates the appropriate robot placement on 
the frame, as well as the correct arm and drill guide that should be fitted to the robot.  As with the PIGA, 
 
Figure 14 – Innomotion system, 
photo origin unknown. 
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and Innomedic the ultimate responsibility for the tool insertion or implant placement relies upon the 
doctor. Mazor indicates that with their system 1 mm placement accuracy is obtainable, radiation dose is 
lowered because only a single pair of fluoroscopic images is needed and complications and revisions are 
reduced. 
Multiple studies have demonstrated 
Mazor’s robots’ efficacy. An early 10-
cadaver study [56] examined 54 implant 
placements, using a variety of procedures. 
After eliminating failures where the 
implant broke or bent, 47 placements were 
within 1.5 mm of target, with all procedure 
types exhibiting an average accuracy of 
1 mm. In 2006, 65 clinical cases were 
performed in the US, Germany and Israel, 
with the SpineAssist aiding in the insertion 
of 316 screws, of which 235 (93%) were 
implanted as planned. More extensive 
studies have continued to demonstrate efficacy. In 2011 the results of a 112-case study [57] comparing 
traditional open (midline incision) and robot guided open and percutaneous (2-3 cm incision for clamp 
and 2 cm for screw placement) surgery between 2006 and 2009 were published. Out of 536 screws, 286 
were placed conventionally and 250 with robotic guidance, with respective accuracy rates of 94.5% and 
91.5%.  Average X-ray exposure time was significantly reduced from 77 to 34 seconds, though dose was 
not recorded, and a non-statistical significant increase in per-screw procedure time was observed. 
Significant reductions in postoperative hospitalization, pain, infections and revision surgeries were 
evidenced with the robotically assisted procedures conducted via percutaneous approach. 
Mazor has been listed on the Tel Aviv exchange since 2007 and in 2009 closed a $13 million public 
offering [58]. Mazor’s revenue model consists of capital, disposable and service sales. These include: 
Capital sale of the entire system for approximately $759K, implantables valued at $6-8K per procedure, 
disposable clamps and fiducial grid costing $1.2K per procedure and a $76K service agreement per year. 
Surprisingly, despite being a much smaller robot with a more limited application, the sale price is only 
about half of that of a da Vinci Surgical System, described in Section 2.5. In 2010 Mazor reported $4.18 
million in revenues, minus $1.01 million in cost of goods sold (COGS) for a gross profit of $3.17 million.  
The next product under development and approval is an adaptation of the current system for cranial 
applications including brain biopsies, deep brain stimulation (DBS) implant and shunt placement. [59]  
In its introduction, Mazor’s seminal patent [55] highlights some of the challenges associated with 
surgical navigation systems. Although a detailed discussion of these is beyond the scope of this work, all 
rely on a preoperative (or intraoperative) image and overlay images of the tracked tools, thus enabling 
blind access while reducing the need for x-ray imaging. Optical tracking fits tools’ handles with multiple 
fiducials, typically reflective spheres, and requires a clear line of sight between an emitter/detector and 
the tool.   Magnetic tracking employs a magnetic field generator and small detector coils wired to the 
tools, which must be nonferrous. Both methods are still limited by the clinician’s hand–eye coordination 
 
Figure 15 – Mazor Robotics Renaissance system showing 
frame, robot and arm with guide, through which clinicain 
is inserting a tool [51]. 
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and, unless a coil can be embedded in the tool, working tip position is extrapolated and not directly 
sensed. An informative comparison between navigation systems, floor mounted robots and patient-
mounted surgical tools is provided in [60] describing the SpineAssist’s first iteration and reproduced in 
Table 3.  This shows clear benefits resulting from smaller scale robots which reference directly to the 
patient. 
Table 3 – Characteristics of three types of computer-aided surgery (CAS) systems: Navigation systems, 
fixed floor or bed mounted and patient-mounted, [60]. 
 
2.4. Steerable Robots 
2.4.1. Hansen Medical 
Significant work has focused on manipulating endoscopic tools from outside the body, another class 
of robots is able to semi-autonomously navigate within the body.  The most prominent of these is the 
Sensei X Robotic Catheter System produced by Hansen Medical, Mountain View, CA. The system is 
designed for electrophysiology procedures under X-ray guidance. Traditionally, the clinician wears a lead 
vest, for protection from x-rays, and stands bedside while manually threading a catheter from a 
patient’s groin through the femoral vein to the heart. Once in the heart the catheter is curved into the 
ventricles and into contact with their walls.   Various probes are inserted through its annulus to monitor 
signals, stimulate the heart so as to induce irregularities and ablate faulty tissue “wiring.” 
The Sensei X consists of multiple modules that, together, enable remote operation and eliminate the 
clinician’s radiation dose. The Artisan Extend Control Catheter has a flexible, cable driven tip that 
extends and can execute c-shaped curves.   The IntelliSense Fine Force Technology Interface provides 
the operator with a handle that is manipulated about 5 DOF in space (axial rotation of the catheter is 
not necessary) to specify the catheter insertion, curvature and direction.   This is used in conjunction 
with the CoHesion 3D Visualization Module, which integrates C-arm fluoroscopy images and a model of 
the catheter position within the heart. Once in place, the sensing and ablation occurs normally.  
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Figure 16 – Hansen medical system showing (left to right) the catheter, the patient side base unit and 
the operator interface with detail of the hand piece, [61]. 
Hansen medical was co-founded in 2002 by Dr. Moll after leaving Intuitive Surgical and in 2005 the 
two firms executed a cross-licensing agreement [62]. Industry, experience clearly shortened the 
development and commercialization process and in the following year Hansen went public.   In 2007 the 
early Sensei Robotic Catheter System and the Artisan Control Catheter received FDA 510(k) approval and 
a CE mark, Hansen made its first sale and a European subsidiary was opened. Approval of the newer 
Sensi X and Artisan Extend was received in 2009 and Hansen is actively partnering with Siemens and 
Phillips. 
A recent study at the Texas Cardiac Arrhythmia Institute, Austin, was conducted with 197 patients 
receiving radio frequency ablation treatment for atrial ﬁbrillation via manual catheter manipulation and 
193 via robotic navigation [63]. An increased success rate from 81 to 84% (with medication previously 
ineffective) was observed and mean fluoroscopy time dropped from an average of 58.4 to 48.9 min.  A 
significant learning curve was observed, with robotic procedure times longer for the first 50 procedures 
and overall no faster than the manual procedure. This demonstrates the observed trend toward 
increased procedure times with the use of robotic surgery. 
2.4.2. TU Delft 
Extensive and promising work has also been conducted into miniature, steerable robots at TU Delft, 
Netherlands, by Prof. Paul Breedveld.  A summary of recent work is provided in [64] which has focused 
on the mechanics of small, highly flexible scopes and graspers; the smallest 0.5 mm in diameter for 
retinal surgery is pushing the boundaries of manufacturing technology.  One of his key innovations is to 
eliminate the jointed segments, seen in Figure 16, and use instead a tight ring of cables that operate in 
both tension and compression, which were inspired by squid tentacles. Currently, manual tools are 
being developed by the spinoff Deem Corp., Amsterdam, but there are clear robotic applications. 
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2.5. daVinci Surgical System 
The most recognized medical robot and the 
only one to have gained significant market 
traction, is the pioneering da Vinici Surgical 
System, from  Intuitive Surgical, Inc., Sunnyvale, 
CA [65]. The da Vinci’s technology originated 
during the late 1980’s at SRI International, an 
independent, non-profit research institute 
(formerly Stanford Research Institute), under 
contract with the US army to develop a system 
for conducting battlefield surgery.  Intuitive 
Surgical was founded in 1995 with Dr. Frederic 
Moll, a surgeon with previous medical device 
experience, with Mayfield Capital venture 
funding; later funding came from Sierra Ventures 
and Morgan Stanley Ventures. The system 
operates in a master-slave configuration and 
consists of two main parts: the patient side cart, 
shown in Figure 18, with four robotic arms that 
manipulate minimally invasive tools within the 
patient, and the surgeon console from which the 
robot is controlled. The system launched in 1999 
and in the following year the system received FDA approval for general laparoscopic procedures and the 
company went public. The da Vinci has been approved for thorascopic, cardiac, urological and 
gynecological applications and was initially targeted for cholecystectomies (gall bladder removal), 
though it is currently predominantly used for minimally invasive prostatectomies. [66] Effectively, the 
daVinci is the de facto benchmark against which all other medical robots are currently compared. 
Intuitive’s technology is protected by 160 US and 60 foreign wholly owned patents and 260 US and 165 
foreign licenses. 
2.5.1. System & Safety 
During a procedure the patient is prepped, positioned on the surgical table and four 5 or 8 mm 
trocars placed into his or her abdomen. The robot arms then insert instruments through these trocars 
and move them about 4 DOF: advancement, rotation and two angulations. Intuitive’s EndoWrist 
instruments have intricate 3 DOF cable-driven wrists at their distal ends, which deliver cutting, grasping, 
retracting and cauterizing functions and are able to execute complex sutures. This allows the surgeon to 
regain the two degrees of freedom, normally restricted by the trocars, as well as execute a gripping 
motion, yielding 7 DOF total. The operator sits remotely at the console, views the laparoscope through 
stereo eyepieces and manipulates two hand pieces to control the robot arms. Though force feedback is 
not implemented, the control system provides motion scaling and tremor control. [67] One foot pedal 
“clutches out” tools, so that the hand pieces can be repositioned when they reach an awkward 
configuration, and the other switches control between the four arms. Each instrument is tracked with a 
 
Figure 17 – da Vinci patient-side cart and sample 
EndoWrist attachment [65]. 
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barcode and limited to 10 uses. The entire patient-side cart and arms are shrouded with a single-use, 
sterile drape. In the latest iteration, the da Vinici Si HD Surgical System provides a second console for 
observation or training. 
 
Figure 18 – da Vinic Si HD, showing dual consoles [65]. 
Multiple safety layers exist to prevent unintended motions.  Should the operator remove his head 
from the console all tools lock; they are only reactivated by positively engaging the handles and 
“clicking” both grippers. A “disable” button is located on each arm and, because the surgeon is remote 
from the patient, a resident or nurse is expected to remain besides the table at all times, ready to 
disable and manipulate the tools manually. A search of the FDA’s Manufacturer and User Facility Device 
Experience (MAUDE) database [68] turns up relatively prosaic instrument defects and breakages as well 
as reports of system errors and arm lock-ups, which required conversion to open procedures, reboots 
and service visits with hardware replacement as well as a few reports of unintentional tool motion 
outside the camera’s field of vision causing harm. However, overall the da Vinci has a good reputation 
for safety. 
2.5.2. Adoption & Financials 
Adoption of the da Vinici has grown steadily since 2003, as shown in Figure 19, and hospitals have 
found its use in advertising campaigns to be effective. According to Intuitive’s 2008 annual report [69], 
335 systems were sold in 2008, bringing the installed base to 1,111 (825 in North America, 194 in 
Europe, 92 elsewhere) and 136,000 patients treated, an increase of 60% over the preceding year, 
primarily for prostatectomy and hysterectomy. In the case of cancerous hysterectomy, the system is 
reported to reduce average hospital stays by 6.3 and 1.2 days as compared with the open and manual 
laparoscopic procedures, respectively, which represents a reduction in hospitalization costs. Total 
revenues of $874.9 million were recorded for 2008, an increase of 46%, comprised of $455.3 million for 
systems sold and upgraded, $293.0 million for consumables and $126.6 million for system service. Gross 
profit was $620.8 million and income $204.3 million. Revenue per system sold has steadily increased 
from $1.18 million in 2006 to $1.34 million in 2008. Usage per unit was estimated at once every three 
days, with that number expected to increase. 
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Figure 19 – “Worldwide da Vinci Surgical 
System Installed Base” [70]. 
Figure 20 – Billboard located above the Massachusetts 
Turnpike showing Dr. Ingolf Tuerk from St. Elizabeth’s 
Medical Center, Brighton MA, photo by David L. Ryan, 
Boston Globe, [71]. 
2.5.3. Efficacy & Cost 
While the da Vinci was initially intended to excel at challenging cardiac and narrow surgeries, where 
precision is of utmost importance, these procedures carry the highest risk and, consequently, the 
highest barriers to entry. Instead, to date, the system has found most use in the conduction of 
prostatectomies, where potential loss of erectile function is a (non-lethal) risk that resonates with 
patients. Surprisingly, despite many studies, no randomized prospective studies have been conducted to 
compare da Vinici surgery outcomes with those of experienced surgeons conducting traditional 
laparoscopic or open prostatectomies. The results of retrospective studies are variable, though the 
system is popular with clinicians. While the system’s engineering and performance is impressive, the 
costs of acquiring and using the da Vinci system are significant and, potentially, representative of 
medical care’s unsustainable upward cost trend. Notably, the clinician on the billboard in Figure 19 
asserts that he can obtain equal or superior results without the robot [71]. Multiple studies demonstrate 
inconclusive results regarding the clinical benefits of robot assisted laparoscopic prostatectomy (RALP) 
and sharply question its cost effectiveness. 
One retrospective study, conducted at Tulane University Medical Center’s Department of Urology, 
reviewed 78 robot-assisted laparoscopic, 16 retropubic and 16 retroperineal radical (complete removal) 
prostatectomies conduced over 22 months, with the results reported in [72]. The average robot-assisted 
procedure time was 262 minutes; however there was a clear learning curve with the first 20 cases 
averaging 404 minutes and the last 20 225 minutes, a decrease of 42%.  In contrast, the manual 
retropubic and retroperineal procedures were significantly shorter, averaging 202 and 196 minutes 
respectively.  Blood loss was less for the robotic surgery. No significant differences in post-operative 
changes and outcomes were noted. Highlighting the possibility of medical robotics to be a skills leveler, 
Burgess et al. state that “many practicing urologists are not adept with advanced pelvic laparoscopic 
procedures” and thus “robotic technology has the potential to alleviate the technical difficulties 
associated with pure laparoscopy and thus allow more urologists to offer minimally invasive 
prostatectomies.” While the investigators were unable to examine actual hospital costs, the gross billed 
charges indicated average operative charges of $25K for robot-assisted surgery as compared to $17K 
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and $16K for the conventional retropubic and retroperineal approaches. (Capital costs were excluded 
from this analysis.) 
In one paper [73], Hu et al., use data from 2003 to 2007 to compare 1938 minimally invasive 
prostatectomies2 against 6899 open procedures. They report shorter hospital stays, a decrease in some 
in-surgical complications and an equal rate of additional therapy, however the rate of postoperative 
genitourinary complications increased twofold and there is an increased rate of post procedure 
incontinence and erectile dysfunction rates. It is noted that this may be due to reporting bias, possibly 
due to a “heightened expectations.” This is drawn from [74] which demonstrated that some patients are 
dissatisfied with their robotic surgery having expected “better” outcomes commiserate with the 
system’s successful direct-to-consumer publicity. Outcomes improved significantly with surgeon 
volumes, further indicating a learning curve that lasts longer than the 2 day training session. Reviewing 
demographics, white and Asian men were more likely to receive minimally invasive surgery, as were 
patients living in areas of higher education and income.  This is postulated to be due to robot-assisted 
surgery’s marketing demographic and access to appropriate surgeons and hospitals. 
A large retrospective study was conducted by the University of Texas Southwestern Medical Center 
[3]. Citing European studies that have shown increasing costs from open retropubic to manual 
laparoscopic to robot-assisted laparoscopic prostatectomies, Bolenz et al. conducted a detailed, 
retrospective analysis of the direct costs associated with 643 patients treated by experienced surgeons. 
Costs were normalized to 2007 rates, and results indicated significantly higher costs for robot-assisted 
procedures, averaging $6,752 as opposed to $5,687 for laparoscopic and $4437 for open surgery.  The 
primary drivers of the cost were consumables at $2015, $725 and $185, respectively, and operating 
room time billed at $12.9 per minute, resulting in costs of $2798, $2453 and $1611, respectively. Robot-
assisted procedures took significantly longer and a slight learning curve was observed. The robotic 
procedure employed EndoWrist instruments including two needle drivers, a grasper, a forceps, a Hot 
Shears and a ProGrasp, each costing $220 per use when averaged over their 10 use lifespan, and a 
PlasmaKinetics sealer costing $250 per use.  Manual laparoscopic procedures used cheaper, disposable 
tools and open surgery was relatively inexpensive.  If the $1.4 million robot purchase price is amortized 
over 7 years and the $140K annual maintenance costs are divided by approximately 126 cases per year, 
an additional $2,700 are added to the robot-assisted procedures for a per procedure total of $5,013, 
more than the traditional open retropubic procedure.  
This Texas paper pointedly asks: “Can the robot become cost competitive with the other 
approaches?” The authors conclude: “To date, there is not enough evidence of a significant 
improvement in patient care with RALP to justify the high added cost.”  In a postscript editorial 
comment, Dr. Markus Graefen seconds this conclusion with: “… the fact that RALP is extraordinarily 
more expensive than open RP will not change …” and “Robotic surgery is a fascinating approach … 
however, a growing body of evidence shows that the results of RALP are not superior to other surgical 
approaches. It is certainly up to urologists to give the patient a realistic view of what he can expect when 
                                                          
2
 Lacking a separate CPT code it was not possible to conclusively, retrospectively identify procedures that were 
robot-assisted. 
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prostate surgery is performed. Furthermore … we must be aware of our responsibility to society and to 
our patients to deliver the best possible care at justifiable cost.” 
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3. Implications for the Future of Robotic Surgery 
As the preceding literature review demonstrates, progress is being made in the development of 
robotic surgery. However, of the few robots to achieve market success, the Robodoc, Stanmore 
Sculptor, Piga CT, Spine Assist, da Vinci and Renaissance, all but one still embody the cost and stature of 
industrial robots. The da Vinci, the market leader, represents both a high capital and disposable cost, 
while delivering RALP’s outcomes that are comparable to those of a skilled surgeon performing either 
minimally invasive or traditional open prostatectomies. With increasing use in more challenging, 
minimally invasive procedures, it may become easier to demonstrate efficacy. While Intuitive’s success 
is predicted to continue, the remarkably multifunctional nature of the da Vinci’s design makes it 
inherently expensive, and this will eventually lead to a ceiling on the upward trend of the installed base 
shown in Figure 19. 
Intuitive’s ground breaking work in the medical robotics field has led to many discussions as to the 
cost-effectiveness of robotic surgery, both in literature and the medical community. In February 2010, 
the Boston-based Center for Integration of Medicine and Innovative Technology (CIMIT) [75] hosted a 
weekly forum entitled “Current Status of Robotic-Assisted Surgery and the Challenges Ahead.” Dr. Bob 
Nguyen from Children’s Hospital presented his personal experience with the da Vinci Surgical System. 
He spoke positively of increased dexterity, tremor control and the comfortable interface, and asserted 
that the robot facilitated better suturing and decreased scarring. In contrast with the reports of Section 
2.5.3, he estimated that it is 9% cheaper to do surgery robotically, due to reduced hospitalization, and 
15% more profitable. This presentation sparked a lively debate where a common theme in the research-
focused audience, was the need for increased competition despite many blocking patents, such as the 
160+ protecting the da Vinci. Features envisioned for new robots in medicine include self-guidance, 
integrated ultrasound, autonomous operation inside the body, haptics, heads-up displays, addition of 
sensors, tools and software to process images, improved tissue joining via automated suturing, laser 
“welding” and tissue glues.  
The work of Intuitive Surgical has introduced clinicians and patients to the potential for robotics to 
contribute to interventional medicine. In the book, Advanced Gynecologic Endoscopy an entire chapter 
is devoted to asking Do costs of Robotic surgery matter? [76]. This provides a summary of the 
advantages, limitations and costs of using the da Vinci System and concludes that the robotic surgery 
does not yet, but must pay for itself on a per-procedure basis. Dam, et al. suggest ways to reduce 
operating costs, including limiting the variety of tools used, training dedicated specialist surgeons to 
reduce procedure time and steering only complex cases to the robot. However, in the long term “the 
future of robotics looks bright as robots will become even smaller and easier to handle, surgeons will get 
better performing robotic surgery, and eventually robots will become cheaper as almost all electronic 
devices did when they became more mature with many competitors on the market.” There is clearly 
room for disruptive technologies in the medical robotics space. 
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4. Medical Device Prototype Design Process 
Key to the design and rapid prototyping of medical devices is a structured process that encourages 
creative solutions and is documentable, as will be required for FDA approval. One such is the 
deterministic design process, described in [77-79]. This evolved from the scientific method in 
combination with industry best practices. The scientific method proposes a hypothesis, designs and 
conducts experiments and then modifies the hypothesis accordingly. The deterministic process begins 
with identification of the (clinical) challenge and careful examination of the solution space. At each step 
of the way functional requirements (FRs) are identified and potential solutions (mechanisms) 
brainstormed. Research, analysis and hands on experiments are used to make a selection from amongst 
the options. Peer review with engineering colleagues and clinicians helps to refine the design and at 
each step, potential failure points (risks) are identified and solutions (countermeasures) developed. As 
the design moves from coarse to fine, unknowns are minimized and the design’s essential elements are 
retained; the process is biased towards producing a lean, minimally complex prototype solution on time 
and on budget. Good record keeping is essential through the process. Each finding and step of the 
design must be noted and archived. This will form the basis of any IP filings, as well as the design history 
file which the FDA requires for all medical devices in order to file for approval as well as continued 
compliance.  
This process has been adapted and iteratively optimized for use in the MIT Precision Machine Design 
course (2.75) which has focused on medical device design for the last 9 years. In this course, student 
teams successfully take a clinician’s challenge to a proof-of-concept prototype in only 14 weeks. During 
the last four years teaching, particular effort has been made to structure the process and identify those 
steps particularly pertinent to designing medical devices. Three distinct phases, which roughly break the 
course into thirds, have been defined and are shown in Figure 21 along with their sub-steps. 
   
Figure 21 – The three-phase deterministic design process, as taught in the Precision Machine Design 
course and applied to designing electromechanical solutions to medical challenges. Numbers 
correspond to the 14 weeks of course. 
The first step of the process is to develop a deep understanding of the clinical practice pertinent to 
the challenge identified. Each summer clinicians who have identified challenges in their practices 
submits applications, of which a subset is selected for presentation to the course. From these 
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presentations, student teams of 3-5 persons each are formed, whereupon the Discovery phase begins. 
Firstly, the problem is precisely defined from discussions with clinicians and by first-hand visiting the 
clinical settings to carefully observe the current procedures and equipment. If practical and permitted, 
notes are taken along with the capture of video and still images.3 Interviewing a clinician is also a distinct 
skill; it does not suffice to simply ask “What can be better?” It is best during the discovery phase to steer 
the discussion towards function, rather than the form of the current tools or techniques.   Experience 
has shown that initially clinicians often seek minor improvements rather than full solutions, because of a 
reluctance to completely rethink the tools and protocols that they are familiar with. 
Rather than developing a robot or device with which to conduct the entire procedure, à la da Vinci, 
this design method specifies narrowing the design challenge to a tightly constrained set of tasks. Using 
the information gathered, the procedure is decomposed into discrete steps, as is demonstrated in 
Section 5.3, and portioned between the clinician and the proposed robot (or tool).  The design team 
should then conduct a virtual “muda walk” 4 to identify inefficiencies - those tasks which, while essential 
to the procedure, are time consuming, challenging, limit precision or do not necessarily add substantial 
value. This is an adaptation of industrial value stream mapping [80] as well as Fredrick’s Taylors’ 
Scientific Management [81] that sought standardization and optimization in place of craft production.  
Given the uniqueness of each patient, medicine is still very much as craft practice; however there is 
evidence that standardizing some treatment paths, as shown in Figure 27, and protocols to encompass 
evidence-based best practices can improve patient care. In developing the Robopsy System, Section 5, 
the CT-guided biopsy procedure was identified as unnecessarily challenging as a result of the current 
manual clinical technique which underutilizes the CT scan’s full 3D positional data. Similarly, the 
improved morcellator design, Section 6, is proposed as a means to automate the removal of large 
excised tissue masses through minimally invasive incisions. Coming at the end of a procedure, the task 
required minimal skill and was time consuming and repetitive. Table 1 provides an excellent guide to 
parsing out those tasks which lend themselves to robotic integration. Tasks identified as inefficient are 
then used to generate a broad set of Functional Requirements (FRs) and define a mission statement that 
concisely summarizes the project’s goal. Through, the goal is to maximize the functionality / complexity 
ratio. 
Simultaneously, it is necessary conduct a prior art review to identify existing products, patents and 
literature pertinent to the current procedure. If affordable, samples of existing devices should be 
acquired for hands-on testing and disassembly. Utility patents often provide inspiration for mechanism 
design and, by tracking the inventors and assignees, a history of the development of current devices. 
However, patent searching proves a greater challenge then identifying products; a 2011 USPTO report 
[82] identifies Medical Devices as spanning 20 classes and numerous sub-classes, covering from 
bandages to imaging methods to surgical tools. The report’s data from 1998 to 2011, plotted in Figure 
22, shows a steady increase in patent issuance.   Interestingly, the three companies with the highest 
                                                          
3
 In some clinical settings detailed chronometry is not permitted; it is felt that an overt focus on procedure time 
could pressure clinicians and result in compromised patient care. 
4
 The term “muda walk” is commonly used to describe an industrial engineer’s physical walk through a factory  
floor to identify wasted actions. 
- 31 - 
number of patents issued in 2011, 
Medtronic Inc. (336), Cardic Pacemakers 
Inc. (307) and Boston Scientific Scimed Inc. 
(401), are all operate in the same market 
space. As afore mentioned, the MAUDE 
database can also provide insight into 
current tools’ shortcomings. Likewise, as 
seen in Section 2, engineering literature 
provides background into past advances in 
the field as well as developing trends, while 
clinical publications focus on the validation 
of new technologies.  In addition, they 
deliver background data on clinical 
conditions, such as cancer rates, and the 
current best practices for treatment 
procedures. Prior art should be frequently 
revisited as the design process continues. 
The next step is to develop possible 
solution strategies. These are intended to 
be broad approaches, rather than specific mechanisms, of fulfilling the Mission Statement. Clinicians 
should be encouraged to participate in creative brainstorming. Sketches and calculations in design 
notebooks are preferred over CAD and Matlab® models which may result in premature “locking down” 
of a solution path. Further literature review, analyses and bench-level experiments are conducted to 
evaluate each proposed solution. In house fabrication of test mechanisms enables rapid iteration and 
controls costs.  
With the selection of the strategy the Design Engineering phase begins. Based on the detailed 
problem understanding and the selected strategy, the FRs are enumerated and become more explicit, 
such as “orient a needle about two angles,” and are accompanied by clear specifications, such as the 
desired torque and ROM. Specifications are often identified by hands-on bench-level testing with 
measurement equipment, as shown in Figure 32. Next specific mechanism concepts are developed that 
execute the chosen strategy and fulfill the functional requirements. These are often mocked up and 
tested and at this point in the design process it is appropriate to begin developing CAD models. With the 
selection of the desired concept, the basic mechanism and its desired operation are understood. 
The next step is to modularize the design, with each module comprising a specific device function.   
Those modules that are fundamental to device operation and will comprise the core intellectual 
property (IP), should receive attention first. For example, in the John Hopkins’s needle driving system 
the PAKY and RCM are the most critical modules since they are directly responsible for the placement of 
the needle into the patient and incorporate novel mechanical designs, while the support arm represents 
a less critical module and hence a lower design risk. It is essential throughout the process to continually 
examine the design and operating protocol for potential failure points and from user and patient safety 
perspectives.  
 
Figure 22 – Foreign, domestic and total US patents 
issued by year, select data shown from [82]. 
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During the Building and Testing phase the detailed design and CAD modeling of the most critical 
module (MCM) is completed.  Once the most critical module’s fabrication is planned and underway, 
work can commence on the supporting modules. As the design develops, placing even partial physical 
prototypes into clinicians’ hands elicits far superior feedback than CAD renderings or sketches. As will be 
shown, testing continually with potential users is essential to differentiating between essential features 
and those that are either “nice to have” or downright unnecessary. Outside fabrication facilities are 
often used such as machine shops and, increasingly, 3D printing facilities. The latter is used extensively 
for speed and to complex geometries, with many integrated features and compound curves, such as 
those in ergonomic handles.  Care must be taken, however, against designing parts that can only be 
realized with low volume 3D printing; even at the prototyping stage, focusing on manufacturability is 
critical to producing cost effective solutions. Table 4 provides a summary of various fabrication 
techniques and their functionality. 
Table 4 – Prototype Fabrication Technologies 
Method Comments 
Machining Wide range of materials, i.e. polymers, metal 
Complex parts challenging, expensive 
Feature size ~0.003 – 0.001” 
Precise fits and finishes can be specified  
Labour intensive, hence longer lead times than other processes  
Abrasive water jet 
(AWJ) 
Cutting without heat affected zone (HAZ) 
Limited to 2D geometries 
Brittle materials pose no challenge 
Layered composites can delaminate 
Feature size ~0.010” as a function of thickness 
Stereolithography 
(SLS) 
Part built with laser hardened epoxy layers   
Properties mimic nylon, but lower toughness 
Prone to embrittlement duet to exposure to normal light 
Low post processing 
With post processing feature size 0.003” horizontally & 0.01” upwards 
Parts require post fabrication sanding and fitting 
Fused Deposition 
Modeling (FDM) 
Part built with extruded polymer threads 
Good toughness 
Poor feature control 
Resin casting A flexible silicon or urethane mold made is from an existing part or 3D printed 
prototype and filled with liquid polymer 
Good for ~10x uses 
Good feature reproduction, certain geometries challenging, i.e. deep cavities  
Rapid Machining Fast machining of parts directly from CAD in polymers and metals 
Machining instructions generated automatically 
Slightly lower tolerances than high-precision machining 
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With the prototype complete, testing can begin, first in the lab and then in a clinical setting. The first 
testing should be conducted on phantoms and, while these need not look anatomically correct, they 
should be crafted to represent the appropriate tissue conditions. Ex-vivo animal organs from a 
slaughterhouse can also be obtained and used to validate mechanical function. Only once confident in 
the solution, is it ethically appropriate to conduct a live porcine trial. As an alternative, it may be 
possible to utilize a deceased porcine or piggy back on the protocol of another researcher’s porcine 
experiment. In vivo tests should attempt to fully simulate the procedure and in doing so will often turn 
up hitherto unnoticed human factors issues. The basis of this testing is used to identify points where the 
device does not integrate smoothly into the existing procedure, as was the case with the Robopsy 
system’s interface, and refine and redesign. 
The overarching goal of this process is to maximize the exploration of options, while rapidly 
converging on a solution that exhibits minimal complexity.  It is hypothesized that an efficient design 
process will tends towards the development of efficient solutions.  Having reviewed the current trends 
in medical robotics, it is further suggested that this may be and effective means of developing disruptive 
technology.  This design process was closely followed in the development of the Robopsy System, 
Section 5, and optimized over through the development of the Medical Device Design Class, Section 7. 
The improved morcellator, described in Section 6, demonstrates the rapid convergence on a concept 
from a clinical need and subsequent prototyping. 
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5. Robopsy – Robotic Biopsy System 
5.1. Introduction 
The Robopsy (Robotic Biopsy) project began in the Precision Machine Design course in the fall of 
2004 working with Steven R.H. Barrett, Conor J. Walsh and Dr. Rajiv Gupta who was training in 
interventional radiology at Massachusetts General Hospital (MGH). Dr. Gupta observed the need for a 
better way to conduct CT-guided percutaneous needle biopsies (PTNB) of the lung and, in general, CT-
guided insertion of probes into a patient.  With training in Electrical Engineering and over ten years’ 
experience at the University of Southern California and General Electric’s Research and Development 
Center, he saw robotic technology as the solution and articulated the project mission statement: 
To create a robotic needle guidance system to assist radiologists in targeting lesions during CT-guided 
lung biopsies. 
The current PTNB procedure is iterative and 
time consuming, even when executed by a clinician 
with sufficient skill and expertise. Each step of the 
needle insertion, from skin surface to target point, 
requires that the clinician alternate between 
acquiring a CT scan of the patient and adjusting the 
needle position until it transits from the insertion 
point to the target location. Each cycle of needle 
manipulation and scanning necessitates moving the 
patient into and out of the bore and the clinical 
team shuttling from the radiation shielded control 
room to the CT room. Current CT scanners can 
provide imaging of structures on the order of 0.5 
mm as well as 3D coordinates; however, with the 
current procedure, whereby the clinician measures angles and depths on the CT slices and manually 
transfers these to the needle during positioning, the target nodule size is effectively limited to 
approximately 5 mm diameter.   The limiting factors are the clinician’s dexterity and ability to perceive 
angles, as well as tissue characteristics that can cause the needle to “spring back” after positioning. The 
effects of Abbe error on targeting lesions is demonstrated in Figure 23. When aiming at the centre of a 
10 cm deep lesion (bariatric patient), a clinician needs to achieve angular accuracy of 3° if the lesion is 
1 cm in diameter and 5.5° if the lesion is 2 cm in diameter. In Table 1 dexterity is listed as a human 
weakness while geometric accuracy and integration of numerical data are robot strengths. The 
opportunity for a robot to address the targeting challenge while utilising the clinician’s judgement to 
increase procedural efficiency was apparent. 
5.1.1. Significance 
Lung biopsies were identified as one of the most challenging biopsy procedures, due to the care 
needed to access a desired target through the ribcage while avoiding vessels and cleanly penetrating the 
lungs’ pleura. Any tears of this membrane increase the risk of a post-procedure pneumothorax, full or 
partial lung collapse. Furthermore, according to the American Lung Association 2012 data [83], lung 
 
Figure 23 – Abbe Error – As depth increases, 
small angular errors lead to increasing lateral 
errors. 
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cancer is the most deadly cancer in the US, killing more people annually than colon, breast and prostate 
cancers together, and accounting for 28% of deaths. In 2012 an estimated 226,160 new cases will be 
diagnosed while 160,340 Americans will die from it; sadly 90% of cases are traceable to smoking. The 
annual costs of lung cancer treatment are estimated at $10.3 billion. Only 15% of cancers are diagnosed 
while localised within the lung and for these the 5-year survival rate is 52.6%; for later diagnoses survival 
rate plummets precipitously. Earlier diagnosis clearly leads to improved survival rates; however, 
preventative screening of at risk persons is not standard practice, while it is for breast, colon and 
prostate cancer. 
Acquiring a diagnostically significant sample from a small lesion requires practice and success rates 
vary between institutions and clinicians. Nodules on the order of 5 – 10 mm are considered the 
minimum size targetable.  Radiologists report that the CT-guided lung biopsy procedure is fatiguing, due 
to the challenge of accurately placing the needle while avoiding surrounding structures. Additionally, it 
is especially challenging to target specific portions of a lesion, such as those which have been shown to 
be metabolically active on a positron emission tomography (PET) scan, as well as collect samples from 
multiple sites in a lesion, which would be beneficial since the central portion often contains inconclusive 
necrotic tissue. The limits on targeting size leads to “watchful waiting” where by small lesions are 
scheduled for observation rather than a biopsy. This results in both a worried patient and a missed 
opportunity for early treatment, potentially with a minimally invasive brachytherapy or radiofrequency 
(RF) ablation therapy. Both of these procedures also require the guided placement of probes. 
A 162 patient study [84] focusing on small solitary pulmonary nodules showed significantly 
decreasing rates of diagnostic success, defined as true-positives and true-negatives. For nodule ranges 
of 20 – 16 mm, 15 – 11 mm and under 10 mm rates were 91.5%, 74.4% and 52% respectively. Due to the 
low accuracy rate, follow up CT scans of lesions less than 10 mm were strongly recommended. Similarly, 
as depth increased success rates decreased from 95% for depths under 10 mm to 12.5% for depths 
greater than 81 mm. The overall pneumothorax incidence rate was 28.4%, positively correlated with the 
number of punctures and depth. It is important to note, however, that equipment and technique was a 
factor: The investigators employed a single 22 gauge (0.644 mm) Wescott needle which was removed 
after aspiration and the sample inspected by the cytologists; when the sample was found inadequate 
the needle was reinserted creating a new puncture. In contrast, the technique at MGH employs coaxial 
needles which are inserted, the stylet removed and a thinner needle deployed to collect samples; the 
stylet can be replaced and the needle left in place while the sample is examined. Regardless, this 
highlights the importance of accurate biopsy needle placement on the first pass. 
CT-based screening, with its high resolution 3D data enables the detection of small, early stage lung 
nodules.  The National Cancer Institute funded National Lung Screening Trial was begun in 2002 to 
investigate whether CT-based  screening could improve upon X-ray based screening, which has not been 
shown particularly effective in reducing mortality, and results [85] were published in 2011.  An at-risk 
population of 53,454 current or past heavy smokers received either a helical CT scan or a standard chest 
X-rays annually for 3 years at 33 medical centres. Data was collected from 2002 to 2004 and patients 
were tracked until 2009. Over all visits, subject receiving CT scans had a 24.2% positive rate of screening 
tests versus 6.9% for x-rays. Positive tests resulted in further evaluation and for each group, 
respectively, 96.4% and 94.5% were false positives, with most detected non-invasively through 
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observation of non-growth during follow-up. In total, 1060 versus 941 cancers were diagnosed with 
mortality of 247 versus 309, representing 20% lower mortality amongst the group receiving CT than 
receiving X-ray screening. Complications amongst those receiving invasive bronchoscopy or needle 
biopsy were rare, with deaths generally attributable to cancer. Clearly further studies are needed to 
definitively demonstrate screening’s efficacy; however, it is likely that screening will increase, resulting 
in the detection of more small nodules that require biopsy. 
Although CT-guided biopsies are considered safe and can be tuned to deliver low doses, they are 
recognised as delivering more radiation than other diagnostic techniques, such as X-ray (lower dose) or 
ultrasound (no dose.) As was seen during a detailed biopsy study, Section 5.3.1, radiologists focusing on 
the target are frequently unaware of how many repetitive steps this actually entails. There is a growing 
public and medical concern regarding radiation doses, particularly the cumulative effects, as evidenced 
by a recent article entitled “Americans get most radiation from medical scans” [86]. Thus any technology 
lowering the number of scans is likely to be positively received, though this savings cannot be directly 
monetized.  
5.1.2. Frequency of Percutaneous & Image Guided Approaches 
In a recent Radiology paper [87] Kwan et al. used Medicare data to study the effect of “advanced 
imaging technology” on biopsy approaches and practitioner specialty between 1997 and 2008.  The 
paper shows modest annual growth rates of 3% in the total number of biopsies and an 8% increase in 
percutaneous approaches, from 59% to 67%, as a portion of total biopsies for all regions.  Percutaneous 
approaches were consistently employed more than 50% of the time in bone, breast, kidney, liver and 
pancreas, with chest just topping 50% in 2008. For most procedures CPT codes do not distinguish 
between image-guided and non-image guided procedures, with the exception of fine needle aspirations 
(FNAs), where fluid rather than a solid sample are collected often in conjunction with a biopsy, for which 
an increase from 54% to 77% is reported from 2004 to 2008.   
A reliable proxy for the use of image guidance is the biopsy practitioner and the overall percentage 
of biopsies conducted by radiologists increased from 48% to 66%, while those by general surgeons and 
pulmonologists decreased. A chart showing breakdown by anatomical region is reproduced in Figure 24. 
In addition, the Kwan et al. propose that while imaging technology is enabling less invasive biopsies, 
since the overall growth rate is modest, it is not encouraging unnecessary biopsies. While CT data is 
displayed to the clinician as a picture that he or she uses to confirm the needle position as it is placed 
into the patient, the underlying data is coordinate based, thus any increase in the use of imaging 
technology with interventional procedures also increases the potential for robotic assistance which 
could employ that spatial data to assist the practitioner. 
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Figure 24 – Graph shows relative share of all biopsies performed according to specialty from 1997 to 
2008 [87]. (Data in 2003 were affected by a coding discrepancy for FNAs.)  
5.1.3. Project Overview 
Design of the Robopsy system followed the process described in Section 4. Initially a handful of 
biopsy procedures were carefully observed and detailed notes taken; these provided the guidelines for 
the design process.   This was followed up with a 10-case observational study and a later 50-case 
retrospective study. A thorough understanding of the PTNB protocol enabled precise identification of 
inefficiency and minimization of the proposed robotic solution’s DOF, needle gripping, angulation and 
insertion. From this strategies were identified and a concept developed comprising a low cost, 
lightweight, disposable robot, a controller and a clinician interface. Over three generations the design 
progressed from a 3D printed prototype with a simple motion control interface to a prototype with a 
potential production partner and an image guided, point-and-click graphical interface.  Testing has been 
conducted on custom thoracic phantoms as well as two in-vivo porcine models. 
5.2. Prior Art Review 
The first step in developing a solution to assist in the placement of biopsy needles was to review 
existing devices, both in the market and patent literature.  Of the robots described in Section 2.3, the 
PIGA CT, described in was not yet visible in the market when this project was conceived; however the CT 
Bot and Light Puncture Robot were identified as pertinent. Both employ a patient-mounted design 
which partially compensates for respiratory motion and minimizes the structural loop from the patient 
through the robot to the needle’s entry point and represent a more appropriate scale architecture. 
Additionally, since many percutaneous procedures are conducted with local anesthetic and little to no 
sedation, robots which position the needle with respect to the floor have the potential to cause 
significant harm if the patient changes position while the needle is rigidly held. Mounting to the patient 
reduces this risk as well as simplifies robot-patient registration. A review of patent literature and existing 
products turned up few effective active devices to aid in percutaneous biopsies.  However, two passive 
laser-based guidance systems were identified, shown in Figure 25. Both operate in a similar manner 
whereby the clinician scans the patient, measures both the in-plane and off-plane angles and inputs 
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them manually, directing a laser beam to align to the compound angle. The emitter is them moved so 
that beam’s incidence point on the skin pierces the desired insertion point. Finally the needle is inserted 
along the beam, nominally in a single pass. 
  
Figure 25 – Left: The SimpliCT CT from Neorad AS, Oslo, Norway, mounts to a floor based stand, photo 
circa 2005[88]; in later models the system was mounted to an overhead gantry.  Left: The PatPos from 
LAP GmbH Laser Applikationen, Lueneburg, Germany, attaches to the face of the CT machine, photo 
circa 2005 [89]. 
 
Figure 26 – Sample probe insertion patents: (a) “Tactile feedback and display in a CT image guided 
robotic system for interventional procedures” [90]; (b) “Biopsy needle guide for use with CT scanner” 
[91]; (c) “Biopsy guide” [92]; (d) “Biopsy guide” [93]; (e) “Multiple angle disposable needle guide system” 
[94]. 
Reviewing patents for devices specifically designed to assist with the biopsy procedure, excluding 
those associated with the Robots discussed in Section 2.3, yielded a selection of designs of variable 
practicality. There are a few very broad patents for “remote surgery systems” that fail to describe any 
physical embodiment such as  “Computer controlled guidance of a biopsy needle” [95], with a CT, MRI 
or ultrasound vision system. Other patents are more specific, such as “Tactile feedback and display in a 
CT image guided robotic system for interventional procedures” [90],  which appear to be scaled-down 
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industrial robots with haptics and integrated imaging and planning.  There was a dearth of methods of 
compensating for breathing motion. The majority of biopsy assistance devices were passive guides. The 
“Light beam locator and guide for a biopsy needle” [96]  proposes a Cartesian frame to which lasers are 
mounted that project intersecting beams to “mark the location of the tumor and to guide the biopsy 
needle.”  The “Biopsy needle guide for use with CT scanner” [91]  can be best described as giant 
Plexiglas protractor mounted over a patient.  Passive stereotactic frames mounting to the head for brain 
biopsies were also noted such as “Biopsy guide” [92], and one device was found, “Biopsy guide” [93], 
which consists of a ball shaped needle guide and socket that screws into a burr hole drilled in the skull; 
the ball is oriented, locked into place and needle passed through its hole into the desired target. 
Multiple products and patents exist that combine a ultrasound probe with adjustable or multi-position 
needle guides, for example the “Adjustable needle guide apparatus and method” [97] and the “Multiple 
angle disposable needle guide system” [94], assigned to CIVCO Medical Instruments, Kalona, IA. 
5.3. Procedural Analysis 
 Concurrent with the prior art review, a 
detailed study of the CT-guided lung biopsy 
procedure as conducted at MGH was 
undertaken. The first step was to 
understand MGH Radiology’s process for 
managing cancerous nodules, which is 
summarized in Figure 27. Typically nodules 
are first found either incidentally or due to 
screening of an at risk patient. New nodules 
smaller than 8 mm in patients with no 
history of cancer are subject to “watchful 
waiting” and scheduled for follow up 
imaging.  Not all nodules are cancerous; 
some are bacterial infections, fungus balls or 
scar tissue from past infections. Larger 
nodules or those in at risk patients are 
scheduled for a diagnostic intervention, via a 
PTNB, bronchoscopic-guided biopsy or, less 
frequently, video assisted thorascopy.  Cases 
are split 50/50 between PTNB and 
bronchoscopy, with the former more 
appropriate for peripheral lesions and use of 
a guidance system. It is important to note 
that MGH is a “quaternary care center,” 
medical parlance for a hospital that is 
equipped to handle everything from severe 
trauma to mystery infections requiring containment. Therefore, MGH receives a significantly higher 
portion of the region’s difficult biopsies and has a protocol that may be more time consuming, but is 
 
Figure 27 – Flow chart showing the process by which a 
patient arrives for a biopsy procedure at MGH, with the 
point where robotic assistance is proposed highlighted. 
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appropriate for biopsies that are small and/or deep and in compromised patients.  Quoting one 
radiologist while conducting a difficult manœuvre, “I have no choice; if I don’t do the biopsy today [the 
patient] won’t get a biopsy and a diagnosis.” Additionally, radiologists at MGH are specialized; there is a 
department devoted to interventional thoracic (chest) radiology, and the radiologists are less 
constrained by time or equipment demands than their colleagues at community institutions. Therefore, 
in designing the robot-assisted biopsy protocol and interface, there is the potential to incorporate some 
their “best practices” so that even less experienced or more time-constrained users can more efficiently 
and reliably conduct their procedures. 
5.3.1. Biopsy Observation & Task Partitioning 
PTNB lung procedures were personally observed at MGH and detailed notes taken beginning with 
the patient’s entrance to the CT room and concluding with their exit. The scanners used were Siemens 
Somatom 64 slice scanner. From this observation the procedure was decomposed into the discrete 
steps, shown in Table 5. Figure 28 is a schematic showing the setup, with the patient in the scanner, as 
well as a CT slice of a phantom showing how an intervention is planned. 
Table 5 – Manual Biopsy Protocol Steps 
1. Prior to the patient arriving, the clinician reviews a previous x-ray or a CT scan to locate the 
nodule, roughly plan the insertion path and select the correct patient positioning.  The four 
common patient positions are: prone (face down), supine (face up) and left and right lateral 
decubitus (on side), all with the head pointing into the scanner bore. 
2. Patient arrives, gives consent, and is placed on the scanner bed and lightly sedated 
intravenously.5 Dangling limbs are secured with rolled towels, Velcro straps and/or tape.  
3. An initial “scout” scan, with 5 mm slices and approximately 30 cm in length, is acquired and used 
to confirm the approximate planned trajectory. The patient is withdrawn from the bore. 
4. A Fast Find grid, tissue paper printed with metallic lines and manufactured by the Webb 
Manufacturing Corporation, Philadelphia, PA, is adhered to the patient over the approximate 
insertion zone. In a CT slice these lines show as a slice as a series of dots, as seen in Figure 28, 
and provide transverse coordinates. The patient is inserted into the bore. 
5. With the grid attached, a detailed, 2.5 mm slice thickness “planning” scan is taken. The clinician 
then uses this and onscreen drawing and measuring tools to explore various entry points and 
trajectories. Angles measured in a single scan slice are referred to as “in-plane” while the “off-
plane” angles are approximated by flicking through multiple slices. Normally, the scanner gantry 
is tilted until the desired trajectory can be visualized in a single slice. Trajectories perpendicular 
to the skin surface are preferred. 
6. The insertion point selected on the scan is transferred to the patient by reading the axial 
position from the point containing slice’s DICOM headers, advancing the bed to this position, 
                                                          
5
 Not all hospitals use sedation, preferring to remain in communication with the patent.  These hospitals follow a 
“breath hold” technique whereby patients are instructed to inhale and hold their breath during scanning and 
needle insertion. MGH, however, has found it more reliable to prevent the patent from moving and rely on the 
clinician to manually perform “respiratory gating.” 
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and finding the intersection between this scan plan, indicated by the bore’s lasers, and the 
appropriate line on the grid. The point is marked with ink and the grid removed, the area 
sterilized and the patient draped. 
7. Lidocaine (local anesthetic) is injected into the insertion point and the short needle 
left in position, marking the entry point and the trajectory’s’ approximate 
compound angle. The patient is scanned and, if necessary, the injector needle’s 
angle is adjusted and the patient rescanned.   Occasionally the needle is withdrawn 
entirely and repositioned by 1 – 2 mm laterally. 
8. The injector needle is removed and a small incision is made at the entry point.  This 
facilitates the biopsy needle’s entry and prevents entrainment of epithelial cells into 
deeper tissue, which could cause a growth. A 19 gauge (0.912 mm) coaxial biopsy 
needle is partially inserted at the skin, replacing the injector needle, and the patient 
is scanned again. Even though the collection of consecutive slices comprise a 3D 
coordinate system, when working “out of plane” over multiple slices clinicians were 
observed to approximate angles, rather than find them geometrically. This was 
identified as a significant source of additional scans. 
9. The needle is advanced in an iterative process whereby scans alternate with 
adjustments of the needle. The skin serves as the pivot point and occasionally the 
needle is rotated so that its bevel induces a slightly curved trajectory in a particular 
direction.  The biopsy kit is furnished with a ruler that is used to set a sliding collar 
on the biopsy needle to the correct depth. Generally, the clincian perfroms 
“respiratory gating” whereby patient is scanned and the needle is angled and 
inserted at the same point in the patient’s respiratory cycle. Some clinicians 
reported that twisting the needle during insertion impoves stability in muscle tissue. 
10. Depending on clinician, insertion may be stopped at the pleura so that the stylet can 
be removed and additional Lidocaine injected.  Crossing the pleura is generally 
accomplished with a single swift jabbing motion; this avoids “tenting” which 
increases the risk of pneumothorax.  
11. Once the needle reaches the target the stylet is removed and a longer 22 gauge (0.644 mm) 
needle attached to a syringe and inserted. Fluid aspiration is accomplished by making small 
jabbing motions while drawing back on the syringe. Samples are squirted onto a slide or into a 
vial and fixed. A tissue sample may be collected by deploying a 20 gauge (0.812 mm) side cutting 
“biopsy gun.” The samples are then viewed either onsite or in the hospital’s pathology lab. 
12. Once the pathologist confirms that a diagnostically meaningful sample has been obtained, as 
opposed to fluid or unclear tissue, the biopsy is complete.  One more scan is taken to verify 
patient condition, then the needle is removed, a bandage applied and the patient flipped onto a 
gurney so that they are lying over the insertion site so as to apply pressure.  Experience at MGH 
has shown that enforcing this position decreases the incidence of pneumothoraxes. 
13. The patient receives two follow up X-rays to check for pneumothorax before being released. 
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Figure 28 – Schematic of patient in CT bore. “In-plane” angles are measured in the CT slice while “off-
plane” angles project across multiple slices, on and out of the bore. The CT display provides drawing and 
measuring tools to plan the intervention from the grid, visible as a series of dots, to the target. 
First hand observation provided a thorough understanding of the biopsy procedure process flow and 
suggested establishing metrics regarding procedure time and needle manipulations, both inside and 
outside the pleura, and radiation dose addressed with a more rigorous study, Sections 5.3.2 and 5.3.3. 
After decomposing the procedure into specific steps, the next design step was to identify those where 
robotic assistance could increase procedural efficiency and to partition tasks between the robot and the 
clinician.   Target identification and intervention planning appeared to be conducted satisfactory by the 
clinician using the grid and the on-screen tools. However, Steps 7 – 10 were identified as challenging and 
time consuming, with the clinician performing tasks that Table 1 identified as more appropriate for a 
robot and not fully exploiting the 3D data. Finally, while clinicians did sometimes experience difficulty in 
acquiring histologically significant cell samples, the actual time spent sample collecting was minimal and 
did not require super-human dexterity. Improving yield would require redesign of the aspiration needle 
and biopsy gun, a separate project. Therefore, the scope of the Robopsy project was limited to the 
placement of the biopsy needle from insertion point on the skin surface to target positions.  
5.3.2. 10-Case Observational Study 
As a follow on to the initial biopsy procedure observation, later in the summer of 2007 a series of 10 
procedures were observed at MGH. All were carried out by either a member of the thoracic radiology 
staff or a fellow under their direct guidance. Each step was recorded along with timing and the dose 
report which was printed out after each procedure. The following pertinent metrics were identified and 
the results are given in Table 6. 
 Scans to target – The total number of scans from scout to scan showing the needle in position. 
This roughly correlates with radiation dose. 
 Time to target (min) – Measured from the moment that the first scan was taken to the time 
when the needle is confirmed in target and it is sample time. 
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 Insertion Points – The number of times the insertion point was selected (minimum one). 
Generally, the adjustments were small, on the order of a few mm, and made with the injection 
needle, not the coaxial biopsy needle. 
 Manipulations Outside Pleura – The number of discrete needle motions executed in order to 
reach the pleura.  A single orientation and insertion counted as one motion. 
 Manipulations Inside Pleurea – The number of discrete motions executed from the pleura. 
These are liable to cause tearing and pneumothorax. 
 Pathology wait time (min) – This was the time spent waiting between sample acquisition to the 
pathologist’s arrival to review the sample; this contributor to procedure time was not directly 
controllable by the radiologist. 
 Procedure time (min) – This was measured from the moment that the first scan was taken to the 
moment that the needle was removed and bandage applied. 
  
Table 6 – Results of 10 Cases Observational Biopsy Study 
  
The mean observed time to target was in excess of a half hour; nearly 50% of the time was taken up 
with simply placing the needle into the target, which corresponds to an average of 12 scans, not 
counting the scout scan..  On average, 5 discrete motions were observed before crossing the pleura 
after which there is only an average of 1.6 motions. It is necessary to note that in cases 1-7 there was up 
to a 26 minute intra-procedure delay while waiting for pathology; by the time of the last three biopsies a 
pathology station had been installed in the radiology suite, thus reducing this delay. Interestingly, 
despite keeping careful notes through the procedure, in 6 out of 10 cases scans were recorded on the 
dose report that could not be linked to specific recorded actions. These “extra” scans, which passed 
unnoticed in the observer’s notes, may have been repeats due to slight adjustments of the CT 
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1 2-Jul-07 Posterior, right lung 9 29 3 3 1 16 56 52%
2 9-Jul-07 Anterior, right lung, above breast 18 52 3 8 3 18 97 54%
3 9-Jul-07 Right lateral decubitus, left lung 11 32 2 3 1 26 82 39%
4 11-Jul-07 Anterior above breast, right lung 11 35 4 5 1 24 94 37%
5 17-Jul-07 Anterior, left lung 13 39 1 5 3 15 73 53%
6 18-Jul-07 Posterior, right lung 11 28 2 5 1 18 70 40%
7 23-Jul-07 Prone, left lung superior 14 41 1 5 2 10 79 52%
8 23-Jul-07 Prone, left lung superior 11 31 1 6 1 na 51 61%
9 16-Jul-07 Prone, central lesion 20 na 1 6 2 na 51 na
10 21-Jul-07 Right upper apex, posterior 15 30 2 11 1 na 67 45%
Range (min): 9 28 1 3 1 10 51 37%
Range (max): 20 52 4 11 3 26 97 61%
Averages: 12.3 35.9 2.1 5.0 1.6 18.1 75.25 48%
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parameters; nevertheless this indicates the lower priority given to limiting patient radiation dose than 
precise targeting. 
5.3.3. 50-Case Retrospective Biopsy Study 
In-person observations were time consuming and disruptive to the clinicians, therefore a more 
rigorous retrospective study was conducted and the results are reported in [98]. Using MGH’s picture 
archiving and communication system (PACS), 50 consecutive procedures from 2007 were retrieved and 
the scans read in order by a trained radiologist. The time stamps provided sufficient information to 
collect much of the same data as during direct observation. The procedure was divided into 5 steps: 
trajectory planning, needle placement, extrapulmonary (outside the pleura) needle insertion, 
intrapulmonary (inside the pleura) needle insertion and sampling and follow-up; for each the number of 
scans was tracked. The effects of patient characteristics (age, gender, history of lung surgery), procedure 
characteristics (needle angle to pleura, patient position) and lesion characteristics (size, depth, lobe) 
were investigated. In addition, the diagnostic success rate, pneumothoraxes and post procedural 
insertion of chest stubs were tracked. Total patient radiation dose was calculated. To the authors’ best 
knowledge, while previous studies investigated diagnostic success and complications, none sought to 
correlate patient, procedure and lesion characteristics with number of scans, especially when concerned 
about radiation dose.  
 The population studied ranged from 32 to 89 in age and 
comprised 26 women and 24 men. The procedures were 
conducted by 5 radiologists at MGH with 5 to 26 years’ 
experience using a Siemens Somatom Sensation 64 helical 
scanner and following a standardized procedure for scanner 
settings and procedural steps.  Lesions varied in size from 0.7 
(near the limit that can be biopsied) to 7.9 cm with a median 
of 2.1 cm and varied in depth from skin surface from 2.7 to 
15.2 cm, with a median of 7.3 cm.  As expected, given the 
wide ranges of lesion characteristics, the number of scans 
per procedure also varied greatly, with a range of 11 to 38 
with a mean of 21. Procedure time averaged 1 hour. Of the 
total scans, planning accounted for 18.5% of the scans and 
insertion 52.9%, which together yielded 15 scans to compare 
with the mean of 12.3 from the prospective study. As 
expected, smaller and deeper lesions and shallower pleural approach angle were all associated with 
increased scanning. With decreasing lesion size and increasing depth the number of (undesirable) 
needle manipulations after crossing the pleura increased was seen to increase.  
Radiation dose was evaluated using the CT dose index (CTDIvol) reported in milliGray (mGy), which is 
the approximate mean dose delivered to a volume of a standard cylindrical phantom, and the dose 
length product (DLP) which is this value multiplied by the scan length. The effective dose E in 
milliSieverts (mSv) is used to quantify risk and was found using the ImPACT (Imaging Performance 
Assessment of CT Scanners) CT Patient Dosimetry Calculator, a Microsoft Excel based tool from the 
Imaging Performance Assessment of CT scanners (ImPACT) Group at St George's Hospital, Tooting, 
 
Figure 29 – A representative CT scan 
showing the parameters that were 
recorded from the images [98]. 
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London [99]. This tools overlays scans on the appropriate region of a model patient and applies scale 
factors to account for organs’ differing radiosensitivity and reports E as a single number. Also calculated 
was the effective skin dose (ESD) in millisievert (mSv), which is pertinent since a CT-guided biopsy 
concentrates scans in a relatively small area. For the entire study, an average E of 14 mSv and ESD of 249 
mGy with a maximum of 534 MGy were reported.  For reference, a dose of 2 Gy to the skin will cause 
visible damage; therefore dose does remain in a safe range. This paper concludes, “Ultimately, the 
results of this study illustrate the iterative nature of CT-guided interventions. This information highlights 
the need for hospitals to set low tube current and voltage levels for their CT-guided intervention 
protocols to minimize the radiation dose per scan, and also to explore the use of devices to aid needle 
placement to reduce the overall number of CT scans required.” Such devices would be most beneficial is 
targeting small and deep lesions while increasing procedural efficiency. 
5.3.4. Financial Consideration 
Cost is also an important factor and at MGH CT scanner time is booked in 20 minute blocks with 
each block costing approximately $250 dollars, for a total of $750 per/hour.  Although, as observed, they 
can run shorter, percutaneous lung biopsies are scheduled for two hour time slots and are reimbursed 
at rates between $560 (Medicare) and $1000 (average). Smaller, deeper lesions and multiple sample 
sites correlate with longer biopsies. It is important to note that charges billed by hospitals to payees are 
not necessarily paid in full, nearly all payees negotiate rates with self-pay patients often also receiving a 
discount. Based on the results of this study, it was estimated that by shortening the lesion targeting 
phase and aiding sample collection by stabilizing the needle it might be possible to consistently shave 20 
minute off scheduled procedure time. This slot can be filled with another revenue generating non-
interventional scan reimbursed at an average of $276. This informed the design process to focus on 
minimizing the disposable components’ costs. 
5.4. Strategies, Functional Requirements & Concept Development 
5.4.1. Strategy Selection 
With the needle placement procedure thoroughly understood, and the tasks portioned between the 
clinician and the robot the following broad FRs and corresponding 6 DOFs for the robotic device were 
identified, in order of operation: 
1. Needle gripping (1 DOF) 
2. X-Y position of needle tip about the patient’s abdomen (2 DOF) 
3. Needle inclination about two axis compound angle (2 DOF) 
4. Axial needle insertion (1 DOF) 
Firstly, there must be a way, either manual or automated, of gripping the needle. Secondly, the tip must 
be placed correctly at the insertion point, which may or may not need adjustment, as was seen during 
the biopsy observations. Thirdly, with the needle positioned, it is inclined about a compound angle so 
that it is aimed at the lesion.  Finally, it is inserted to the lesion, with angular adjustments if needed. A 
7th degree for freedom was identified, corresponding to rotation of the needle during insertion, however 
this was eliminated since no clinician indicated that it was essential. 
Using these FR’s and working with the two other mechanical engineers in the team two strategies 
for a patient-mounted robot were developed: a Cartesian frame and a gimbal-like mechanism, both 
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shown in Figure 30. The strategies are notably broad; at this stage the selection of actuators or detailed 
mechanical design would have been inappropriate. 
 
  
Figure 30 – Left: Cartesian frame for x-y translation with roller driven needle. Right: Two hoop, 
gimbal-like mechanism with overlapping slots, through which the needle projects. 
These represent two significantly different operating modalities:  
In the first strategy, a carriage with two rollers grips and secures the needle to fulfill FR #1. 
Translating this carriage about X-Y, with belts, screws or another mechanism, specifies the insertion 
point and fulfills FR #2.  Once the needle is in the desired position, it is lowered into the skin surface. 
This becomes the pivot point with subsequent motion of the carriage now causing the needle to 
angulate and fulfill FR #3. Finally, with the correct compound angle specified, the roller drive is used to 
actuate the needle to the target, fulfilling FR #4. 
In the second strategy, a spherical device is 
built around a single pivot point. A pair two hoops 
are arranged so that the rotational axes are 
perpendicular. Each is slit in the middle so that the 
needle can be contained in the intersection of the 
slots. By angulating the two hoops, the needle can 
be made to describe a compound angle, fulfilling 
FR #3.  This was inspired by various designs for 
robots wrists; particularly those of Mark Rosheim’s 
seminal Robot Wrist Actuators book [101] and 
various spherical actuators for pointing radar 
dishes. FR #1 and #4 would be addressed with the 
design of a “carriage” riding in the dual slot that 
comprises a method of gripping and inserting a 
needle.  In this design there is no method of 
 
Figure 31 – “Spherical Wrist Joint” [100] 
developed in 1980’s at Rensselaer Polytechnic. 
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selecting the insertion point, other than gross positioning of the robot on the patient. 
Based on study of multiple procedures and clinician interviews, it was determined that positioning 
of the insertion point was not a critical requirement. In Table 6 the insertion point was moved on 
average 1.2 times per procedure; however it was often not strictly necessary. Therefore, in accordance 
with the minimalist design philosophy, the 2 X-Y position DOFs were eliminated and the second strategy 
selected, as most likely to lead to an appropriate scale device. In the cases where moving the insertion 
point was critical; this task could be accomplished by the clinician repositioning the entire robot. This 
reduced the total to 4 minimally essential DOF and the focus was narrowed to the development of a low 
cost, lightweight and disposable device to be placed directly upon the patient, independent of the CT 
machine.  Target lesion size was selected as 5 mm. 
5.4.2. Functional Requirements & Concept Development 
With the double hoop wrist strategy selected, a concept system evolved as the functional 
requirements were expanded upon and further detailed in Table 7. Details of the device’s design are 
presented in a 2005 ASME Design Engineering Technical Conference paper [102], which showed the first 
prototype, and a 2008 ASME Journal of Medical Devices article [103], which built upon this and showed 
the second prototype. Much of the following material is drawn from these two papers. 
Table 7 – Robopsy System Functional Requirements 
1. Sizing – Fit inside a 70 cm diameter CT machine bore, between the patient and top of the bore, 
while not restricting access to the patient. 
2. Pitch & Roll – Angulate the needle about 2 DOF with the center of rotation placed at the skin 
surface. A cone of ±25° was identified as the workspace addressable in 1° increments. An 
approximate torque of 60 N-mm was observed during the testing shown in Figure 32. 
3. Insertion & Retraction – Place and withdraw the needle in 1 mm increments with a maximum 
force of 10 N. 
4. Radiolucency – Minimize CT scan artefacts (distortion) within the region of interest (ROI). 
5. Maintain Sterility – Design for disposability, select sterilizable materials and components and 
sheathe as appropriate. 
6. Chest Motion – Maintain needle in fixed reference frame with respect to rising and falling chest. 
7. Organ Motion – Provide for selective needle gripping to accommodate motion. Observations 
indicated a range of motion up to 25° with a fully inserted needle. 
8. Intuitive Interface – Provide the clinician with an operating procedure that enables 
straightforward integration with the current procedure.  
9. Safety – Reject unintentional motions and enable rapid stoppage, removal and conversion to a 
manual procedure. 
Normal CT bores are sized at 70-80 cm so as to provide a close fit around average patients (and a 
significantly snug fit around bariatric patients) so as to maximize image quality.  In general, needles of 10 
– 15 cm in length projecting from patient do fit within the bore. Therefore, it was important to minimize 
device size and a nominal diameter of 10 cm was selected as the maximum that could be 
accommodated.  In addition, larger devices such as the CTBot and the Light Puncture Robot, despite the 
straps, were seen as challenging to reliably mount on the curved surfaces of a patient.  
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Limited data is available on the actual forces during 
needle manipulation and insertion. One paper [104] 
reports on the placement of a 1.27 mm needle into ex-
vivo bovine livers and reported an average puncture 
force of 2.3 N. 10 N was estimated as an upper bound 
on the maximum insertion force. In order to determine 
the force needed to orient a needle during insertion 
testing was conducted in a turkey breast. As shown in 
Figure 32, a 19 gauge (0.912 mm) needle was inserted 
to depths of 10, 50 and 100 mm and the lateral force, 
at the fixed distance from the insertion point, to orient 
the needle measured with a spring scale.  At the 
deeper depths of 25 and 50 mm torques of 25 and 60 
N-mm were observed. 
Based on observation and discussion with clinicians, a 50° cone was determined to be a reasonable 
maximum range of motion. This is beyond the maximum tilt of any CT machine gantry. Clinicians strive 
to insert the needle as perpendicular to the skin as possible, both to aid in imaging and minimize the risk 
of pleural tearing. Angles of greater than 30° are needed only when no other unobstructed path to a 
target is available; this rarely occurs. In keeping with the design philosophy that eschews adding 
complexity, it was decided to focus on the majority of procedures. 
Avoiding metallic elements in the image range is essential to 
preserving image quality. As the CT beam emitter and detector 
rotate around the patient, they take a series of images which are 
subsequently reconstructed into a single slice image. Any errors in 
this are referred to as artifacts, excellent coverage of which is 
provided in [105]. Some are due to the physics of how X-rays are 
absorbed by the body and scanner emitter and detector 
operation, but the most severe artifacts with regard to this project 
are caused by metal objects, whose density exceeds the range of 
normal tissue, in the scanned region.  These effectively wash out 
and show up as white patches with radiating streaks that distort 
and obscure the image, as seen in Figure 33. Some software 
correction is possible to remove streaking; however this cannot 
address the localized degradation. Incidentally, with long slender 
objects a streak will appear to emanate from the object’s tip. In the case of biopsy needles, radiologists 
use this streak to preview the needle’s straight line trajectory. The best practice is to keep metal outside 
the ROI and this led to the decision to manufacture the robot structure entirely from polymers. In 
addition, this left the design space open for the potential later development of an MRI compatible 
robot, though MRI compatible actuators are still in their infancy and expensive. 
Sterility can be addressed through a combination of disposable components: those that can be 
sterilized, and those that require protective sheaths, similar to the sheaths used to cover the da Vinci’s 
 
Figure 32 – Measuring force required to 
angulate a needle previously inserted into a 
turkey breast. 
 
Figure 33 – Artifacts emanating 
from a pellicle implant, without 
correction [105]. 
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arms. The major sterilization methods employed in medical devices include steam autoclave for 
reusable devices and ethylene oxide and gamma irradiation for packaged disposable devices. The 
selection of radiolucent polymers also facilitated the decision to make the end piece’s structure low 
cost, lightweight and single use. 
Patient motion, both gross and that of internal organs also causes artifacts, hence the use of a robot 
to manipulate the image should not interfere with application of the “breath hold” technique during 
scanning or needle manipulation. In addition, a sufficiently light robot placed on the patient should rise 
and fall with respiration, as well as move with him or her in the case of a gross motion, such as a shift in 
position.  In addition, the need for a complete releasing of the needle was identified by Dr. Jo-Anne O. 
Shepard, Division Chief of Thoracic Radiology at MGH, as critical. In the fully inserted state, needles were 
observed to “waggle” from side to side by approximately 20° due to internal, respiration-driven organ 
motion. No contemporary device was found to truly have this feature. While the PIGA does grip and 
release a plastic bushing, through which the needle is inserted, the needle is intended to be inserted in a 
single pass. The Light Puncture Robot provides for step-wise insertion; however it is not clear that free 
motion is permitted when the needle not gripped. Being able to release the needle on command would 
also afford the clinician free access to manipulate the needle during sample collection, as well as permit 
easy conversion to a manual procedure.  
In order for robotics to gain wider acceptance in lower value procedures, with significant potential 
for efficiency improvement, the philosophy of appropriate scale should also apply to the clinicians’ 
interaction with the device.  So while providing an “extra hand” to perform the tricky manipulations 
inside the bore, the interface should enable the user to follow current procedure as closely as possible. 
Additionally, minimizing the disturbance between the clinician and patient will enable easier conversion 
to a manual procedure in the case of device failure. 
With an understanding of the functional requirements, the design was separated into three 
modules, with the first identified as the most critical. 
Table 8 – Robopsy Modules 
1. Robotic Actuator – The device that sits directly on the patient inside the CT (MCM) 
a. Base structure and double hoop angulation sub-module (2 DOF) 
b. Needle gripping and insertion sub-module, the “carriage” that is carried by the hoop. 
(2DOF) 
2. Control Box – Connected to the device and remote from the patient, nominally on a cart beside 
the CT bed. 
3. Clinician Interface – This comprises a software graphical user interface (GUI) as well as a 
hardware interface, such as a joystick, stylus or mouse. 
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Figure 34 – Robopy system concept and modules. 
5.4.3. Actuation Modality 
Before progressing with the structural design, it was necessary to select an actuation means. Various 
options are presented in Table 9 encompassing two basic modalities: Remote and Local. The former 
would generate force within the controller and transfer it to the device and while the latter placed 
electric motors directly onto the device. The remote options could, potentially, have resulted in a more 
economical design, by placing more expensive components in the controller, the drawbacks outweighed 
the benefits: While pneumatics are clean and easy to connect, they have poor positional control, a 
challenge only overcome by Innomedic after years of work. Hydraulics, using incompressible fluids, 
provide better position control; however their resolution is limited due to friction in the seals which 
must be tight if leakage, unacceptable in a medical environment, is to be avoided. This was extensively 
explored in [106], the authors masters’ thesis, with negative findings. Both hydraulics and pneumatics 
would require a hose with a minimum of 4 lumina, 8 if a dual acting configuration were sought, the 
stiffness of which would be a concern when placing the device. Both flexible drive shafts and cable 
drives could be constructed of sterilizable materials; however they are typically bulky, suffer from 
windup and are better at delivering unidirectional torques.  Therefore, it was decided to place 4 
micromotors directly on the device with a single, flexible cable connecting to the controller.  Further 
discussion of the actuators is provided in the context of each prototype. 
Table 9 – Actuation concepts for the robotic device 
  
Cleanliness 
Flexible 
Transmission 
Positional 
Accuracy 
CT 
compliance 
Serializability 
Pneumatic Remote ✓ ? X ✓ ? 
Hydraulic Remote X X ? ✓ ? 
Flexible drive shaft Remote ✓ X ? ? ✓ 
Cable drive Remote ✓ X ? ? ✓ 
Micro motor Local ✓ ✓ ✓ X ? 
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5.4.4. Prototype Overview 
Three generations of the Robopsy robot, called Alpha, Beta and Gamma, were constructed and are 
show in Figure 35. All prototypes were modeled with SolidWorks CAD software, Waltham, MA.  The first 
two devices were created with SLA rapid prototyping, using a local vendor and assembled and tested at 
MIT. Both micro stepper and micro servo motors were tested. The third prototype was developed in 
partnership with Saia-Burgess Dresden GmbH, Dresden, Germany, part of the Johnson Electric group, 
Hong Kong [107], which custom designed a stepper motor and integrated it into the design.  The third 
prototype was resin cast from urethane molds. All three control boxes were designed and assembled at 
MIT. Each prototype was demonstrated to clinicians, tested and refined. 
Conversations with clinicians indicated openness to a robotic biopsy assistant, provided they 
remained in control and the learning curve was short. This contrasted with systems such as the da Vinci 
where extensive training is commensurate with complexity. Developing and refining a user interface 
proved as challenging as the mechanical design. The goal was that one the device was placed on the 
patient, the clinician would be “fly-by-wire” from the control room, updating the image as needed, until 
the needle was successfully located in the target. The first two graphical user interfaces (GUIs) were 
programmed in Microsoft Visual Basic 6, which permitted basic graphics and rapid prototyping, and 
required the clinician to be the bridge between the CT display and the robot interface. The second was 
used with the Beta prototype in both phantom trails and a porcine trial. The third interface was 
developed and as joint project with the German Cancer Research Center (DKFZ) Division of Medical and 
Biological Informatics in Heidelberg, Germany. This direct point-and-click control and was used, again, in 
both phantom trails and a porcine trial. 
 
Figure 36 – Three generations of Robopsy interfaces showing progress to point-and-click guidance. 
   
Figure 35 – Three generations of Robopsy devices and controllers: alpha, beta and gamma. 
- 52 - 
5.5. Alpha & Beta Prototypes 
5.5.1. Structural Design 
 
Figure 37 – Alpha prototype SolidWorks CAD model showing components with the needle unclamped. 
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The alpha prototype, shown in Figure 37 
and Figure 38, encompassed all of the major 
design features. The structure was 3D printed 
polymer and weighed 200 g, including the 
motors but excluding the wiring harness. This is 
significantly less than the CT Bot’s 3 kg. The 
base plate is intended to rest directly upon the 
patient and was equipped with tabs which 
could be taped down and slots for straps. Later 
in the process, tape was found to be more 
satisfactory and a two sided, starfish-shaped 
adhesive pad developed, discussed in Section 
5.5.1. The nominal diameter of the device is 10 
cm, which made it easily handleable and able 
to accommodate motors of sufficient torque. 
This sizing was maintained in all 3 prototypes. 
For future embodiments, an array of bases 
with geometries fit a particular region of the 
body was prevue. 
 The two hoops snapped into raised tabs on the base and shared a central pivot point. Two motors 
fit into sockets and directly drove the hoops. The nominal needle pivot point was located at the 
intersection of the hoops’ axes. Ideally, this would be located right on the skin surface; however it was 
lifted by 8 mm, the motors’ 5 mm radius plus their 3 mm thick sockets. In practice, the actual pivot point 
is indeterminate and located somewhere inside the dermal tissue. Restraining the needle to pivot at a 
specific point was not seen as desirable and liable to cause tissue tearing and needle bending. Placing 
the motors in a vertical configuration with a bevel gear drive would have facilitated a more compact 
configuration, but would also have increased part count and interfered with the envelope of the 
carriage’s movement. 
The carriage rides in both hoops’ slots and was aligned with the upper hoop, while the lower hoop 
provided the second DOF, thus the compound angle was described. Inside the center of the carriage is a 
25° cone shaped opening, termed the “waggle window,” through this the needle passes and is free to 
move when not gripped. Various needle gripping and insertion methods were considered, including drill 
chucks and propelling pencils, but the simplest was found to be a 2-roller friction drive.  The driven roller 
is mounted to the carriage while the opposing roller is free spinning and attaches to a curved slide, 
which rides in slots in the carriage and is driven by a rack and pinion. As the slide closes from one side, 
moving the lower hoop a corresponding 12.5° centers the needle in one direction, while a scalloped 
guide, incorporated into the slide so that it advances ahead of the roller, centers the needle along the 
rollers axes.  A more complex mechanism that would close from both sides was brainstormed, but 
eschewed in preference for a drive motor mounted to the carriage. The slide is curved concentric with 
the top hoops to ensure that the rollers provide a griping force that is tangential to the needle axis and 
does not tend to cause misalignment. This clamping mechanism allows for a range for circular needles to 
 
Figure 38 – Detail of Alpha prototype with CT 
machine’s alignment lasers visible. 
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be inserted, including ablation probes.   Opening the slide leaves the needle free for immediate device 
removal and conversion to a manual procedure. 
The plastic structure was designed to be disposable, 
following the principles of DFMA (Design for  Manufacture 
and Assembly) of Boothroyd, Dewhurst and Knight [108], 
with the intent that in a production all parts would be 
injection molded, with the minimum of side pulls and 
complex mold geometry, and snapped together during 
assembly without adhesive or screws.  No separate bearings 
were used; plastic-on-plastic sliding contact was satisfactory 
for the forces and desired lifespan. The final part count was 
as follows: Base, hoops (2), carriage, pinion, slide, rollers (2), 
rubber roller covers (2), micromotors (4), wiring harness. CT 
compatibility was addressed in the same manner as with 
Johns Hopkins PAKY, by positioning the motors so as to leave 
a 2 cm metallic free zone in the center of the device, as 
shown in Figure 39. It is necessary to align the device as 
shown with the taps parallel to the scan plane and the hoops at 45° angles so that the device’s 
kinematics are defined in relation to the CT machine’s coordinate system. 
This prototype’s components were printed by, Vaupell Rapid Solutions, Hudson, NH, in Somos 14120 
photopolymer resin from DSM, Elgin, Il which produces tough, white parts with mechanical properties 
similar to ABS.  All critical components sizing was validated with SolidWorks’ COSMOSWorks using a 
Young’s modulus of 2.46 GPa and a UTS of 45.7 MP, which are comparable to the properties of 
engineering plastics that would be used in a production device. The SLA parts required light sanding on 
the points with sliding contact.  During assembly the hoops were first aligned so that the carriage can be 
snapped into both slots, then the lower hoop is rotated 90° and they are both snapped into their 
respective tabs. The slide is fitted to the carriage, the passive roller snapped in and the driven roller and 
pinion slid into their sockets. All driven elements (hoops, roller and pinion) had tapered, star-shaped 
bosses which mated with couplings bonded to the motors’ shafts.  Once the motors were fitted into 
their sockets and clamped with zip ties the entire assembly was secure. 
5.5.2. Torques & Motor Selection 
Torque requirements for the motors were determined from the specifications, the robot geometry 
and masses, as shown in Figure 40, and the associated equations. Using the maximum desired insertion 
force of 10 N and a nominal drive roller diameter of 10 mm, a necessary drive torque of 50 N-mm was 
determined. By assuming a frictional coefficient of 0.25 between the roller’s rubber cover and the 
needle, the necessary max pinion torque was estimated to be 160 N-mm. The slide and pinion gear 
teeth were designed to deliver a 40 N gripping force.  A pitch angle of 20°, a pitch diameter of 8 mm and 
a width of 10 mm was selected. Using the DSM material’s properties, a mod 1 gear pitch provided a 
reasonable factor of safety balanced with sufficient pinion teeth (an 8 tooth pinion is near the minimum) 
for smooth motion. Likewise, as shown in Figure 40 B, the torques necessary to orient the lower hoop B 
and carriage were estimated with the carriage at a maximum angle of 30°. Using a carriage mass (m) of 
 
Figure 39 – Top view of Alpha prototype 
showing metallic free scan plane. 
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~100g including motors, a plastic-on-plastic frictional coefficient (µ) of 0.25, a radius (l) of 50 mm and an 
estimated preload of 0.6 N between the hoops and carriage and a measured torque of 50 N-mm 
necessary to orient a needle at a depth of 10 cm, the torque required to actuate a hoop B and the 
carriage was estimated to be in the range of 100 N-mm.  
 
Figure 40 – Estimating the torques for 
needle clamping, orientation and 
insertion [103]. 
NmmmmN
driverroll
r
insertion
F
driveroll
50510 
  (1) 
Nmmmm
N
pinion
r
roller
insertion
F
pinion
r
grip
F
pinion
1604
25.0
10




 (2) 
        
  NmmNmNmm
Ngkggkg
needle
l
preload
Fmgmg
needlefrictionalmassorient
1001.005.005.0
25.06.030cos1.030sin1.0
)cos(sin






 



 (3) 
  
For the purpose of sourcing and mounting efficiency, it was decided to use the same actuator for all 
axes, therefore the limiting peak torque was approximately 160 N-mm. The Alpha prototype employed 
10 mm diameter model AM1020 bipolar stepper motors with 256:1 ratio gearboxes from Arsape, part of 
Faulhaber GmbH, and represented by Micromo, Clearwater, FL. The gearboxes were rated to output 
100 N-mm of torque continuously (200 N-mm intermittent), which is within the device’s requirements, 
with a speed of approximately 360°/s, which ideally translates to a 1 s needle clamping time and a 20 
mm/s insertion rate. Steppers are inherently position controlled, albeit without feedback, and the 
bipolar design needs only 4 wires. Additionally, in the case of a broken connection, they stop 
immediately without the chance of spinning wildly, as can happen with servos. For the clamping axis, 
overdriving the servo and deliberately allowing steps to skip provided sufficient clamping force. Four 4-
conductor telephone cables comprised the wiring harness, with each plugging into the control box. 
Inside the control box was a power supply, four stepper drivers and a USB addressed motor controller 
from Arcus Technology, Livermore, CA. Components were sourced from NetMotion Inc., Santa Clara, CA. 
With all prototypes a long cable was run from the control box next to the patient, under the control 
room door to a laptop running the interface, shown in Figure 42. With no direct sensing of position, 
during initialization the device must be manually or automatically homed and zeroed. 
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5.5.3. Alpha Interface 
 
Figure 41 – Basic Alpha interface, used to confirm device operation. 
The first interface, shown in Figure 41, provided direct slave control over the robot and minimal 
feedback to the clinician. After planning the intervention, plugging in the robot and powering the control 
box, the Altera controller was activated via by clicking the “Load” button. Now the robot could be 
secured over the insertion point, the hoops centered and the slide opened manually. Clicking the “zero” 
button energized the four motors and set the counters to zero. The interface displayed a (rather 
gruesome) cross section of a patient’s lungs and indicated the off-plane (theta) and in-plane (phi) angles, 
explained in Figure 28, as well as the depth (Z). Gripping and releasing was controlled manually via the 
“Clamp Needle” button. Beginning with the needle gripped in the upright position and gripped, the next 
scan would be used to find the in-plane and off-plane angles. Then after drawing the desired trajectory 
on the CT display, the difference between the needle’s current angles and the desired angles would be 
measured. These were then typed into the “Angle Position” box and the “Go” button clicked. For finer 
adjustments the interface provided 1° “Jog” buttons. Likewise, the distance from the needle tip to the 
target was measured and the needle inserted by either 
direct input or 1 mm increments. 
5.5.4. Robot-Assisted Biopsy Protocol 
Throughout the interface design process the words of 
Henry Dreyfuss (1904-1972) were kept in mind: “If the 
point of contact between the product and the people 
becomes a point of friction, then the industrial designer 
has failed,” [109] as well as the guidelines provided by 
Don Norman [110] and Sanders and McCormick [111]. In 
all three generations of the interface, minimizing features 
and coordinating with existing clinical protocol was 
stressed. Working with the first interface, the following 
 
Figure 42 – Operating the Alpha prototype 
from the CT control room. 
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general “Robopsy Assisted” protocol was outlined, with the intent of ensuring that all motions were 
made in “near real-time,” i.e. based on a recent image, while minimizing the number of scans. 
Table 10 – Robopsy Assisted Biopsy Protocol 
1. With the insertion point selected, the device is placed onto the patient, centered over the 
insertion point and powered up and initialized.   The needle is placed and clamped in the upright 
position. The patient is then returned to the scanner bore along with the device and the clinician 
returns to the control room.  
2. A scan is done in which the needle is visible; this effectively registers the needle position. 
3. The path is drawn from the needle tip, which coincides with the insertion point, and the 
difference in-plane and off-plane angles measured.   These are inputted into the interface and 
the device moved to the desired compound angle.  
4. Another scan is taken and the needle’s orientation is verified; if not correct, it is adjusted and 
another scan taken. 
5. If no adjustments are needed, the depth from the needle tip to the target is measured and the 
device actuated towards that depth. 
6. If desired, an interim scan is taken before the needle crosses the pleura and additional Lidocaine 
injected.  Any final angular adjustments are made at this point. When not being actuated, the 
needle is unclamped and permitted to waggle freely. 
7. The distance is measured from tip to the target again, and insertion is completed. The needle’s 
successful location in the target is confirmed with a final scan, then the patient is removed from 
the bore and sample acquisition commences in accordance with current procedure. At the 
clinician’s discretion, the needle can be stabilized with the clamp. 
8. Optionally, should samples be desired from multiple positions, Steps 2 – 6 can be repeated, with 
care taken to not tear the pleura. 
5.5.5. Alpha Validation Testing 
The first testing of the Alpha prototype device, shown in Figure 43, was conducted in December 
2004 on a thoracic phantom and a foam block using an MGH Siemens Somatom Sensation 64 CT.  This 
focused on confirming the device’s mechanical functionality as well as the central region’s radiolucency. 
  
Figure 43 – CT image of Apha prototype on 
thoracic phantom.  The robot is visible but the 
needle is not distorted. 
Figure 44 – Testing with turkey tissue. Plastic ties 
strap the robot to the turkey. 
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As seen in Figure 43, when the robot is correctly aligned, the polymer structure is visible, but no artifacts 
cause distortion. Subsequent tests were conducted in September 2005, shown in Figure 44, on a store 
bought turkey with metallic spheres placed inside the cavity as targets. This test was conducted at the 
MGH Volume CT lab, an experimental facility with a flat panel CT scanner. Partial success was achieved 
in targeting the spheres, however the turkey tissue proved a poor analogue for human tissue, so future 
tests employed a gelatin phantom. 
5.5.6. Beta Prototype 
 Testing of the alpha prototype eventually 
proved destructive, with the SLA material 
embrittling from exposure to light. Therefore, a 
new prototype was fabricated, shown in Figure 45.   
This prototype had the same base dimensions, with 
minor design tweaks, including a longer motor, a 
function of switching to micro servos with 
encoders. The wiring harness was improved with 
the introduction of “super flexible” wire and better 
cable management. A ring-like guide was added to 
the center of the base to facilitate its positioning 
over the desired insertion point and minor 
adjustments were made to the carriage geometry. 
The control box was upgraded with the use of 
an industrial 4-axis control board, model DCM-
2143, from Galil Motion Control, Rocklin, CA. This 
board was addressed via Ethernet or RS232 and 
Galil graciously donated their control software and Active X toolbox for development use. This board is 
both able to receive motion commands as a slave and autonomously run programs, though the latter 
capability was not used. It also accepts a range of add-on driver and breakout boards and in the Beta 
prototype it was coupled with a Galil servo control board, model AMP-20413. Both boards were sourced 
from Automation Solutions Atlantic, LLC, Beverly, MA. As an experiment, Faulhaber micro servo motors, 
model 1024, were selected for this prototype. These 10 mm diameter motors were fitted with the same 
256:1 gearbox and an HEM 1016 magnetic encoder for a total package length of 60 mm. The motors 
have a recommended maximum 1.28 N-mm torque which with 60% gearbox efficacy brings the 
deliverable torque to 200 N-mm. The recommended maximum speed is 47 RPM after reduction, which 
meets specifications.  
Via the controller, the hoops and drive roller were operated under closed-loop position control. To 
grip the slide was commanded to an overshot position and the gripping force controlled by sending a 
current limit command Galil board, which effectively limited the torque. Maximum insertion force was 
also modulated this way. Using absolute encoders in this size scale was not feasible, therefore a homing 
procedure was specified and the current limit command used to modulate the force applied to the 
structure, during this operation step. Each axis required two wires for the motor and four for the 
encoders, totaling 24 individual leads. To alleviate stiffness issues, 27-conductor Superflex wire from 
 
Figure 45 – Beta prototype, shown atop a foam 
block inside a CT scanner. 
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Cooner Wire, Chatsworth, CA, and a pair of D-Sub connectors was used to connect the robot to the 
control box, which was made from a standard project box. 
5.5.7. Beta Interface 
  
Figure 46 – Beta interface, which guides the clinician through the procedure and provides graphical 
feedback of needle planned and actual position with respect to the stylized patient graphic.  
Testing with the Alpha interface confirmed the device’s functionality, but also highlighted several 
weaknesses: Radiologists had difficulty in translating the angles measured on the CT display to the 
“theta” and “phi” of the Robopsy interface. Moreover, selecting the correct length needle, 5 cm longer 
than would be needed for the conventional procedure was challenging. Surprisingly difficult was 
bridging the gap between the coordinate systems used by engineers and radiologists. While engineers 
can intuitively think in compound angles and coordinates, a radiologist positions a needle with respect 
to a patient’s body. It became clear that it was important to provide the same in-plane and off-plane 
views. Therefore, the second interface, shown in Figure 46, was developed with the goal of providing a 
1:1:1 mapping between the view of the patient visible through the control room window, the CT display 
and the Robopsy interface. The design of this interface was described in the proceedings of the 2007 
EMBS conference [112]. 
The Beta interface guided the clinician through the procedure and provided a stylized 
representation of the patient and the needle’s position. Panel 1 prompted the clinician to plug the robot 
into and power up the control box, indicate whether he wished to use a joystick, establish a connection 
with the controller and then perform the powered homing procedure. This entailed driving the hoops to 
their limits of travel then returning them to a central position and opening the slide. At this point the 
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robot was ready to be placed on the patient and secured at the insertion point. In Panel 2 the patient 
position on the scanner was selected (head first supine, head first prone, etc.) which caused the cartoon 
graphic to change along with the labels for +/- sign conventions, caudad (towards posterior) and 
cephalic (towards head). Entering the measured distance from insertion point to lesion resulted in the 
interface adding 5 cm and rounding up to the minimum acceptable needle length.  Entering the gantry 
angle updated the green box on the patient cartoon. Only once the required information was entered in 
Panel 2 did Panel 3 become active, thus the possibility for erroneous actions was decreased. 
Panel 3 provided control over the needle angulation. The needle’s position was displayed as a solid 
line and clicking the arrow keys or entering an angle or depth value generated a preview blue dashed 
line on both the off-plane and in-plane (transverse) views. The current position was represented by the 
black line.  This preview could then be accepted with the “Execute Orientation” button or cleared with 
the “Cancel Orientation” button. Since the hoops are oriented at 45° to the scan plane, the commanded 
in-plane and off-plane angles were transformed to robot commands and motor steps with Equation (4). 
Included in the position of Hoop B was an adjustment ClampStep to account for Hoop B’s movement in 
sequence with the slide during clamping. 
 
  ClampStepstepsOffPlaneInPLane
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HoopB
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
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 (4) 
The clamping and unclamping was automated, though the clamp could be activated manually, such 
as when a sample was being collected as a means of steadying the needle.  As before, the insertion 
control was decoupled from orientation so as to prevent compound angulation and insertion motions. 
Clinician response to this interface was improved and it was used in both a phantom and a porcine trial. 
In response to questions as to whether haptics could be added to the system, this interface also 
served as a test bed for incorporating joystick based control. The hypothesis was that, rather than 
clicking and measuring on the screen, tilting a handle in the same direction as the needle would be 
intuitive, as was done with the Sensei X catheter. Surprisingly, user testing promptly demonstrated that 
this was a hindrance to the workflow, rather than an asset. Radiologists are comfortable working in a 2D 
space and flipping through multiple slices to approximate a 3D view, as well as tilting the gantry. 
Clinicians were more comfortable with continuing to specify in-plane and off-plane angles than remotely 
“driving” the device. Therefore, this option was removed. This example demonstrates the importance of 
continuous user feedback through the design process. Interest did remain in being able to sense 
penetration through various tissue layers, however the design and production costs of implementing 
force sensing into the robot would be substantial and not justified given the near real-time feedback and 
ability to precisely control depth. Additional feedback could be effected by adding a camera to the 
control box, and feeding the image back to the interface to provide visual confirmation of the robot’s 
function, allow for remote patient monitoring and, possibly, assist with respiratory gating.  
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5.5.8. Beta Phantom Testing 
With the fabrication of the Beta 
prototype and interface, a uniform and 
sanitary thoracic phantom was constructed 
from Vyse ballistic gelatin, used to simulate 
human flesh for armaments testing, from 
Gelatin Innovations, Schiller Park, IL. The 
gelatin was cast around plastic pipes, which 
mimicked the patient’s ribcage, with 2 to 20 
mm radiopaque glass beads underneath, 
which served as targets. A layer of thin (shelf 
liner) foam served as the skin. Mechanical 
and interface testing with this phantom 
design in January 2007 prepared for 
subsequent porcine testing. Testing followed 
the protocol defined in Table 10.  For each 
insertion attempt, the total positioning and insertion time and number of scans were recorded. This 
data was compared to manual lesion targeting trials, following standard protocol, with the same 
phantom. Rigorous analysis, however, was not conducted during this test. In general, it was found that 
the gelatin provided reasonably realistic resistance to angulation, but clinical opinion indicated that it 
was too easily cut by the needle. The container’s clear sides and the gelatin’s translucency enabled 
direct observation. The glass beads, while indeed visible in the CT, displaced when targeted by the 
needle, leading to a lack of clarity in evaluating targeting. Therefore, in future phantoms they were 
replaced with penetrable materials. Overall, phantom testing with the Beta prototype indicated that, 
under ideal conditions it may be possible to complete a procedure with only 4 scans: 1. Planning; 2. Post 
device placement for needle registration; 3. After angulation; 4. After insertion to confirm correct 
placement in lesion. 
5.5.9. User Feedback 
Early contact with clinicians not affiliated with a project is essential for obtaining candid feedback to 
guide the design (and potentially the commercialization) process. In November of 2006 the Robopsy 
Beta system was privately exhibited at the Radiological Society of North America Annual Meeting in 
Chicago, IL. The trip was organized by a company with a potential interest in the technology and the 
prototype, under joystick control, was demonstrated to 40 – 50 select clinical radiologists, with a portion 
considered key opinion leaders (KOL). Along with a request for general feedback the following guiding 
questions were asked:  
1. Do you see this device adding value to CT-guided biopsy procedures? 
2. For what type of procedures would you use this device? 
3. How much do you think this device should be priced? For hardware? For the consumables? 
4. Future enhancements? 
Though the demonstration format did not allow for a statistically controlled or analyzed study, notes 
were taken and the results summarized: 
 
Figure 47 – Testing on a ballistics gelatin thoracic 
phantom with positioning grid and robot. 
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 Most radiologists thought the device would be valuable to help save time going back and forth 
between the scanner and control room. The reported length of time for lung biopsies varied 
depending on the expertise of the doctor doing the procedure, but most felt that the MGH slot 
of 2 hours was too long. 
 Some clinicians commented that while they had the expertise to target lesions without the 
assistance of a mechanical device, “less experienced” radiologists might benefit.  
 Responses varied as to whether patient radiation dose was of sufficient concern for reducing it 
to be perceived as a benefit.  
 Potential hospital targets included both small community establishments where clinicians have 
less confidence and practice in performing biopsies, as well as those familiar with high tech 
devices. 
 Procedures that would benefit from this device included lung, kidney, liver, pancreas, adrenal 
glands, RF ablation, prostate seed placement. Breast biopsy was never mentioned since 
ultrasound is the most commonly imaging modality and lesions are relatively accessible.  
 All clinicians wanted to see animal and, later, human studies using the device along with clear 
date on accuracy. 
 Pricing was explored with a range of $50 – $300 for consumables; $200 was perceived as 
reasonable.  Acceptable pricing for the control hardware was less than $5000; this, however, is a 
significantly lower number than is typical for comparable systems, such as Mazor’s Renaissance. 
 Mounting to a patient with straps was seen as a challenge, especially with bariatric patients; 
adhesives appeared to be a better option.   
 A future enhancement could also be the addition of limited haptics or an indicator to allow 
clinicians to feel changes in tissue as the needle was inserted.  
 Pertinent to the question of whether to make the robotic end piece entirely consumable or in 
two parts, with the motors and wiring harness salvaged, was in part answered by the assertion 
that any complexity in the assembly procedure would be negatively perceived. 
5.5.10. Robot Mounting 
 Adequately securing the prototype was an 
ongoing challenge. Testing indicated that the straps 
did not provide a particularly secure mounting. 
Moreover, placing the straps around an actual 
patient, after they had been appropriately 
positioned, the intervention planned and the 
insertion point marked on the skin, would be a 
significant disturbance to procedural flow. Nor did 
taping down the device tabs prove satisfactory. 
Therefore, a starfish shaped adhesive pad was 
developed, inspired by Nexcare Active Strips, from 
3m Medical, St. Paul, MN. Personal experience 
showed that (only) these adhesive plasters, by virtue 
of their foam backing and particular adhesive chemistry, adhered reliably, resisted moisture and peeled 
 
Figure 48 – Adhesive pad without and with 
Velcro and alignment grid. 
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off hair painlessly. The same material was sampled from 3M and various durometers tested. Adhesive 
tape 9781, a PVC foam, coated on one side with an acrylic adhesive and totaling 0.6 mm in thickness, 
was selected for its moisture resistance and high conformability. When cut into the starfish shape, the 
legs can be stretched during application to the skin, resulting in tensioned grip.  During the 2007 porcine 
test, the material was found to satisfactorily attach the device over the bristle of an unshaved porcine, 
as seen in Figure 52.  Both bonding the pad directly to the base of the device with a double sided tape, 
also from 3M, and using a Velcro interface and integrated locating grid were prototyped. With the latter, 
the pad would be placed right before the planning scan and the integrated grid used to locate the 
insertion point on the patient, whereupon the skin would be nicked and the robot Velcroed to the pad, 
with the possibility of adjusting the insertion point, without having to peel off and replace the pad. 
However, the Velcro base limited the grid's size and unless the insertion point was luckily in the center 
of the grid, the device and the pad would not align, resulting in unsecure attachment. Providing 
replacement pads for the occasional adjustment was a more efficient solution for the occasional 
remounting challenge. 
5.5.11. In-Vivo Porcine Trial with Beta Interface 
The first live porcine test of the Robopsy system was conducted at MGH in July 2007 on a Siemens 
Somatom Sensation 16 scanner. All MGH regulations pertaining to animal testing were observed, the 
testing protocol was approved by institutional review and a veterinarian monitored the procedure for 
compliance. Images of the test are shown in Figure 49. The porcine was anesthetized, intubated for 
positive ventilation and placed in a head first, left decubitus position. Rather than surgically implanting 
targets or using a porcine that was positive for cancer, a handful of artificial targets were created with a 
mixture of agar and 37% iodine CT contrast agent. An initial scan was conducted and this was injected 
with a 22 gauge (0.64 mm) needle, as seen in Panel B, and hardened into blobs visible under CT.  
After taking another scan, a target of approximately 2 cm was selected and, subsequently, the test 
followed the protocol described in Table 10. The insertion path was planned, the skin nicked and the 
robot homed and placed; the adhesive base was attached, and satisfactory performance was confirmed.  
The second scan was taken with the needle clamped in the upright position.   Using the CT display, the 
angles between the needle and the trajectory from the tip/insertion point were measured, as was the 
depth. The needle was angulated and inserted and a third scan acquired. From this a 3° angular 
correction and 4 mm further insertion were needed. This was executed and the needle was confirmed 
touching the target in the fourth scan, as seen in Panel (f).  
The primary goal of this test was to in-vivo validate the system operation; with only a single porcine 
it was not possible to conduct a significant comparison between the manual and Robopsy assisted test 
and time was not kept. During testing the device was observed to rise and fall approximately 2 cm with 
respiration and the needle to oscillate by 10° when unclamped, thus highlighting the applicability of the 
patient mounted model as well as the “waggle window.” Targeting was accomplished with the expected 
4 scans, as compared with the over a dozen observed during the observational study in Section 5.3.2. 
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Figure 49 – Porcine testing with Beta system. 
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While this porcine trial further validated the mechanism, as the scans show, the procedure was not 
entirely successful: Firstly, the initial incision was of a depth such that when placed into the robot the 
needle already penetrated the thoracic cavity, as seen in panel (d). This prevented the needle from 
being accurately angulated pre-insertion. Secondly, backlash in the motors combined with the hardness 
of the artificial lesion resulted in a tangential, rather than central targeting of the ~15 mm diameter 
lesion. Thirdly, whereas a human is able to cross the pleura with a quick jabbing motion, as panel (e) 
shows, there is evidence that the robot’s slower, steadier insertion can cause a pucker in pleura and a 
minor pneumothorax. This is also, in part, due to the ventilation of the porcine which was necessary due 
to the complete sedation. Measuring angles and depths on the CT display and transferring them to the 
interface proved undesirably complex, and this gave the impetus to implementing a direct point and 
click interface. 
5.5.12. Patent 
 A U.S. provisional patent was filed on January 28, 2005 
and followed with a utility patent application on January 27, 
2006 [113], which is still pending. The assignee is the 
General Hospital Corporation d/b/a Massachusetts General 
Hospital, and is managed through their Corporate 
Sponsored Research Licensing (CSRL) office. Robopsy’ 
twenty-four claims describe a structure and function that 
appears unique. They describe the mechanism and its 
intended function of aligning and inserting a generic tool 
into tissue.  Claimed is a base which facilitates fixturing to a 
patient and supports the pair of opposed rotating hoops 
which drive a carriage.  The carriage is equipped with a viewing window through which a tool passes and 
is selectively secured with a sliding clamp.  The tool is driven into tissue via one or more rollers.  A 
partially polymeric structure is claimed.  Remote image guidance is covered, whereby the trajectory is 
adjusted via an image of the device and target surgical site, without specifying whether the doctor 
makes the adjustments while viewing the CT image, as with the current prototype, or the adjustments 
are made automatically by linking to the CT data.  
5.6. Gamma Prototype 
5.6.1. Motors, Structure & Controller 
In both the Alpha and Beta prototypes, motors represented the most costly element of the robot, 
with each small-quantity priced at ~$50-100, too expensive to be disposable. This led to investigating 
whether the motors and wiring harness could be made detachable from the disposable plastic structure 
and reused. This raised sterility concerns and protective sheathing was evaluated. Unfortunately, 
placement of the four motors, with two stationary and two moving with the carriage, as well as the 
needle’s passage through the center of the device, would have made for an unduly complex and 
challenging to use challenging to use design. Alternately, sealed motors and gearboxes with heat 
resistant lubrication that could be autoclaved, e.g. Klübersynth UH1 64-62, Klüber Lubrication, 
Londonderry, NH, but were identified but found to be prohibitively expensive and only able to withstand 
limited sterilization cycles. In either case, reusing the motors and harness would require an intuitive 
Table 11 – Key Robopsy IP Claims 
“ Guidance and Insertion System” 
 Base for patient mounting 
 Rotating hoops describing two angles 
 Needle clamping  / unclamping  
 Friction drive for insertion 
 Polymer structure 
 Image-based guidance 
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attachment/detachment method, with each motor keyed to the appropriate axis, as well as an extensive 
self-test procedure. Moreover, this would run counter to current practice in the CT suite. Whereas 
operating theatres are equipped to handle reusable devices, such as the hand pieces of surgical drills, all 
the equipment necessary for biopsies is disposable and delivered sterile and sealed in a plastic tray.  
(This includes gloves, drapes, needles, syringes etc.) Therefore, it was decided that following a fully 
disposable model with the Robopsy system, and indeed similar medical robotics, would best facilitate 
integration into current procedures. The challenge was to source a motor costing few dollars that could 
nevertheless provide position control. 
Addressing this challenge, the Gamma prototype, shown in Figure 51 and Figure 52, was developed 
in partnership with Johnson Electric; the goal was a pre-production prototype of a fully disposable 
solution. Johnson Electric is a supplier of low cost motors and electrical systems to a wide range of 
industries and the Saia-Burgess division specializes in stepper motors and low volume prototypes. For 
the Robopsy project, they custom designed a low cost, high torque prototype stepper motor, with an all-
plastic gearbox that snap fit onto the structure. The decision to return to steppers was made after 
further studying the operational procedure, described in Table 10 and which consists of measurements 
followed by and discrete movements with the loop closed through the clinician, and recognizing that the 
servos were underutilized when used solely as slaves. 
 The work of Saia-Burgess’ Pre-Development team resulted in 
the custom design of a low cost, disposable stepper motor, 
estimated to cost under $10 per unit at volume. This was an 
adaptation of an existing base design UAG3 Saia bipolar stepper 
motor, to which a 3 stage, all polymer planetary gearbox was 
attached. Working from the stepper’s specifications, the gearbox 
was designed based on desired output power. The approximate 
output requirement for each axis was determined based on the 
estimated speed and required torque; closing the slide and 
gripping the needle was determined to be the most demanding 
axis. Power at the output shaft (delivered to the slide) was 
conservatively calculated from the closing of the slide 25° at a 
radius of 50 mm in 1 s along with the gripping force, Fgrip from 
Equation (2). 
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(5) 
From this estimate of 1.2 W at the output shaft, Johnson used proprietary tools to design the motor and 
gearbox. The combined package is sized 20 mm diameter by 37.5 mm long. In later testing, performance 
was found to be more than sufficient; however, broken pins (axels) on planetary carriers occurred. 
Correction of this would be expected in a production model. As can be seen in the picture, the final 
carrier terminates in a splined connector which mates with the device’s structure, while the gearbox 
casing has two notches that mate with cantilevered snap fits projecting out of the structure. 
 
Figure 50 – Detail of Saia motor 
and gearbox. 
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Working from the Beta prototype CAD model, custom actuators were integrated and the design 
refined. Full covers were added to the motors, the slide was moved to the top of the carriage, notches 
were added to better indicate where the device should be aligned with the CT’s laser beams and the 
four motor wires were brought together inside a handle which enables more convenient placement. In 
the alpha prototype up to 3° of undesirable backlash was observed and in a meeting in Dresden with 
Saia-Burgess a solution was developed. Two curved plastic springs that anchored to the base and 
connected to the axes of the hoops that these served to preload the gearboxes of the motors and 
greatly reduce backlash. The structure was made by first 3D printing a positive, then urethane casting a 
replica. The rubber tubing covering the drive roller was replaced with durable O-rings, between two of 
which the needle seated. 
 
Figure 51 – Detail of Gamma prototype. 
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Figure 52 – Gamma prototype, shown during porcine testing with needle clamped. 
For the third prototype a Galil DCM-2143 control board was used with an ICM-20100 breakout 
board that facilitated connection to four of Johnson’s Samtronic 102 stepper control boards. In a 
production device, the control board and drives would be integrated. In this iteration the RS232 
communication was used between the Galil board and the laptop; this left the laptop’s Ethernet port 
free to receive images “pushed” to the third generation interface from the CT scanner via the hospital’s 
PACS network. The control box was sourced from OKW Enclosures, Inc., Bridgeville, PA. Their Meditech 
line is highly customizable, equipped with handles and available in “medical white.”  The case assembly 
is shown in Figure 53. Connections to the robot and the laptop were placed on the case front along with 
red, yellow and green status indicator LED’s. As can be seen by adding up the components and 
estimating for the donated parts, cabling etc. the entire reusable controller has an approximate and 
affordable cost of $2000. For completeness,  
Table 13 provides a summary of all controllers and drivers tested in all three Robopsy prototypes. 
Rough production cost estimates for both the control hardware and robot are given in Table 12. 
Table 12 – Estimated Volume Production Costs for Robopsy System 
Control Module 
  Interface/software $960 
  Amplifiers  $600 
  Controller  $400 
  Cables / Connectors  $25 
  Other      $15 
  Total      $2000 
Disposable Actuator Module 
Motors   $65 
 Cables / Connectors $15 
 Plastic Body       $10 
 Assembly  $10 
 Total       $100 
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Figure 53 – Gamma prototype assembly 
 
Table 13 – Three generations of Robopsy Motor & Controller Specifications 
Prototype Alpha Beta Gamma 
Motor 
Arsape AM 1020  
Bipolar stepper  
18° step, 4 wire 
Faulhaber 101-1024 
Brushed Servo with 
relative magnetic encoder 
Johnson Electric Prototype* 
0A-VD10-105 
(Approx. $10 each) 
Gearbox 
Series 10/1 256:1 
100 N- mm continuous 
200 N-mm intermittent 
10 x 34.8 mm with motor 
Series 10/1 256:1 
(same as Alpha) 
Integrated custom all polymer  
3 stage planetary 
Controller 
Proteus-XES 4 Axis Galil DCM-2143 
 
Galil DMC-2143-DC24 ($1295) 
Galil ICM-20100 ($95) 
Driver Data unavailable Galil AMP-20341 Johnson Samotronic 102 ($50) 
Power Data unavailable CUI Inc. VMPT-65B Meanwell RS-50-12 ($75) 
Case Custom cut from acrylic Project box OKW Meditech ($50) 
Cable 
Telephone to motors 
USB to computer 
Cooner Superflex Wire  
Ethernet to computer 
Custom harness 
RS 232 to computer 
Ethernet to hospital PACS  
* Denotes that item was donated 
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5.6.2. Gamma Interface 
The final interface was designed in partnership with Alexander Seitel, a visiting PhD candidate from 
the DKFZ.  Working from the desired workflow presented in Section 5.5.4 and using the DKFZ’s Medical 
Imaging Interaction Toolkit (MITK), a prototype “point-and-click” interface was built where the stylized 
patient images were replaced with the CT images. The laptop running the third generation interface was 
issued with a static hospital IP address and provisioned with an open source DICOM client. Robopsy was 
then added to the CT machine’s list of clients, so that after each scan the images could be pushed to it 
over the PACS network, while the system remained CT machine independent.  The workflow was 
structured and the interface customized so as to completely replace the CT machine’s display, however 
only those features appropriate for probe insertion procedures were incorporated. Safe operating 
procedure was enforced – after each needle motion, the interface locked and forced a new image to be 
loaded. 
Screenshots from an 11 November 2008 porcine trial are shown in Figure 54 through Figure 56. In 
the first the planning image can be seen loaded into the interface. The path is described by clicking the 
“Insertion Point” button and using the crosshairs to indicate the appropriate point on the display, 
followed by the “Target Point” button and then another click on the display.  Points may be located in 
multiple slices; the slider will allow the user to “fly down” a selected path to check for obstructions. To 
eliminate tilting of the gantry, a significant source of additional scans, the interface is equipped two non-
traditional viewing options: A recomputed plane along the selected path or along the needle’s trajectory 
(grayed out in the figure). These digitally “tilt” all the scan planes and, although this causes some image 
degradation, modern scanners provide significant resolution that viable images are generated.  Once the 
ideal path has been selected the: “Accept Path” button is clicked.   At this point the user is prompted to 
connect the robot and place it at the insertion point. The interface then locks until a new scan is loaded. 
With the robot zeroed and affixed to the patient and the needle loaded and gripped, the next scan is 
taken and loaded into the interface. Once this scan is received, the needle is registered by first indicating 
its tip followed by an additional point on its length, as seen in Figure 55. With the needle registered the 
slider is moved until the crosshairs indicate the needle’s intersection with the skin surface.  In the first 
scan, this is nominally collocated with the insertion point, but in subsequent scans as the needle is 
inserted it is not. In this figure the robot can be seen connected with a green indicator, which matches 
the green LED illuminated on the control box in Figure 35, and the recomputed view corresponding to 
the needle’s current trajectory is selected. With the insertion point and the target point, again, selected 
the “Accept Path” button is clicked, triggering the third interface panel to display.  
The third panel enables control over needle motion. Based on the needle’s current trajectory and 
the planned insertion, the in-plane and off-plane angles are displayed for confirmation; to prevent 
errors no opportunity is provided for adjustment other than the “Back” button.  After successful 
angulation, the interface again locks preventing further motion until a new image is acquired and the 
needle and path are registered anew.   Though slightly tedious, this modality prevents registration and 
planning errors from propagating, as well as accounts for anatomical shifts that can occur over the 
duration of a procedure; though possible, a deliberate decision was made not to permit the path to 
transfer from one scan to the next. After angulation the clinician uses arrows or the slider to indicate 
how far along the path he wishes to place the needle. This facilitates stopping midpoint, i.e. at the 
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pleura, for final adjustment. Needle gripping is again automated. In case of fault the “Stop” button will 
end motion and trigger the needle to be released. 
 
 
Figure 54 – Gamma Interface, planning stage showing the desired path from insertion point to target. 
- 72 - 
 
Figure 55 – Gamma Interface with needle registered and path from insertion point to target indicated. 
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Figure 56 – Gamma Interface, needle actuation panel. 
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5.6.3. Phantom Trial with Gamma Interface 
The Gamma prototype and MITK-based 
interface provided the first system, sufficiently 
functional and reliable, with which to conduct 
repeated tests. Both gelatin phantom and porcine 
trials were performed in November 2008 at MGH 
with a General Electric Lightspeed H16. In this 
phantom trial a selection of penetrable targets 
(fruit, clay) were cast into the gelatin, shown in 
Figure 57, and targeted using both the new and the 
previous interface. The results were presented in 
[114] by Alexander Seitel at the 2009 SPIE Medical 
Imaging conference and are reported here. 
Two sets of 5 targets each were cast into the 
phantom with one set used for testing with the Beta 
interface and one set used for the (new) Gamma 
interface. To reduce the effects of needle bending, 
an 18 gauge (1.3mm diameter) coaxial needle was 
used.  One target group was selected for use with 
the Beta interface and the other with the Gamma 
interface, with the preparation, planning and needle 
placement portions of the procedure timed and the 
results plotted in Figure 64.  For each set of trials, 
the robot was placed once and then each target in 
the group was addressed individually with a “Path Planning” and “Needle Placement” stage. The path 
planning stage evidenced an approximate 3 min savings, 8:40 versus 12:04 minutes, with the use of the 
image guided interface. Additionally, slightly fewer scans were needed. The overall 11% decrease in 
procedure time was attributed to the elimination of gantry tilting. Contrarily, a 1 min increase in the 
needle placement time, 8:29 versus 7:39, was observed.  This was attributed to the time spent 
transferring scan to the interface and repeatedly indicating the path and registering the needle.  
This mini-study was severely limited in scope. Trained radiologists were not available, so the testing 
was conducted by a project team member who had significant biopsy observational experience. 
Comparison to first hand observation and the retrospective study indicated that the phantom provided 
a greatly simplified targeting challenge; it is predicted that under more realistic conditions with ribs and 
blood vessels to avoid and respiration, the benefits of direct image-based control would be more 
marked. 
  
 
Figure 57 – Testing the gamma interface on 
gelatin phantom. Soft targets are under 
wooden dowels simulating ribs. 
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Figure 58 – Top: Averaged time needed for the diﬀerent steps of the workﬂow. The standard deviation is 
only shown for the needle placement, because the other steps were not performed for all targets. 
Bottom: Total procedure time broken into percentages for the diﬀerent steps. [114] 
5.6.4. In-Vivo Porcine Trial with Gamma Interface 
Directly after the phantom trial, a second 
porcine test of the Robopsy system was 
conducted at MGH with a GE LightSpeed. As 
with the previous porcine trial, this was 
conducted as an in-vivo validation of the 
system. Conducting a statistically significant 
comparative study of the conventional manual 
versus a Robopsy assisted procedure would 
have required the sacrifice of over a dozen 
porcines; unacceptable at this stage of the 
development. As before, the porcine was 
sedated, ventilated and placed in a head first, 
left decubitus position.  Artificial lesions were 
injected into its lungs and the standard 
procedure was followed.  Images from this trial 
are shown in Figure 54 through Figure 56, which as with the previous trial followed the protocol outlined 
in Table 10.  Similar to the previous trial, an artificial lesion was targeted with 4 scans. However, 
 
Figure 59 – Porcine test of Gamma system with 
porcine in scanner and robot mounted. 
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operational difficulties with the new interface which precluded timekeeping were encountered.  The 
preload springs adequately reduced the backlash and the 0-rings provided a firm grip in the needle 
during insertion. Despite providing high torque, insertion motor speed proved too low, with a 6.5-cm 
insertion accomplished in 18 seconds. This tented the pleura and caused a significant pneumothorax.   
While the roller drive facilitates unclamping and free needle motion, the Light Puncture Robot is 
superior in more closely mimicking a clinician’s swift jabbing motion. 
5.7. Conclusions & Future Work 
Development of the Robopsy system has demonstrated the potential for a small scale, disposable 
robot to increase the efficiency of a well-constrained procedure. In addition to lung biopsies, the system 
is applicable to a range of procedures where probes must be inserted into a patient under image 
guidance, such as lung, kidney, liver and pancreas biopsies, RF ablation, and prostate brachytherapy 
seed placement. In addition, a family of robots could be developed which would use similar image-
guided interfaces and control hardware, but connect to different lightweight, low cost and disposable 
end pieces to facilitate a wide range of interventional procedures while limiting capital costs. 
By mounting directly to a patient, the structural loop was minimized and patient motion 
accommodated. Through both phantom and porcine trials the device was shown to integrate 
satisfactorily into the current procedure and reduce the number of scans necessary for successful 
targeting. However, without a large porcine study comparing manual to Robopsy assisted interventions, 
it is not possible to definitively demonstrate time savings.  Despite a cumbersome underlying 
architecture, the MITK-based interface provided an adequate replacement for the CT display. In the 
future images should be pushed to it automatically or with a single click. Indeed, the Robopsy software 
could be run on CT machines’ own interfaces, however CT hardware is tightly locked down by 
manufacturers. Robotic interfaces, by walking a clinician through the procedure, have potential to serve 
as a training tool as well as enforce specific protocols.  This suggests performing a phantom trial 
comparing the performance of experienced radiologists with neophytes using the interface. Regardless, 
intuitive operation and short learning curves are essential if more robots are to be integrated into 
clinical practice. 
One major addition is needed to the interface: the ability to accept the robot in any orientation 
while sending the correct commands to the hoops’ axes. Addressing this would, at a minimum, require 
the addition of 3 or more metallic sphere fiducials to the base.   These would be identified in each scan 
and each clicked on by the clinician to define the device’s orientation in space. Alternatively, in order to 
decrease the number of clicks, the clinician would register the robot and needle after each scan.  It 
might also be possible to automatically detect the spheres and the needle and present a tentative 
registration to the clinician.   
Respiratory gating is also a challenge, with the patient located remotely from the clinician while the 
needle is inserted.  Adding a small, unidirectional accelerometer and displaying the trace on the 
interface would provide a representation of the patient’s respiratory cycle with which the clinician 
would trigger the insertion. Another challenge is tenting of the pleura, observed during porcine testing. 
This suggests that, if powered needle insertion is maintained, there will need to be a mode that permits 
the rapid jabbing motion that a physician is able to execute manually. Ideally, this would be 
- 77 - 
accomplished with the existing friction drive and a software “button” that executes a rapid, limited 
travel motion, but it may be applicable to consider an alternate mechanism such as that of the Light 
Puncture Robot, discussed in Section 2.3.4. 
Unfortunately, the Robopsy system, as conceived, is currently stalled. Extensive efforts were made 
to determine exactly what payments both hospitals and physicians received for biopsy and ablation 
procedures proved futile.  Hospitals are unwilling to provide such data and, despite being public 
information, the fees schedule’s numbers provided by the CMS’s website appear to disagree with those 
of the local contractor responsible for the Boston area. The reason for this could not be determined. 
Nevertheless, it was estimated that biopsies of the chest, liver or lung reimburse in total at less than 
$1000. Therefore, at an estimated production cost of $100, even before applying a 2-3x markup, the 
device is too expensive to be disposed of after each biopsy procedure. Compounding this was a 
substantial reduction in reimbursement for radiological procedures in 2010, the exact details of which 
are mired in a political and legislative discussion. However, for procedures of higher value than biopsy, 
such as ablations, which were estimated to reimburse in the area of $4000, and brachytherapy seed 
implantation, adding cost to a procedure in exchange for increased precision would be more acceptable.   
Additionally, while a biopsy can relatively easily be repeated, should an insufficient or a diagnostically 
inconclusive sample be acquired, these procedures require precise probe placement on the first pass. 
Fluoroscopic interventions could also be conducted remotely with minimal radiation doses for the 
medical team. 
Indeed, there is a dearth of developed, low cost actuation modalities that are compatible with 
imaging, particularly MRI. Johns Hopkins pneumatic stepper MRI actuator [43] represents a promising 
advance and thin hoses can be used to deliver short, high pressure blasts. In addition, the use of water 
(or saline) based hydraulics should be revisited. Pistons, vane actuators and even expanding bladders, 
could be made from cheap polymers, potentially resulting in lower-cost disposable actuators than the 
$10 motors prototyped for this project. Hose flexibility (without kinking) will still be a critical limiting 
factor. Piezoelectric actuators, whereby a vibrating beam is drives a surface in a linear or rotary motion, 
are also showing promise in MRI applications, however they are still cost prohibitive and require tight 
controls over assembly and preload in order to operate reliably and durably. There is certainly a 
potential space for a disruptive actuator technology. 
Later, after the Robopy development, an additional product entered the market, which addressed 
the targeting challenge. The See Star, Figure 60, from AprioMed, Uppsala, Sweden, is a small, all-plastic 
device that with a patented design incorporates the same double hoop structure as the Robopsy system 
as well as projecting ears that are taped to the patient [115, 116]. The needle guide rides in the two 
hoops and is comprised of two parts that screw together; tightening them in place and locking the 
hoops. The center of the guide comprises a metal tube, through which the needle is inserted, that 
projects towards the rotation point.  During scanning this is visible and creates a long, white artifact. 
Therefore, the device can be angulated so as to point at the target before the needle is inserted. The 
needle is then manually inserted, which allows the clinician to be in full control and feel the tissue as it is 
penetrated.  The major shortcoming of this device is the lack of guidance in setting the angles; the 
clinician must still iterate to obtain the correct angle. Therefore, serving primarily as a needle support 
device, its popularity in clinical use is limited. 
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One way to address this, while leveraging the cost advantage of a non-powered device, would be by 
adding a smart interface and angular markings to the device.  Considering that with the Robopsy 
planning interface, precise angulation interventions can be accomplished with just 4 -5 scans as opposed 
to over a dozen, it is pertinent to ask whether the device truly needs to be fly-by-wire.  This gives rise to 
a manual Robopsy device concept. This is mocked up in Figure 61 and continues to fulfill the FRs 
described in Table 7. In this device, the hoops’ motors are replaced with calibrated manual dials. 
Interventions would follow the same protocol as given in Table 10 and be planned using the same 
interface.  Then, rather than commanding motors to actuate the hoops to the desired angles, the 
clinician would reenter CT room, reach into the bore and dial the hoops to the correct angle. After 
verifying this with another scan and making any adjustments, a slide on the needle would be set and the 
insertion conducted manually. This would enable both slow and steady and sharp piercing motions as 
the clinician desired. Rather than a bushing, the clamp is retained so the needle can be released.  With 
this concept, all system intelligence and capital expense could be transferred to a single tablet PC, 
running the same interface as the Robopsy robot sans the motor driving commands, and disposable 
production cost would be minimal. Removal of all automated needle actuation would also address the 
significant safety and liability concerns, inherent in all robotic surgical systems, while still providing the 
clinician with an appropriate scale smart tool. Prototype development of this concept is recommended 
as the next project step. 
 
 
Figure 60 – AprioMed SeeStar taped to patient 
[117]. 
Figure 61 – Manual Robopsy concept with 
protractor-dials to indicate hoops’ angles.  
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6. MITE – Minimally Invasive Tissue Extractor 
6.1. Introduction 
The design method and theme of appropriate scale medical robotics extends to procedural tasks 
which are necessary, but non-complex and often tedious. Consulting Table 1, it is seen that robots excel 
at tasks that are monotonous, without suffering fatigue or inattention. A means of identifying potential 
opportunities to improve efficiency is thus to divide a procedure into tasks that are value adding and 
non-value adding. Using an example from manufacturing, work on the piece that creates the desired 
geometry (that the customer will pay for) in a machining process is value adding, while cleaning up the 
chips and conducting regular machine maintenance represent costs that are non-value adding.  
Pinpointing similar tasks within a medical procedure can reveal neglected opportunities for innovation, 
where an increase in automation has the potential to improve procedural efficiency.   
The Minimally Invasive Tissue Extractor (MITE) project 
prototyped a concept for a new morcellator, a tool that is 
used to remove masses of excised tissue during minimally 
invasive surgery which are too large to pass bodily through 
a trocar or its small incision. Design and prototyping of an 
improved morcellator was conducted in the summer of 
2009, led by Ewout Arkenbout, a visiting student to the 
research group from TU Delft, Netherlands, and in 
collaboration with Dr. Jon Einarsson, Division Chief of 
Minimally Invasive Gynecology at Brigham and Women’s 
Hospital. 
Two exemplary gynecological procedures where tissue 
removal is a challenge include myomectomy, where 
fibroids, benign uterine growths shown in Figure 64, are 
removed, and hysterectomy, where the entire uterus, including or excluding the cervix, is excised. 
Fibroids can reach the size of a grapefruit and have the consistency of rubber balls. Dr. Einnerson 
estimates that the mass of an excised uterus ranges from 40 (small postmenopausal) to 2000 g, with an 
average of 300 g. When growths are benign it is not necessary to preserve tissue margins and histology, 
therefore, widening (or tearing) of the trocar incision is not acceptable and tissue is removed piecemeal 
via morcellation.   This method is slow and painstaking, with a typical achievable removal rate of 45 
g/min. During actuation the tip of the morcellator must be carefully guided within the insufflated 
abdomen to avoid damage to surrounding organs. In an article on supercervical hysterectomy (cervix 
preserving) [119] a 10 mm morcellator was used to remove 41 uteri ranging from 60 to 569 g and 
averaging 146 g.  Mean operating time was 94 minutes and, from 19 cases videotaped, morcellation 
times of 4 – 23 min were observed, with an average of 11.8 min, 12% of overall time.  
Morcellation is applicable to a range of procedures and can even, at clinician discretion, be used to 
remove cancerous tissue provided that it is first contained within an endoscopic bag. With some 
techniques morcellation can also be used to directly remove masses from the underlying tissue. In the 
book, Advanced Gynecologic Endoscopy morcellation receives less than a single sentence and a picture 
 
Figure 62 – Fibroids and uterus [118]. 
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in the chapter Total Laparoscopic Hysterectomy [120].This lack of attention is commiserate with a task 
that is necessary, but requires minimal surgeon skill. 
6.2. Current Devices & Operation Review 
Most current morcellators share 
the following operating principles: 
The device consists of a hand piece 
from which a long, annular blade 
inside a sheath projects.  A motor in 
the hand piece rotates the blade 
when a trigger or foot pedal is 
pressed. There is also a duckbill (or 
similar) seal inside the hand piece 
which maintains pressure inside the 
patient. In order to remove tissue, 
the barrel is placed into an 
insufflated patient through a large 
trocar or in place of the trocar.   The 
tip is positioned in free space and 
then, in an iterative process, a 
grasper is inserted through seal and 
down inside the blade, a tissue 
mass is acquired, the blade is activated and the gripper is withdrawn, severing a strip of tissue against 
the blade. This is deposited outside the patient and the process repeated until the desired amount of 
mass is removed. In a total hysterectomy, the mass may be shaved down until it can be removed 
vaginally, but in a supercervical hysterectomy the entire mass must be removed via morcellation. Some 
morcellator tips feature shields which slide down around the blade, providing partial protection. These 
types of tip can also incorporate a lip, as seen in Figure 64, which encourages a peeling motion so that 
long strips of tissue can be removed from a mass, as opposed to short cores. 
A product search was conducted and the most common morcellators in use were identified: 
 GyneCare Morcellex – Ethicon, Cincinnati, Ohio 
 Wisap Morcellator – Wisap Endoscopy, Munich, Germany 
 ROTOCUT G1 – Karl Stortz, Tuttlingen, Germany  
 SAWALHE II Supercut Morcellator – Karl Stortz, Tuttlingen, Germany 
 
 
Figure 63 – Morcellation showing tissue drawn into the annular 
blade and cut [120]. 
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Figure 64 –Left Ethicon GyneCare Morcellex - The single-use hand piece connects to the base via a 
flexible cable drive [121]. Right: Karl Stortz Sawalhe II Supercut, available in 12 and 15 mm diameters, 
shown with obturator (plug) inserted and matching forceps for grasping tissue [122]. 
An alternative morcellator design, shown in Figure 65, for removing intrauterine fibroids and polyps 
hysteroscopically incorporates a side-cutting blade which rotates and reciprocates to take small nibbles 
of tissue, which are then aspirated with a continuous flow of saline.  According to the website  of 
Interlace Medical, Framingham, MA (now part of Hologic Inc.) [123], a 3 cm diameter fibroid can be 
removed in 10 min. It is not clear that this tool design, relying on aspiration, with the assistance of fluid, 
as the transport mechanism, would be appropriate for large mass removal in a gas environment. Some 
morcellation techniques entail maneuvering the excised mass into an endoscopic bag, such as Covidien’s 
Endobag™ or Cooks’ LapSac™, and then morcellating it within the enclosure, so as to prevent tissue 
dispersion and possibly better control the mass. This and general morcellator technique is described in 
[124]. Bag perforation is a risk, though distending the bag with fluid or gas reduces it. In addition, no 
combined bag and trocar exist.  Energy methods also exist for nibbling away small morsels of tissue, 
though they do not facilitate bulk removal and are not examined here. 
 
Figure 65 – Interlace Medical Myosure Tissue Removal System incorporating 
a rotating, translating side cutting blade, irrigation and aspiration. 
The project began with a first-hand observation of a laparoscopic hysterectomy at Brigham and 
Woman’s Hospital and a review of the most common circular cutting, peeling morcellation method. 
From this the following weaknesses give in Table 14 were identified. The final point is most surprising: 
When conducting robot-assisted da Vinci surgery, no integrated tissue removal solution is available.  At 
the end of a procedure, during which all the treatment has been conducted remotely, the robot must be 
undocked and displaced from the patient, then a standard morcellator is inserted and the tissue 
removed via traditional laparoscopic methods.  
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Table 14 – Primary Morcellator Challenges 
 The discretized extraction procedure is manual, iterative and inefficient, motivated by the 
instrument’s operating modality and capability, rather than a clinical need. 
 The exposed rotating blade often scatters bits of tissue within the abdominal cavity, leading to a 
painstaking search for scattered morsels.  All tissue must be removed since remaining tissue can 
cause inflammation, regrowth or necrosis; all serious complications. [125] 
 The exposed rotating blade (even when partially shielded) can accidentally damage other 
organs. This necessitates that the clinician actively manage the tool’s distal tip position 
throughout the procedure, leaving only one hand free to acquire and manipulate the tissue. 
 Most current morcellators do not typically use trocar ports, thus the removal of a port is 
necessary. Tissue removal speed generally scales with morcellator diameter; however, a more 
efficient process could compensate for a smaller morcellator. 
 There are no known solutions for integrating morcellation with robotic surgical equipment. 
6.2.1. Predicate Concept 
A first attempt at improving morcellator design was explored in 2006-2007 with Dr. Zev Williams, of 
Brigham and Women’s Hospital, Boston, MA.  The resulting concept was nicknamed the “Endoblender.”  
This tool compromises a folding, spinning blade on the distal end of a slender stem sized to fit through a 
15 mm trocar, a hand piece and integrated irrigation and suction. Using it involves inserting an endobag 
into the patient, maneuvering the excised organ into it, inserting and activating the Endoblender, then 
suctioning out the bag’s contents.  This tool was initially prototyped in the Precision Machine Design 
course and as a senior thesis of Daniel Hernandez-Stewart [126].  Subsequently Dr. Williams received a 
small grant which funded the creation of a more robust prototype by an outside design firm. 
 
Figure 66 – Prototype “Endoblend” with details of the tip and the deployable guard in a bag. 
Protecting the bag from the rotating blade remained a problem and a separate senior thesis [127] by 
Darragh Buckley focused on creating a deployable guard around the blade.  The resulting guard 
employed three nitinol rings and polyethylene fibers, and was reasonably successful at protecting the 
bag and directing tissue into the blades. This method is most applicable for fluid filled, hollow organs 
and other situations where absolute containment is necessary. While development of the combined 
prototype proposed a creative solution to improving tissue removal efficiency, it represented a 
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significant change from current practice and an unnecessarily drastic method of debulking. Therefore, 
an alternate design was pursued. 
6.3. Procedural Analysis & Functional Requirements 
Morcellation is a common step in many procedures and, as such, may be treated as a mini-
procedure, which be further broken down into discrete steps. This was done based on both a literature 
review and first hand procedural observation, and the current procedure’s steps are shown in the left 
hand side of Table 15.   From this list it was apparent that efficiency would be improved if steps 3 – 12 
were automated. Taking the morcellator insertion and removal tasks away from the clinician’s sphere of 
responsibility would not add any value. Therefore, working from the weaknesses summarized in Table 
14 and the shortcomings of the first concept, the project mission was defined as: 
To create a morcellator that automatically debulks, transports and disposes of excised tissue in a safe 
and continuous fashion. 
Table 15 – Potential reduction of morcellation steps with automated morcellator 
Traditional Morcellator 
1. Remove trocar 
2. Insert morcellator 
3. Insert grasper through morcellator port 
4. Find and grab tissue with grasper 
5. Manually draw tissue through 
morcellator’s cutting blade 
6. Deposit strip of tissue outside body 
7. Reinsert pincer 
Repeat 4 -7 as needed 
8. Look with endoscope to locate remaining, 
scattered pieces 
9. Pick up piece with grasper 
10. Draw piece out through morcellator 
(without morcellating action) 
11. Deposit tissue piece 
12. Reinsert pincer 
Repeat 8 - 12 as needed 
13. Remove morcellator 
14. Conclude procedure 
 Automated Morcellator 
1. Remove trocar 
2. Insert morcellator 
3. Activate morcellator 
 
 
4. Use laparoscopic tools, already in patient, to 
continuously feed tissue into the morcellator’s 
distal end 
 
5. Tissue is debulked, transported and bagged 
 
6. Look with endoscope to verify that all tissue 
has been removed 
7. Feed any remaining masses into morcellator 
 
 
 
8. Remove morcellator 
9. Conclude procedure 
 
Table 16 – Improved Morcellator Functional Requirements 
1. Cut tissue morsels from larger mass. 
2. Transport tissue to exterior of patient and contain it. 
3. Protect the patient from unintended laceration 
4. Fit within a standard trocar or trocar incision. 
5. Free one or both of the clinician’s hands to manipulate tissue into the morcellator.  
6. Work with multiple tissue types. 
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6.4. Strategy Development 
   
 Figure 67 – Morcellator strategies, from left: Slicing blade and auger, dual serrated tubes, spiral 
electrocautery wire cutting, sketches by Ewout Arkenbout. 
 The automation challenge was broken down into cutting and transportation, with tissue disposal 
determined to be relatively trivial. Two broad operating modalities were considered: a continuation of 
the Endoblend where the tissue is placed in a bag and disintegrated or a more traditional operation with 
a tube incorporating automated cutting an integrated transport mechanism. The latter was selected and 
three new strategies, reproduced from Arkenbout’s notebook, are shown in  Figure 67. The first 
comprises a side opening below which a blade oscillates axially. Tissue is placed in this opening and 
morsels are sliced off.  Simultaneously, a rotating auger 
transports the tissue away. The second features a pair of nested 
tubes, both with serrated ends, and the inner tube having rear-
facing barbs.   The outer tube is fixed and the inner tube vibrates 
in 2 DOF: the first about its axis, to slice off chunks with a 
scissors motion, and the second along its axis so that the barbs 
urge the tissue backwards. Tissue is still grasped and pulled 
through the device, but without a spinning blade, the risk of 
prematurely severing the tissue strip and scattering morsels is 
reduced. The third concept proposes placing the tissue in a bag 
and uses energy methods to slice it into a long, spiral strip that 
can be removed singly. 
Inspiration for the first strategy was taken from a meat 
grinder, which accepts cubed meat into a funnel and uses a 
rotating auger to force it through a cutting head into a sausage 
casing. It was hypothesized that if the auger was longer it would 
transport it out of the patient. The side port presented no sharp 
edges to the patient and contained the tissue, although use of a 
bag was not precluded.   The second strategy addressed only the 
cutting challenge, but retained an exposed sharp edge and did 
not improve upon transport. The third strategy required initial 
 
 
Figure 68 – Exemplary meat grinder 
by The Sausage Maker, Inc., Buffalo, 
NY [128].  
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bagging of the tissue, inflation of the bag and then deployment of the cutting wire and its actuation in a 
helical manner. Overall this mechanism represented significant complexity. 
Considering that the form factor and basic operating principle of exiting devices satisfied clinicians, 
but not the repetitive nature of the tissue removal or the chance of causing internal lacerations, the first 
strategy was selected as most versatile and the least disruptive to current practice. Additionally, this 
design is not likely to scatter tissue, thus further reducing procedure time. This strategy was then 
developed into a proof-of-concept prototype. 
6.5. Concept Prototype 
The linked functions of cutting and transport were identified as the most critical; therefore, all 
prototyping effort was focused on developing and validating this module. Tissue containment post 
extraction and the drive mechanism were not emphasized. The prototype device is composed of two 
nested tubes and an auger.  The outer tube is fixed in position and has a bluntly capped distal end and 
openings in the side at the proximal and distal ends. Translating back and forth inside this tube is a 
second tube tipped with a circular blade, similar to those found in current morcellators. Two options for 
the slicing direction were considered: Sideways in a rotary direction, and up and down.  Both were 
prototyped and the former was found more adept at pushing tissue aside than into the auger, while the 
latter took sharp bites as it passed over the inlet opening in the outer tube.  Any tissue that enters the 
opening is nipped off and fed into the auger which rotates inside and oscillates along with the inner 
tube. This transports the tissue to the proximal end where an opening in the inner tube coincides with 
an opening in the outer tube.  The tissue is forced out of this outlet and into a catch bag which can be 
removed, sealed and disposed of, or sent for pathological evaluation. 
  
Figure 69 – Schematic side view of Minimally Invasive Tissue Extractor mechanism. The auger rotates 
and translates back and forth; the inner tube translates back and forth synchronous with the auger; the 
outer tube is passive. At the tip the slicing action is performed. Cam-action provides combined rotation 
and translational oscillation; image from [129]. 
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Figure 70 – MITE assembled. 
 
Figure 71 – MITE disassembled. 
The prototype’s drive mechanism is built from the base of a repurposed oscillating spindle sander, 
the remnants of which may still be identifiable in the photo. (Note that the final device is unlikely to 
require a ¼ horsepower motor!) This sander’s patented [129] design, shown in Figure 69, consists of two 
pulleys, separated by a cam and driven by a single motor. The pulleys have slightly different diameters 
and, consequently, different rotation speeds.  The rear pulley is fixed axially and has a sinusoidal cam 
feature on its face. This engages a matching cam feature on the font pulley which moves axially, with 
return force provided by a spring.  The front pulley is directly connected to the auger, which both 
rotates and translates. The front pulley also pushes, via a thrust bearing, against the inner tube which 
also oscillates synchronously with the auger, but is constrained to the stationary outer tube so that it 
cannot rotate. The prototype was tested with butcher-supplied meat and found to perform 
satisfactorily. A summary of the prototype is provided in Table 17. 
Table 17 – Specifications and Features of MITE Prototype 
Motor power ¼ HP Approximate tissue volume per 
slice based on half-filled inlet 
assumption 














 l
OD
V
2
22
1
  
~ 800 mm3 
Auger speed 1750 RPM 
Stroke frequency (f) 50 slices/min 
Stroke length 12.7 mm (½”) 
Outer tube OD 19.05 mm (¾”) 
Inner tube ID 12.7 mm (½”) 
Semicircular inlet length (l) 12.7 mm long Tissue removal rate 
(density of 0.001042 g/mm3) 
~ 42 g/min  
Active length* ~ 101 mm (4”) 
*The device was sized based on that of available components; hence this length was limited by that of 
the ½” auger bit. 
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 The rotating auger is not directly exposed and the translational, oscillation cutting blade is 
entirely contained within the stationary outer tube. The device’s distal tip is completely blunt. 
 There is no need to manually remove anything from the patient, once positioned the auger 
automatically transports and disposes morcellated tissue outside the abdominal area. 
 The morcellation speed of the MITE, in the case of the proof-of-concept prototype, is only on 
par with that of the currently used device; during initial testing with fresh butchered meat a 
removal rate of 42 g/m minute was achieved. There is significant room for optimization of the 
design to greatly increase this speed. 
 Two operational modes are proposed: 1) automatic and 2) semi-automatic. The former would 
continuously debulk and remove tissue fed into the mouth while the latter would be triggered in 
a “nibbling” fashion to remove tissue in situ. 
 The design MITE can be scaled; no elements impose fundamental size limitations. 
6.6. Future Work 
The concept prototype appears promising and the few clinicians who have seen it expressed interest 
in testing a more polished prototype. Creating this will require a significant engineering design effort, 
beginning with optimization of the cutting method and evaluation with hard tissue.   Thus far, testing 
has only been conducted with soft tissue and there is concern that the side cutting mechanism may not 
be able to acquire large diameter tissue or tough, spherical fibroids. A larger opening is needed and 
there may be aspects of the collapsible guard, designed for the Endoblender, that can be incorporated. 
Additionally, while tissue must currently be pushed directly into the inlet, it may be possible to design 
the cutting mechanism so that tissue is actively pulled inwards. Similarly, the transport mechanism will 
also require study and optimization with respect to thread profile and cutting speed to increase removal 
rate, and exploration of the effects of system scaling. 
If the most critical module can be shown to work reliably, the next step will be to focus on the drive 
module. Ideally, the disposal module will be detachable and single use so that it can be discarded along 
with the excised, bagged tissue. Unlike the current morcellator that has one rotating blade, the MITE 
design has two independently moving parts to interface. The drive requires compaction and fitting 
inside a comfortable, sealed, sterilizable hand piece. Gears should probably replace belts, with care 
taken to eliminate vibrations. Offsetting the motor, which is currently axially aligned, will enable tissue 
to exit more directly from the end of the disposal module, rather than a slit in the side.  
There is no need for the surgeon himself to manipulate the device: It can be mounted to an 
adjustable arm and “parked” within the patient or held by an assistant, leaving the surgeon two graspers 
free to manipulate the tissue mass in the abdomen. Finally, there exists the possibly of integrating the 
device with the da Vinci. In particular, the da Vinci arms are already designed to provide power and 
actuation to Intuitive’s tools. It should be possible to configure a morcellator to mount onto and utilize 
the existing hardware for actuation, thus allowing an entire procedure culminating in tissue removal to 
be conducted minimally invasively. 
Subsequent to this project, Arkenbout’s Master’s research focused on the design of morcellators.  A 
detailed comparative literature study of morcellators is presented in [130] which identifies every 
morcellator design, since the first in 1993, and characterizes their procedural application, functional 
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modalities and removal rates.  While he reports an increase in removal rate and with the current 
“peeling” modality as yielding the fastest removal rate, the paper concludes with a suggestion that 
morcellation safety and speed can be improved with the implementation of both a bag and a method 
that allows for continual rather than discretized tissue removal.  A sister paper [131] proposes a method 
for better data gathering during a morcellation procedure and its subsequent analysis, so as to quantify 
morcellator performance and compare different morcellator models and designs. 
Bringing this work together is an article [132], currently under revision, which uses in-vitro porcine 
tissue testing and data from actual hysterectomies to conduct a detailed time-action analysis of the 
function of a traditional rotary morcellator with peeling action.  Data showed an overall morcellation 
rate of 20 g/min, which rose to 66 g/min if the time spent manipulating the tissue before and after 
cutting with the morcellator was included in the analysis. Removal rate was found to increase with 
organs; this is attributed to the steady peeling of long strips, which is not possible with small or irregular 
masses. An additional, final “cleanup” step was also identified, whereby the abdomen is irrigated to 
dislodge and aspirate very small debris hiding between organs and in folds of intestines. The larger the 
mass and more strips of tissue removed, the longer this takes. Together this research highlights an 
opportunity to create a more complete and automated solution to issue removal. 
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7. Development of a Medical Device Design Course 
7.1. Introduction 
The design methodology proposed in this thesis was 
developed over the past 9 years that the Precision Machine 
Design course has focused on the design of medical devices in 
partnership with CIMIT. Each of the 52 prototype-development 
projects has essentially been a mini-experiment and in the last 
4 years, during which the author served as teaching 
assistant/instructor, significant work has been accomplished in 
optimizing the course including the project selection and team 
formation, design process and curriculum. Throughout, the 
working hypothesis has been that merging applied research 
and education can be educationally effective, while providing 
the means to rapidly and economically evaluate a wide range of 
ideas and designs and, thus, efficiently contribute to the launch 
of new technologies that have the potential to improve care. 
Therefore, in this section a review of the course is presented 
including the process’ best practices, three case studies, the 
latter two for which the author served as a mentor, a review of 
student outcomes and an examination of past projects. 
Although the time frame and funding does not typically enable the development of full-scale robot 
systems, student teams are able to develop novel devices following efficient design principles. The 
course goal is demonstration of base function, not a beautiful, ergonomic device; form and finish can be 
improved in the follow-on development course, Design of Mechanical Products (2.753). Students’ lack of 
clinical background, rather than being a hindrance, leaves them open to ingenious solutions which often 
represent translation from outside engineering experience. Projects initiated in the course have 
generated IP and peer-reviewed publications, stimulated additional research, furthered student and 
clinician careers and, recently, resulted in a technology license and a successful start-up venture. The 
model has been able to support traditional mechanical engineering devices, such as surgical tooling, as 
well as mechatronics projects that come closer to the robots or smart tools which are the subject of this 
thesis. In 2010, as a test, and the course partnered with the Electrical Engineering Department to 
increase student diversity and better incorporate sensors, custom circuitry and embedded control. The 
results were positive, in part resulting in the formation of the startup company described in Section 
7.3.3, and this will be continuing in 2012. 
7.1.1. Comparable Courses 
Literature and books [133] consistently prove the effectiveness of project-based learning at all 
levels. One of the pioneer programs since 1963 is Harvey Mudd College’s Engineering Clinic, which 
engages teams and resources on industry sponsored projects [134, 135]. Focusing exclusively on 
medical, Stanford University’s Biodesign Innovation Class leads multi-disciplinary teams of students 
(medical, engineering and business) through a two semester program. Appropriate projects are 
 
Figure 72 – Flyer advertising 2012 
course and showing collaboration 
with the electrical engineering 
department. 
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identified by experienced program fellows who spend three months in a hospital environment studying 
clinical needs.  Stanford’s Zenios, Makower and Yock have written the definitive book “Biodesign: The 
Process of Innovating Medical Technologies” [133]. Other analogous courses include the University of 
Minnesota’s New Product Design and Business Development Course and the Johns Hopkins University’s 
Biomedical Device Innovation and Design Course [136, 137]. The growing number of courses and 
dedicated programs in this field is encouraging. 
7.2. Project Process 
7.2.1. Project Selection & Team Formation 
The first key to successful outcomes is the recruitment of enthusiastic clinicians and appropriate 
project selection. The same desired clinician and project characteristics apply whether selecting for the 
course or a for long-term research collaboration. Each spring a call for proposals is distributed to the 
Boston-area clinical community. Only two pages are requested covering the clinical challenge and its 
significance, current practice and background (pictures, videos and references), functional requirements 
of the desired solution and a disclosure of any previous work. The ideal proposal will define the 
challenge, but be sufficiently open, without a hardened, pre-conceived solution, so that students start 
with a clean slate. The project must require the development of new mechanical and mechatronic 
hardware and reasonably fit within the constraints of one semester, a workbench and $4,000 budget. 
Finally, project diversity is important commensurate with students’ broad interests and skills. Experience 
has shown that projects having significant prior work or requiring only modification to an existing device 
do not furnish engaging challenges. 
Finalist clinicians pitch their proposals to the 50-student class and the ultimate selection is made by 
the students, who self-form into teams of 3-5 people. This size facilitates efficient interaction and work 
distribution and correlates with research into team sizing and satisfaction [138]6. Clinicians are expected 
to be active collaborators, rather than clients, with responsibilities, including biweekly team meetings, 
participating in brainstorming, sessions providing access to hospitals to view procedures and laboratory 
access for testing. Projects where a senior clinician delegates responsibility to a junior clinician have 
evidenced difficulties. Junior clinicians often lack free access to hospital facilities for equipment and 
testing and must give priority to fellowships and residencies.  Often older clinicians have considerable 
medical mentorship experience and enjoy the change of working with engineering students. 
7.2.2. Design Process 
The second key is the structured, managed design process. By following the methods detailed din 
Section 4 and the steps shown in Figure 21, creativity is encouraged but focus maintained on the goal of 
producing a working prototype. The emphasis on narrowing the scope to only those functions where the 
clinician’s performance or efficiency is limited as well as the constrained budget serves to encourage 
lean solutions; in choosing both concepts and strategies students are guided to the most reasonable 
                                                          
6
 As a result of this research 4.6 members is widely cited, particularly by pop psychology, as being the “ideal” group 
size, however this neglects the authors caveats that satisfaction does not necessarily map directly to performance. 
Additionally, testing was conducted at both Yale University and The University of Illinois with groups at the former 
indicating evidencing more severe interpersonal difficulties. 
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functionality/complexity ratio. The emphasis on analysis, bench level experiments and prototypes 
rapidly eliminates untenable designs, before significant resources are expended on detailing and 
hardware. Students are granted purchasing authority; however the instructors have oversight to detect 
instances where ordering a multitude of components to “see which works” is substituted for proper 
sizing and part selection. Three in-class presentations, occurring at the crucial check points before 
strategy selection, concept selection and final fabrication, serve to involve the entire class in the peer-
review process, as well teach students professional communication of technical material. 
Throughout the process course instructors serve as project managers and mentors, meeting with 
each team weekly to review progress, brainstorm solutions to current challenges, suggest resources 
and, if needed, assign action to individual team members. Instructors maintain a list of vendors 
(machine shops, 3D printers, blow molders, etc.) who are prepared to work with students, occasionally 
sample parts and invite them to visit their 
facilities. Instructors benefit from professional 
advancement; not only do they further hone 
their design skills through an active role, but 
they frequently contribute essential elements to 
the design and are, therefore, authors on papers 
as well as inventors on patents. The same is true 
for clinicians, especially those who continue with 
their projects, as seen with the ACL Repair Gun 
and 7.3.3. Sleep Sensing Shirt, Sections 7.3.1 and 
7.3.3.  
Good documentation is emphasized and all 
important drawings, calculations and findings 
are recorded in bound lab notebooks, which 
preserve IP. A secure wiki serves as a design 
history file and facilitates communication, 
without being a burden. Teams upload scanned 
sketches, working papers, testing notes, 
presentations, videos and CAD models.  
The final prototypes are presented to an 
invitation-only academic, clinical and industry 
audience who are asked to sign confidentiality 
agreements and invited to provide feedback to 
the teams using the form shown in Figure 73. 
This does not factor into grading, but is 
immediately provided to the teams so that it can 
be incorporated into their documentation. The 
presentation begins with a 1 minute “pitch” that 
briefly summarizes the challenge and then 
proceeds to provide clinical background, present 
 
Figure 73 –  Feedback form filled out by final 
presentation audience members 
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the design decisions and culminates in a demonstration of the final prototype. Outside assessment is 
valuable, with clinicians often identifying additional applications for a technology and medical device 
industry professionals demanding better testing data and evaluation.  A consistent challenge has been 
to encourage students to present an accurate assessment and explanation of failures to meet functional 
requirements and specifications; more traditional final presentations often encourage a more positive 
tone. However, in this merging of research and education, the results of testing the final prototype can 
indicate that a design is ultimately impractical, as is often the case, without negatively affecting grades 
or the learning value.  
Written deliverables include: a crisp, American Society of Mechanical Engineers journal-quality 
paper and a one-page prospectus, rather than a lengthy, more traditional “project report.”  This 
encourages conciseness and ensures that both students’ time writing and instructors’ reviewing are 
productive, since many papers are submitted to the ASME Design of Medical Devices (DMD) conference, 
held in April at the University of Minnesota, as well as form the basis of later journal papers. 
Increasingly, students are producing short, edited demonstration videos. In sum, the availability of 
professional documentation has proven essential to project continuation, review by MIT and hospitals’ 
technology licensing offices and contacting potential corporate licensees and sponsors. 
7.2.3. Curriculum 
The third key is a supportive curriculum with clear educational goals. Formal lectures, held for only 
the first 2/3 of the semester, teach fundamental mechanical and electrical engineering design principles. 
Supporting guest presentations cover literature and IP searching, real product case studies and clinical 
topics. Supplementary tours to medical device industry facilities, such as Ximedica in Providence, RI, are 
also organized. The specific learning objectives are listed in Table 18. In a study conducted by and with 
Harvey Mudd undergraduates “the three most important skills that students require help on are: 
practical project planning and scheduling techniques; dealing with personality conflicts within the team; 
running efficient meetings” [135]. The MIT experience correlates and specific leadership and teamwork 
elements have been added to the curriculum. Particularly in order to fulfill undergraduate requirements, 
communication is a formal course element encompassing the presentations and written material and 
supported by a dedicated communication instructor, who also coordinates intra-team dynamics. 
In the first weeks of class students are also assigned a short, hands-on mini-project. The goal of this 
assignment is to foster creativity and introduce students to campus fabrication resources, sourcing 
materials, building and testing. Each student is tasked with designing, modeling and testing something 
that demonstrates exact constraint (kinematic) design principles. Students start with a blank slate and 
no particular resources other than directions to MIT machining and hobby shop facilities whose staffs 
ensure that the students receive safety training and hands-on assistance with fabrication in wood, 
aluminum, steel and plastic. Students evaluate their devices’ performance with respect to stiffness and 
mechanical repeatability.  Many use dial indicators to measure both stiffness when loaded and 
positional repeatability. Others affix laser pointers to their devices and track the beam on graph paper 
on the other side of the room; working with limited equipment is a hallmark of the bench level 
experimentation. Brief reports are submitted and projects demonstrated to the class. Designs have 
included three ball and groove “kinematic coupling paperweights”, wine bottle holders and a unicycle 
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stand. As stated from one student’s course evaluation: “The lab assignment was useful to gain access to 
the shop, and a great way to get us started with a rapid design project." 
The grading metric encompasses mastery of the lecture material, following the process to a 
functional prototype and individuals’ performance, as observed during weekly meetings and validated 
by formal, confidential peer ratings of team members. These are administered using the online CATME – 
Comprehensive Assessment of Team Member Effectiveness, developed at Purdue University, primarily 
for academic use and based on research into team dynamics [139]. This assessment asks students to 
rate both their own and teammates effectiveness in five areas along a seven point scale; however, 
rather than asking for a number, a behavioral description of each rating is provided to which students 
match themselves and their teammates. Instructors receive detailed information that flags specific 
individual and group conditions, such as “low” where a student performs badly or “clique” where a team 
has fractured. Grade correction factors are also computed. Optionally, students can receive a summary 
of their self-ratings in comparison to teammates and the average. The CATME is loaded with the class 
list and administered twice during the semester; first at the midpoint to assess and, potentially, rectify 
problems, and then at the end to adjust grades by up to a letter. 
Table 18 – Course Objectives  Table 19 – Approximate Grading Metric 
Students in the 2.75 course will learn: 
 A structured, deterministic design process 
 Translating a challenge into requirements 
& specifications 
 Prior art & IP research 
 Advanced mechanical & electrical design  
 Multidisciplinary teamwork 
 Hands-on prototyping &  testing 
 Hardware procurement & fabrication 
 “On-time” & “on-budget” project 
management 
 Effective, professional oral & written 
communication of technical material 
 Distribution: 
Team project 
     Execution of process 
     Design & execution 
     Demonstration of prototype 
Communications 
     4 Presentations 
     Written final documentation 
Individual, weekly progress  
Mini-project 
Peer ratings 
Total: 
 
50% 
 
 
 
20% 
 
 
10% 
10% 
10% 
100% 
7.3. Case Studies 
7.3.1. ACL Repair Gun 
In an audit of past projects, the earliest successful one identified was a gun to help repair torn 
anterior cruciate ligaments (ACL), a condition that affects over 450,000 Americans per year. The ACL’s 
location in the center of the knee joint and bathed in synovial fluid prevents normal clotting and healing, 
thus grafts have not proven long term stability. In 2004, Dr. Martha Murray of Children’s Hospital 
Boston, having developed a gel containing platelets and collagen which could serve as a scaffold to 
enable healing, described her need for a tool to warm, mix and deliver the gel during arthroscopic ACL 
repair surgery.  By the end of the fall semester she and her graduate student team had developed a “gel 
gun,” employing a heater and a collapsible augur, which served double duty as mixer and plunger, and a 
nozzle to deliver a drying CO2 blast followed by a precisely metered amount of gel, all through a 1 cm 
incision. Dr. Murray stated: “The engineers helped us a great deal. They are working on a crucial 
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component of the project, and they are enthusiastic, 
dedicated and smart. We’ve really benefited from CIMIT 
helping us access some terrific engineering talent.” 
 Post course, while none of the students were able 
continue with the project, Dr. Murray obtained a $100K 
CIMIT Proof of Principle Grant and engaged a professional 
design firm to refine the prototype.  Both are shown in 
Figure 74, where all the original design elements are 
retained in the “professional” prototype. The gel, along 
with a third generation device is currently undergoing 
testing with support from an NIH RO1.  Preliminary results 
indicate significantly stronger ACL repairs [140, 141]. Dr. Murray is now scientific co-founder of 
Connective Orthopaedics, a venture funded startup. 
7.3.2. Thoracoscopic Screwdriver 
Development of the thoracoscopic screwdriver, a now licensed-out technology began in 2009 when 
Dr. Suresh Agarwal of Boston University Medical Center presented the challenge of stabilizing 
compound rib fractures. Such fractures cause flail chest and compromise breathing. The typical 
treatment is positive ventilation until healing 
occurs naturally; however this leads to long 
recovery times and complications. The 
alternative is an open thoracotomy, which 
cuts musculature, to place titanium 
osteosynthetic plates on the outsides of ribs. 
This team’s mission was “to design a tool or 
method for minimally invasive video assisted 
thoracoscopic rib fracture stabilization,” so 
that ribs could be fixed minimally invasively 
from the inside. 
Three main repair strategies were 
considered: custom, absorbable implants 
adhered to the rib, modular implants fitting 
around the rib and a minimally invasive 
method of installing the same plates used in 
open surgery, seen in Figure 75 (A). The first 
two strategies required significant technology 
development, while the third significantly 
narrowed the project scope to the design of a 
single surgical tool – a laparoscopic 
screwdriver. Key functional requirements 
included: fitting through a 12 mm trocar and 
 
Figure 74 - Student prototype with inset 
showing second generation prototype. 
 
Figure 75 – Thoracoscopic screwdriver design from 
need (A) to final prototype (F). 
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articulating by 60° to access fracture sites, as shown in (A). Additionally the tool needed to positively 
engage the 2 mm, self-drilling bone screws until placed, deliver sufficient torque and be operable with 
one hand.  
The process accelerated as the team bench-level prototyped and tested mechanical concepts for the 
critical rotation and angulation functions. A universal joint failed to provide smooth rotation, adequate 
compactness or a sufficient angular range of motion and the flexible shaft (B) proved more promising, 
but did require a relatively large bend radius. The team struggled to find a simple angulation method, 
considering cable drives, push rods and linkages. With the realization that a flexible shaft could support 
both torque and axial load, a novel solution emerged! 
As seen in (C) and (D), the flexible shaft passes through the joint, which is hinged off center. Pulling 
on the shaft causes the joint to bend, while a nitinol beam spring provides the return force. By slotting 
the joint, the flexible shaft is able to project outwards and maintain its necessary minimum bend radius. 
This mechanism was first bench level prototyped (C), validated and then the diameter was reduced, 
bushings and a pocket for the nitinol spring added and tolerances specified. By week ten this most 
critical module was complete, with housing and screwdriver tip. Following this module came a retaining 
collar which pops back only once the screw is seated in bone against the plate. Finally, the handle/drive 
module was constructed, containing a gear motor, a forward and reverse trigger and a nut, which pulls 
on the housing to actuate the joint.  
The entire prototype was completed by week twelve and tested in a surgical simulator. The final 
paper won a presentation award at the 2010 Design of Med. Dev. Conference (DMD) [142]. 
Development continued into the spring semester course, culminating in the polished prototype, shown 
in (E). This was published in the ASME J. Med. Dev. Design [143], underwent porcine testing and was 
presented at the 2010 New England Surgical Society Annual Meeting [144]. Subsequently, the team 
formed a startup company, acquired the technology and in late 2012 signed a licensing agreement, 
details of which are not yet public. 
7.3.3. Sleep Sensing Shirt 
This case study presents the Sleep Sensing 
Shirt, a potentially disruptive technology that 
in just one year launched an angel funded 
startup and in two began clinical trials. In 
September 2010 Dr. Matt Bianchi, a 
Massachusetts General Hospital (MGH) 
neurologist, explained that 1 in 3 Americans 
reported sleeping problems, yet diagnosing 
them relies on in-hospital sleep labs that are 
inconvenient, uncomfortable, with sensors 
stuck all over a patient, and, too expensive, at 
$2,000 each; would it be possible to create an 
at-home sleep monitor that would produce 
clinically significant data? 
 
Figure 76 – Rest Devices Inc. co-founder Pablo 
demonstrating the sleep sending shirt, insets showing 
raw data and the latest infant monitoring model. 
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Three undergraduate roommates, who had vowed to select the “best” project and launch a 
company, signed on to the project. Studying current practice they realized that most primary care 
physicians receiving sleep study data relied on an aggregate “sleep score” to diagnose and refer; maybe 
a only a single sensor could provide data that would serve the vast majority of cases. After exploring a 
myriad of modalities, they hit upon the idea of a shirt with non-contact, co-planer, capacitive plates that 
would measure the fabric’s stretch as the patient breathed. Machine-sewing wire and bonding metal foil 
failed; the end design comprised silk screened metallic pads and traces, protected by iron-on vinyl 
appliqués. Circuits were first bread boarded and then ordered from a vendor. The final device features a 
tiny, snap on, micro-USB equipped data logger. As important as the patented hardware design, a custom 
algorithm capable of processing a night’s worth of data into a sleep stages and an equivalent score, in 
under 30 seconds. These results also won a presentation award at the 2011 DMD [145]. By August 2011 
funding was secured and the sewing machine, silk-screening frame and heat press transferred from MIT 
to Rest Devices’ office, Boston, MA.  
Quoting Dr. Bianchi, now promoted to director of the MGH Sleep Lab: "The course was an ideal 
setting to match clinical need with engineering solutions, and the resulting product has not only fueled 
my research productivity and career advancement, but also holds great potential for advancing patient 
care." Currently, the product is being sold for research purposes to sleep labs and a consumer baby 
monitor is under development. The work was presented in 2012 at the Associated Professional Sleep 
Societies Conference and the Military Health System Research Symposium. 
7.4. Outcomes & Assessment 
7.4.1. Overview 
As seen in Figure 77, since 2004 enrollment has more than doubled from 20 students to a high of 49, 
with a total of 264 students having worked on the 52 projects. Team size has remained constant in the 3 
- 5 student range and project selection has steadily become more competitive from all proposals 
selected to only 1 of 3. This allows a more precise tailoring of the projects presented to the students in 
terms of diversity and predicted feasibility.  Overall of a total of 172 eligible proposals 30% have been 
addressed. By the most recent count there are a dozen provisional or utility patents currently pending 
on course-based technology. Course evaluations place it significantly above the department median, in 
the 1st quartile. Over two dozen papers have been published and aided students’, clinicians’ and 
instructors’ careers. Alumni data also show students consistently landing jobs in the medical device 
design industry. The model has also been extended to industry sponsored projects as well as energy 
related projects, which account for the “non-medical” bars on the graph. 
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Figure 77 - Student enrollment and project statistics 2004 – 2012. (2012 data not complete) The course 
model has also been applied to select non-medical projects. 
Clinicians, many of whom have strong creative instincts but lack in time and engineering resources, 
are now champions for the course among their colleagues.  A prominent surgeon states: “It was fun to 
work with the student team. They grasped the clinical problem and developed a creative concept to 
address the challenge of negative pressure wound therapy in a low resource setting. I had been working 
in my basement workshop on a concept device, and the students opened my mind to other potential 
approaches which have led to the current prototype.” 
Assessing student learning is a special challenge in a course which presents an open ended design 
problem and expects deliverables in the form of a physical prototype, a presentation and a paper, rather 
than tests and other evaluation metrics that produce numerical data. Peggy Maki in “Assessing for 
Learning” states: “At the graduate level we educate people to become experts who explore new 
territories in their fields or professions and question findings, challenge claims, or rethink tradition-
bound perspectives on or approaches to issues that lead to new directions in research and lines of 
enquiry” and, moreover, “standardized testing” fails to “represent our diverse learner’s achievements or 
our institutions’ education effectiveness” [146]. While an investigation of project-based learning is 
beyond the scope of this paper, three metrics are relevant to assessing student outcomes:  1) Student 
Evaluation of Teaching (SET) reviews, 2) Course alumni’s careers and 3) Project Outcomes.  
7.4.2. Student Evaluations of Teaching (SET) 
SETs are administered independently by the Mechanical Engineering Department and ask students 
to numerically review and comment upon both the course in general and the performance of individual 
instructors. Course evaluations for the years 2004 – 2010, including survey questions and comments, 
were obtained. MIT students take the SETs seriously and often provide detailed feedback; one 
evaluation from 2010 speaks specifically to the process, as well as offers some criticism:  
“It is such a fantastic opportunity to have the clients come to us and present such well researched 
project ideas. I am used to having to do all that myself. As I saw it we were handed a quarter of the 
design process on a plate and are then able to make significant progress in a semester. The involvement 
of an external client motivates students to really deliver and work hard on their design. I like the 
awareness of intellectual property introduced from the start, and thought about reciprocity a great deal. 
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This was a new approach to me so that was great. The prospect of publishing a paper, applying for a 
patent, and presenting at a conference are all personal goals of mine so this class was ideal. I think there 
is huge value in forgoing problem sets/exams in terms of allowing students to really work on something 
worthwhile so I think this is a great aspect of the course. It meant I could focus entirely on the project 
and get out of it what I thought was important. Whilst brief, it was useful for the quick fire lectures on 
the fundamentals notes to know that it was there and available although I will admit I did not use them. 
The lab assignment was useful to gain access to the shop, and a great way to get us started with a rapid 
design project. I zoned out during the electronics stuff and I do not think it added to my learning.” 
Numeric SET data was available from 2006 – 2011 and analysis focused on applicable questions in 
the sections: “Factors in Learning,” “Assessment of Learning” and “Subject.” Questions pertaining to 
particular instructors’ performance were excluded. The mean rating data was examined for trends, 
hypothesizing that as the course process was honed over the last 7 years this should be reflected in 
student experience and feedback. Moreover, while it would be improper to compare the course to other 
design courses in the department, the course could be compared to a baseline rating of 5, 
corresponding to a rating of “Average.” For each rating (M) and the number of students responding (N), 
standard errors were calculated and presented in Table 20. Then pooled t-tests were used to determine 
whether the means were higher (or lower) than the baseline (5) and to compare one year to the next 
looking for improvement, both at a 0.05 level of significance [147].  
The primary statistic is the mean “Overall rating of the 
subject,” plotted in Figure 78. In 2006, when the medical-
focus was only 3 years old, the rating was not differentiable 
from Average and the course placed in the 3rd quartile of 
the department. (Departmental comparative data is not 
publically available, but was reviewed.) In subsequent years 
2007, 2009 – 2011 the course rated higher than average and 
placed in the 1st quartile. On many other assessment 
questions, starred in the table, the rating is also significantly 
higher than baseline. It should be noted, that graduate 
elective courses generally score higher than mandatory 
courses. The responses’ large standard deviations obscured 
yearly improvements so, despite the visible upward trend, 
only from 2009 and 2010 was the improvement significant. 
 
Figure 78 – Plot of mean course 
evaluation by year.  Error bars show 
standard errors. 
4.68 
5.75 5.47 5.88 
6.38 
6 
0
1
2
3
4
5
6
7
R
at
in
g 
year 
Overall Rating of Subject 
- 99 - 
 
Table 20 – Student Evaluations of Teaching (SET) results showing means and standard errors (SEm). 
  2006 2007 2008 2009 2010 20113 
Total # of responses: 25   14  19   32   35   35  
Response rate of students registered for credit (%): 86   87  74   72   85   70  
  Mean SEm
1
   Mean SEm Mean SEm Mean SEm Mean SEm 
Assessment Questions / Rating Scale Rating Scale: 1=Very Poor, 4=Average, 7=Excellent 
1. Overall rating of the subject 4.68 0.34 5.75* 0.28 5.47 0.33 5.88* 0.26 6.38* 0.16 6.0* 0.19 
2. Lectures contributed to my learning 4.67 0.33 5.54* 0.27 5.00 0.41 4.48 0.40 5.55* 0.26 4.8 0.32 
3. Electronic material contributed to my learning 4.12 0.32 5.73* 0.38 5.35 0.25 5.38 0.32 5.66* 0.25 5.9* 0.18 
4. Feedback on assignments was helpful 3.43 0.29 4.73 0.54 5.81* 0.25 5.25 0.37 5.00 0.36 6.0* 0.33 
5. I have a good understanding of the subject concepts 4.12 0.33 5.92* 0.24 5.65 0.39 5.88* 0.25 5.91* 0.20 5.8* 0.20 
6. I can apply the subject concepts 4.21 0.34 6.15* 0.25 5.71* 0.40 6.04* 0.23 5.91* 0.22 6.0* 0.18 
7. I learned a great deal in this subject 4.08 0.40 5.92* 0.26 5.47 0.42 5.73* 0.30 6.06* 0.21 6.1* 0.22 
8. Subject Pace (4 is best) 4.62 0.22 4.25 0.18 3.53 0.26 4.14 0.12 4.14 0.11 4.6 0.16 
  Rating Scale: 1=Very Poor, 4=Average, 7=Excellent 
9. Graded fairly 4.33 0.24 5.5* 0.26 4.81 0.36 5.23 0.24 4.63 0.21 4.9 0.20 
  Rating Scale: 1=Too Light, 4=Good, 7=Too Heavy 
10. Subject workload 4.36 0.27 4.75 0.25 4.35 0.20 4.65 0.15 4.50 0.13 4.9 0.17 
11. Average hours you spent on the subject per week
2
 12.93   18.10   15.85   16.56   14.83   18.9  
 
Starred (*) values are statistically higher than a baseline of 5, found by applying pooled t-tests at a 0.05 level of significance. 
The 2007 data may not be representative since Prof. Slocum was on sabbatical and Prof. Culpepper taught the course with marked success; 
however students had the option of an alternate, traditional “precision machine design” track. 
1 Student response rates (N) differed by question and, although not shown, these numbers were used to calculate standard errors (SEm). 
2 Hours per week was originally broken into categories "class," "lab" and "homework," the averages of these were summed to obtain total hours. 
3 Question wording changed slightly in 2011 and the data was provided in a new online format with one less significant digit reported. 
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7.4.3. Alumni Careers  
Anecdotal evidence suggests that students are entering the course with a specific interest in 
medical, rather than generic design, therefore a pertinent question is: Are course alumni employed by 
medical device companies? Using student rosters provided by the Registrar, the Alumni Association 
queried their records to obtain employment data for course alumni from 2004 - 2010. Currently 
graduates are employed at Adicept Technologies (the student’s startup), Johnson & Johnson, Claros 
Diagnostics, GE Healthcare, Ethicon-Endosurgery, Hologic, The DNA Medicine Institute and Nyx Devices 
(a 2010 startup from the class).  Two former graduate instructors are pursuing professorships at 
University of British Colombia and Harvard University with foci on medical devices. Another joined a 
tissue engineering research group at Massachusetts General Hospital as its first engineer and, after 
moving to new job, was replaced with a 2010 course graduate. Alumni data was limited with 
approximately a third still in school at MIT. As more course alumni graduate and enter the workplace, it 
may be possible to conduct longitudinal surveying. For comparison purposes, data was also obtained for 
2003, the year before the course focused on medical projects.  Seeing alumni employed at Smith & 
Nephew, Medtronic, MGH, Genomic Solutions and Rubicor suggests that the course may be serving an 
existing interest rather than driving it, a conclusion supported by the popularity and growth of medical 
device programs at institutions across the nation.  
7.4.4. Project Outcomes 
Project tracking remains a challenge and Table 21 presents a best effort to track the statues of all 
projects which have remained active. At least two dozen peer-reviewed papers are directly linked to 
projects originating in the course, in publications including the ASME Journal of Medical Devices, IEEE 
International Conference on Robotics and Automation, IEEE Engineering in Medicine and Biology 
Conference, the Design of Medical Devices (DMD) Conference, which often provides students with their 
first professional publication and networking experience, as well as clinical specialty-specific conferences 
and journals. From the 2009 class, 4 out of 8 projects were presented at the 2010 DMD with one 
winning a pitch prize. From the 2010 class, 7 of 8 medical projects were presented at the 2011 DMD and 
three competed in a pitch contest, winning 2 prizes. From the 2011 class, 5 of 7 projects were entered 
into the conference’s student design showcase. Further funding has been secured from diverse sources. 
Projects have been tested in both simulation labs and in-vivo studies. The renal cooling device (2010) 
was tested in collaboration with Intuitive Surgical, a course sponsor. Over 12, provisional patents have 
been filed with at least 6, converted to utility patent filings, but none have issued yet. Six startup 
companies have been launched, four of which are active, and so far one license agreement has been 
signed. 
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Table 21 – Promising Course Projects 2004 – 2011 
Project (Year), Publications & Clinician Status 
Endoscopic ultrasound needle biopsy (2004), [148] 
Bill Brugge, MD – Massachusetts General Hospital 
Master’s Thesis 
 
ACL repair gun (2004), [140, 141] 
Martha Murray, MD – Children’s Hospital 
CIMIT grant, NIH RO1 grant 
Startup company (Connective Orthopaedics) 
Robopsy – Robotic biopsy (2004), [102, 103, 112-114, 149] 
Rajiv Gupta, MD, PhD – Massachusetts General Hospital 
CIMIT grant 
1
st
 Place 2007 MIT $100K Business Plan Comp. 
NCIIA BMEIdeas Comp. 
2 Porcine trials completed 
Utility patent filing 
Startup company (ended) 
Simplified negative pressure wound therapy (2005), [150-152] 
Rob Sheridan, MD – Massachusetts General Hospital 
Robert Riviello, MD – Brigham & Women’s Hospital 
Master’s Thesis 
3 IRBs received (Massachusetts General 
Hospital, Brigham & Women’s, Rwandan 
Ministry of Health), Clinical testing in Rwanda 
Startup company (WiCare) 
Port for minimally invasive cardiac surgery (2005), [153, 154] 
Pedro Del Nido, MD – Children’s Hospital 
Nikolay V. Vasilyev's, MD – Children’s Hospital 
CIMIT Grant 
 
Endoblender , now MITE (2006), [126, 127] 
Zev Williams, MD – Brigham & Women’s Hospital 
Ongoing development project at TU Delft 
Provisional patent filing 
Pressure monitoring syringe for endotracheal tubes (2008), 
[155] 
Joan Spiegel, MD – Brigham & Women’s Hospital 
Utility patent filing 
Low volume manufacturing 
Startup company (Beaver Medical) 
Preparing for clinical trial 
Endoscopic Vertebral Fusion Balloon (2008) 
Kevin McGuire, MD – Beth Israel Deaconess Medical Center 
Provisional patent filing 
Thoracoscopic screwdriver (2009), [142-144]  
Suresh Agarwal, MD – Boston University Medical Center 
Winner pitch competition at 2010 DMD 
Utility patent filing 
Startup (Charles River Engineering) 
Licensed technology 
Low–cost portable mechanical ventilator (2009),  [156]  
Jussi Saukkonen, MD – Boston University Medical Center 
Gates Foundation grant, CIMIT Grant 
Improved nasal gastric tube tip and flushing device (2010), [157]  
Ali Tavakkolizadeh, MD – Brigham & Women’s Hospital 
Winner pitch competition at 2011 DMD 
Utility patent filing 
Renal cooling for minimally invasive surgery (2010), [158-160]  
Nadeem Dhanani, MD – Mt. Auburn Hospital 
Porcine Trial Completed 
Utility patent filing 
Somnus Shirt – Home sleep monitoring (2010), [145] 
Matt Bianchi, MD, PhD – Massachusetts General Hospital 
Winner pitch competition at 2011 DMD 
Winner CIMIT Primary Care Prize 
Utility patent filing 
Startup Company (Rest Devices) 
Flexural laparoscopic grasper (2010), [161] 
Jennifer Rosen, MD – Boston Medical Center 
Surgical simulation lab testing 
Provisional patent filing 
Minimally invasive specimen remover (2011), DMD poster 
Ian Makey, MD – Beth Israel Deaconess Medical Center 
Porcine Trial Completed 
Provisional patent filing 
Rapid skin closure for long surgical incisions (2011), DMD poster 
Kyle R. Eberlin, MD – Massachusetts General Hospital 
Provisional patent filing 
 
Fine needle aspiration gun (2011), DMD poster 
Sareh Parangi, MD – Massachusetts General Hospital 
Provisional patent filing 
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7.5. Future Work 
Notwithstanding the current record, even for those projects which have particular technological 
promise and are supported by an enthusiastic clinician, project continuity remains a challenge.  Once the 
educational goals are served, students may become “product champions” but when they are unable or 
uninterested in continuing, the projects stall.  Successful projects and excellent students have continued 
on as senior theses or graduate research projects in the Precision Engineering Research Group.  
Graduate students, with their longer educational time constants, have supported project continuation. 
The addition of the follow-on course has served to postpone the “valley of death” by a semester and, 
while initially conceived as a next-step design course, the syllabus now states: “The primary focus of the 
class is to evolve a proof-of-concept prototype into a beta prototype suitable for presentation to 
potential licensees or investors.” A crucial next step is to increase the participation of existing medical 
device companies to sponsor projects, hire more alumni and license technologies that have already 
been first-pass prototyped and de-risked. In addition, more financial support is needed for device 
design, which is often ignored by traditional academic funding sources. 
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8. Conclusions 
Ever since robots were first conceptualized in the 1920’s there has been an exploration of their 
relationship with humans. In the early days, automation was viewed as displacing workers and 
dehumanizing them, but today robots are widely accepted and used extensively in industrial settings, 
where they reduce workers’ burden and increase manufacturing precision and productivity. These 
robots often operate at high speeds and forces and, therefore, both passive protection, such as guards 
and cages, and active protection, such as safety light curtains and dead man’s switches, are necessary to 
ensure worker safety. Profoundly different are robots in healthcare that act directly upon a person and 
under a clinician’s guidance. Despite patients’ expectation that technology should enable more precise 
procedures and improve outcomes, and clinicians’ general openness to devices that can help deliver 
better care, their application is still in its infancy. However, this relatively new opportunity to explore 
the relations between robots, clinician-operators and patients is exciting! 
For the most part, the current state-of-the-art still evidences an industrial heritage in both size scale 
and cost. Orthopedic robots show promise when conducting relatively traditional milling procedures, 
integrating 3D data and shaping bones to receive implants. Probe placement robots are also being 
developed for the guidance of drills, screws and needles. For minimally invasive, soft tissue 
interventions, the multi-function da Vinci delivers superhuman dexterity inside a patient under direct 
visual guidance. For all these systems price and operating costs place them in the million dollar capital 
equipment range and proving efficacy is still challenging. In questioning the sustainability of the current 
trends and pondering the question, “What could be the most appropriate form for robots that interact 
closely with and in the human body?” the philosophy of appropriate scale medical robots emerged. 
From this a methodology has been evolved and is presented in this thesis that takes the first steps in 
enabling a wide range of inexpensive, procedure-specific robots to be developed. The fundamental 
elements of this method are herein summarized: 
 Tight clinical involvement in design process – The design process should be driven by clinical 
need, not technological capability. Select clinicians should be involved, not as clients, but rather 
as active participants in iterative prototyping and testing. Furthermore, it may be possible to 
capture expert knowledge and structure robot operation and interface so as to enable a wide 
range of clinicians to conduct the procedure in a similar manner. 
 Task partitioning & partnership with clinician –Designers must thoroughly evaluate the target 
procedure step by step. Only those steps where robotic assistance offers clear improvement 
over the clinician’s capabilities should be targeted. Providing the clinician with assistance is the 
goal, rather than maximizing automation. Closing the control loop through the clinician reduces 
complexity and risk and enables for human judgment calls. 
 Procedural integration – The device and its interface should enable close adherence to current 
procedure protocols. The goal is to reduce the number of overall steps, rather than developing 
an entirely new operating modality. The size of the robot should minimize the structural loop 
and not hinder access to the patient.  
 Structured process & iterative prototyping – The design should proceed from coarse to fine, 
initially considering a wide range of strategies and concepts and then focusing in to address the 
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core functionality. Throughout the process, partial, appropriate prototypes are essential to 
evaluating and validating design elements and preventing early lock-down of sub-optimal or 
expensive paths. 
 Feature minimization – Each feature added, particularly those later in the process, should be 
subject to strict testing to verify their necessity and whether the task might be as efficiently 
conducted by the clinician.  
 Academic-clinical partnership – Teams comprised of students and clinicians have demonstrated 
effectiveness in evaluating a wide range of electromechanical challenges and rapidly prototyping 
solutions in a cost effective manner. 
Conclusively proving the effectiveness of a design method, which still requires a component of 
inspiration, is never possible. However, as more technologies emerge from this method, it may be 
possible to create a metric that puts dollar values on certain individual tasks and that compares the cost 
of automating them to the time value of human labor. This will require greater transparency in hospital 
costs and insurance reimbursement than is currently typical, but would represent substantial and 
meaningful further research. An improved means of estimating production costs and sales prices, while 
still in the prototype stage, must also be developed. 
Given the long development trajectories of medical projects, thus far only anecdotal evidence of the 
method’s function is available from the handful of projects that are currently active. Nevertheless, this 
design method is showing promise as a means to rapidly generate novel, new technologies that are 
potentially cost effective and thus able to be more widely implemented than current medical robots. A 
handful of promising projects have been prototyped and an important further goal is to develop a 
means, both in terms of funding and design technique, to continue the rapid progression through 
licenses or spin-offs and FDA filings to viable products. Part of this will require the participation of 
existing players in the medical device space who will benefit from access to a wide range of lean 
technologies which, while unpolished, have been prototyped and evaluated. Additionally, by adopting 
similar design methods, internal development cycles can be shortened. Potentially, the method offers a 
new disruptive model for implementing technology in medicine.  
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